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ABSTRACT
The effects of some antioxidants on hepatic microsomal enzymes 
and certain other parameters were studied in rats from 21 to 455 days 
post natum and in neonatal rats from dams given dietary antioxidant 
from 3 weeks before commencement of pregnancy till weaning of the 
neonates. The antioxidants used were vitamin E, butylated hydroxyl- 
anisole, ethoxyquin, nordihydroguaiaretic acid and n-Propyl gallate.
The parameters studied included organ weights, microsomal protein, 
cytochromes P-450 and b^, biphenyl 4-hydroxylase and ethylmorphine 
N-demethylase, and in certain cases glucose-6-phosphatase.
In developing rats, the antioxidants differed in their effect on 
liver weight gain and induction of drug-metabolizing enzymes, and 
enzyme activities rose to peak levels at different rates. Both ethoxy­
quin and nordihydroguaiaretic acid caused dramatic increases in the 
levels of these' enzymes, with ethoxyquin producing the greater effect. 
Short-term studies revealed that after the post-weaning peaks were 
reached, the activities of the drug-metabolizing enzymes quickly 
diminished, but the levels in rats treated with ethoxyquin or nor- 
hydroguaiaretic acid were significantly higher than in controls.
Dietary ethoxyquin increased liver weight and drug-metabolizing enzyme 
activity whether it was given from the 21st, 40th or 365th day of age. 
The enzyme activities always fell after reaching the peak levels, but 
remained at elevated levels compared with controls. Similar results 
were also obtained in long-term studies when the ethoxyquin was 
administered in the diet.
The hepatomegaly and enzyme induction caused by dietary ethoxyquin 
were found to be due to hypertrophy and hyperplasia of the hepatic cells
with proliferation of smooth endoplasmic reticulum. These also caused 
a dilution of hepatic microsomal glucose-6-phosphatase activity. All 
these changes were reversible in 30 days after withdrawal of ethoxyquin.
Ethoxyquin was demonstrated to be a potent competitive inhibitor 
of the activities of biphenyl 4-hydroxylase and ethylmorphine 
N-demethylase and it bound to type I site of cytochrome P-450 with a 
high affinity. Single oral doses of ethoxyquin prolonged hexobarbitone 
sleeping-time in adult rats,while repeated dosing in the diet reduced 
this sleeping-time. In neonatal rats receiving ethoxyquin through 
placental transfer before birth and through rat-milk after delivery, 
the antioxidant inhibited drug-metabolizing enzymes and induced them 
after post-natal exposure for about 12 days. This showed a biphasic 
response of these enzymes to ethoxyquin.
Single oral doses or chronic feeding of ethoxyquin in the diet 
afforded protection against carbon tetrachloride hepatotoxicity. The 
antioxidant gave little protection when carbon tetrachloride was 
administered 2 or 3 days after treatment with ethoxyquin and the 
results indicated that the presence of ethoxyquin in the tissue was 
needed for protection.
In long-tern, studies, ethoxyquin showed some nephrotoxicity, and 
litters from dams fed dietary ethoxyquin had significantly lower body 
weights than those from untreated mothers and postnatal development of 
body hair was delayed.
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Chapter 1
GENERAL INTRODUCTION
1. Food additives and antioxidation
Advancement in food science and technology has made a great 
contribution to the food preservation industry by providing newer 
techniques for the elimination of wastage, preparation of quality 
foods and their storage and safe transportation, and, over and above, 
for the improvement in the standards of nutrition. This'has raised 
the hope of teeming millions struggling for their very existence 
against starvation and malnutrition in many over-populated areas of 
the world where foods are in short supply. In the developed countries, 
food preservation leading to the production of readily available 
attractive and palatable foods having high quality and increased shelf- 
life has made life easy and pleasant to millions of housewives and 
indeed has made food relatively cheap. In attaining these objectives 
food technologists have made extensive use of a large number of chemical 
preservatives which protect against microbial or oxidative spoilage.
In the latter category, antioxidants, used in the United Kingdom for the 
retardation or prevention of the development of rancidity in fats and 
fatty foods, include vitamin E, alkyl gallates, butylated hydroxyanisole 
(BHA), butylated hydroxytoluene (BOT), and ethoxyquin (Antioxidants in 
Food Regulation, 1966). The last named of these has restricted 
application to controlling scald in apples and pears.
2. Toxicity of antioxidants
There is no sharp line of demarcation between a toxic and a non-toxic 
level for all substances, as any material can be toxic if ingested in 
sufficient quantity. Retinol or vitamin A, and calciferol, or vitamin D, 
are both essentially naturally-occurring nutrients; yet an overdose of
either can be a serious matter. This has led to the formulation of 
certain rules to which all food additives should conform before being 
accepted as safe (Lehman et al, 1951; Dacre, 1960). In the case of 
antioxidants,it is considered that the food additive will be safe if 
it fulfils two conditions:- (i) the LD^ must not be less than 1000 mg/kg 
animal body weight, and (ii) it must not have any significant effect on 
growth when fed to experimental animals for long periods, up to 2 years 
at a level of 100 times the level proposed in fats for human consumption.
Two other requirements are also important from the safety point of view.
They are:- (a) longer term toxicity tests with small intakes, usually 
with histopathological examination of the animals, and (b) study of the 
metabolites of the additive and their biochemical effects (Johnson, 1971). 
Guidance on the protocol to be used in toxicity testing of food additives 
has been published by the Ministry of Agriculture, Fisheries and Food,
U.K. (1965). The importance of continuing vigilance in evaluating the 
hazard from food additives is emphasized by the fact that butter yellow 
was used for many years before it was demonstrated to be a carcinogen 
(Weber and Cantero, 1955). More recently, ponceau MX and cyclamates have 
been withdrawn on suspicion of carcinogenic activity, at least in 
experimental animals.
Vitamin E: Unlike other fat soluble vitamins, no report has so far
appeared on the toxicity of vitamin E even at levels as high as 800 mg/kg/day 
for 5 months (Recommended Dietary Allowances, 1968). Life-span studies in 
mice at dietary level of -0.51 revealed no toxicity, rather prolbngevity was 
claimed at this dose level (Harman, 1968a).
Toxicity of phenolic antioxidants: The acute toxicity of some phenolic
antioxidants has been reviewed by Lehman et al (1951), Karplyuk (1959),
Dacre (1960) and Johnson (1971). It appears from these reports that the
acute toxicity is generally low, LD^ values for BHA, BHT, gallate 
esters and NDGA all being in the range 1.25g to 6.5 g/kg in a number 
of species including rat, mouse and rabbit.
Butylated hydroxyanisole: Wilder and Kraybill (1948) reported that
BHA was without adverse effect on growth rate and reproduction in rats 
and that there were no pathological symptoms after 22 months 
administration of a diet containing 0.06V BHA. Effects on body weight 
at higher dose levels (31) were attributed to non-acceptability of the 
diet. Similarly, Graham et al (1954) and Graham and Grice (1955) 
reported that BHA at a dietary level of 100 times the normal human 
intake was without adverse effect on the rat and Clegg (1965) found no
evidence of embryotoxicity at this level in rats.
Extending these results to dogs, Hodge et al (1964) found no 
adverse effects at dietary levels up to 100 mg/kg. There was no tissue
accumulation of BHA in the dog (Hodge et al, 1964) nor in the rat (Wilder
and Kraybill, 1948).
At higher dose levels (1 g/kg), approaching the LD^q , Denz and 
Llaurado-( 1957) found effects on adrenals and on kidney function in the 
rabbit.
Gaunt et al (1965) and Feuer et al (1965) observed that dietary 
administration of 0.5V BHA to rats caused a transient liver enlargement 
with increased ascorbic acid excretion, but was without effect on 
glucose-6-phosphate dehydrogenase,while Creaven et al (1966) found an 
increase in biphenyl 4-hydroxylase and 4-methoxybiphenyl demethylase 
activity at this dose level without liver enlargement.
Further biochemical studies (Spom and Dinu, 1967) showed that BHA 
at a level of 0.11 of the diet depressed oxygen uptake by liver in the
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presence of succinate in vitro, and at a level of IV mitochondrial 
oxidative phosphorylation was also depressed.
It has been concluded from the various evidence quoted above that 
BHA does not represent any hazard to man at the permitted levels of 
use.
Butylated hydroxytoluene: In early studies on BHT at dietary levels
100 times greater than occurring in human diets, Brown et al (1959) 
reported baldness developing in mature rats and anophthalmia in the 
offspring of one group. Subsequent work by Clegg (1965) and Johnson 
(1965) failed to confirm these results and it has been suggested that 
the effects were attributable to vitamin A deficiency. In multi- 
generation studies (Frawley et al, 1965) it was found that BHT was 
similarly without effect on rats at dietary levels up to 1000 mg/kg 
although at a higher level of 3000 mg/kg growth rate was retarded and 
serum cholesterol levels were elevated. BHT at dietary levels of 0.125% 
had previously been shown to have no effect on fertility and egg viability 
in the chicken (Schellenberger et al, 1957) although it has been shown 
(van Stratum and Vos, 1965; Frawley et al, 1965) that residues of BHT 
occur in the eggs of treated hens.
The hypercholesteraemic effect of BHT in the rat mentioned above 
have been reported in other studies at dose levels of 0.1-0.51 BHT 
(Day et al, 1959; Gaunt et al, 1965), female animals being apparently 
more sensitive than males. Increased serum mucoprotein and phospholipid 
were also observed in these studies, but the effects were not detectable 
at lower dose levels.
The effect of BHT in reducing body weight gain may not be wholly 
attributable to unacceptability of the diet since Johnson and Holdsworth (1968)
reported that dietary dose levels of 0.5% increased the basal metabolic 
rate.
Similar nephrotoxicity to that observed after BHA. was reported in 
the rabbit at dose levels approaching the LD^q (Denz and Llaurado, 1957), 
but in general all the effects observed above occurred at dose levels 
of 0.25% to 0.5% of the diet. BHT has even been reported to cause 
pro longevity in mice (Harman, 1968a, b).
Most controversy about the toxicity of BHT centres around the effects 
on the liver. Gilbert and Golberg (1965) observed that daily doses of BHT 
(500 mg/kg/day) increased relative liver weight in both rats and mice, and 
Gaunt et al (1965) found a similar increase in rats fed 0.5% BHT in the 
diet. The increased liver weight was accompanied by very slight fatty 
changes, increased urinary ascorbic acid, proliferation of hepatic 
endoplasmic reticulum, induction of a number of microsomal drug-metabolizing 
enzymes, increased glucose-6-phosphate dehydrogenase activity and decreased 
glucose-6-phosphatase activity (Gilbert and Golberg, 1965; Gaunt et al, 1965 
Feuer et al, 1965; Creaven et al, 1966;Gray et al, 1972), but all these 
changes were reversible when BHT was withdrawn (Gaunt et al, 1965).
Gallate esters: In long-term (14 months to 2 years) feeding studies on
gallate esters, Orten et al (1948) found no adverse effect in guinea-pigs, 
rats and dogs at levels of up to 6% octyl or dodecyl gallate or up to 
0.117% propyl gallate, and Graham et al (1954, 1955) similarly found 
propyl gallate to be without effect on rats at levels far in ex cess of 
human exposure. In life-span studies in rats and pigs Van Esch (1955) 
found the gallate esters to be without effect on survival rates although 
there was some reduction in weight gain at dietary levels of 0.5% octyl 
and dodecyl gallates.
Feuer et al (1965) observed slight fatty changes in the liver of 
rats given propyl gallate at doses of 500 mg/kg/day (i.g.) for one week 
but the changes were reversible when the antioxidant was withdrawn.
hepatic microsomal drug-metabolizing enzymes when given at a dietary 
level of 0.5% for 9 days (Creaven et al, 1966).
• •
The gallate esters thus appear to be extremely innocuous when 
ingested at normal human dietary levels.
Nordihydroguaiaretic acid (NDGA.): Cranston et al (1947) reported that at
dose levels of 0.1% and 0.25% the antioxidant had little or no effect on 
growth. At 0.5% dose level NDGA had a slight effect and these effects were 
marked in rats fed the antioxidant at the level of 1.0%. Further studies 
on the toxicity of NDGA were carried out by Grice et al (1968). They
reported that when fed at levels of 0.5% and 1% of the total diet for 74 
weeks the NDGA caused serious changes indicating severe toxicity occurring 
at both levels. NDGA is converted to quinone in the intestine. At the 
levels used by Grice et al (1968) either the quinone or the acid, or 
possibly both, had a strong toxic effect on the rat, as shown by the
behaviour of the reticulo-endothelial cells. These became hyperactive and 
started phagocytizing' material foreign to themselves. Normal lymphoid
structures were displaced, thereby altering the morphology and functioning 
of the nodes. The macrophages became fixed in the sinuses, producing small 
cysts. With time, these tended to coalesce into large cysts. In the kidney 
the glomeruli appeared normal. Kidney weights in NDGA-treated animals were
significantly heavier relative to body weight than their control counterparts. 
Tubular cells were distended and appeared to block the tubular lumen.
Atrophic tubular changes were not prominent histologically; the picture was
Octyl gallate was found to be without effect on liver weight and
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one of altered function, not of non-function. As a result of these 
deleterious effects of NDGA, the U.S. Food and Drug Administration 
removed this antioxidant from their GRAS (generally recognised as safe) 
list (U.S. Federal Register, 1968). Further work increasing the level of 
NDGA up to 3% of the diet of rats has demonstrated the production of 
cortical and medullary cysts in the kidney (Goodman et al, 1970).
In view of these results, NDGA has been removed from the list of permitted 
food additives in many countries including the U.K. after almost 30 years 
of its use in foods.
Toxicity of heterocyclic anti oxidant, ethoxyquin: Ethoxyquin has been
reported by Wilson and DeEds (1959) to cause death of 5 out of 7 rats 
when given orally at 1000 mg/kg, and 1 out of 5 at 640 mg/kg; the LD^q 
for mice dosed intravenously was 178 mg/kg. Diets containing 0.2% or more 
of ethoxyquin decreased the rate of growth of young rats for the first 
2 to 4 weeks. In male rats, liver weights were increased on diets 
containing 0.1% or more, and kidneys were increased in weight and damaged 
from 0.025%; thyroids were also affected. Changes tended to be milder in 
females. Repeated application of ethoxyquin to the skin of rats and guinea 
pigs caused local lesions, but there was no sensitization on injection. 
Wilson et al (1959) working on the absorption, metabolism and excretion of 
ethoxyquin in rats, observed that this antioxidant was rapidly absorbed 
and excreted and that after a heavy dose unchanged ethoxyquin was found 
in small amounts in the urine.
M ' The toxic effects of large doses of ethoxyquin to establish LDj-q 
have also been reviewed by Chaffard and Thiolliere (1970). They reported 
that the LD^q dose for rats was 800 to 1000 mg/kg (orally), for mice 
800 to 1000 mg/kg (intraperitoneally), and for chickens 6000 to 10,000 mg/kg 
(orally). Chaffard and Thiolliere also reported that numerous experiments
on guinea pig and rabbit showed that ethoxyquin caused only slight 
contact irritation. The inhalation of vapour of ethoxyquin showed no 
toxicity at all. Long-term studies (2 years) carried out on rats, 
dogs and pigs showed that ethoxyquin was not dangerous. Reproduction 
studies on rats also did not show any adverse effect, however these 
authors did not report the dose levels used.
3. Detoxication of antioxidants - a defence mechanism
The naturally occurring antioxidants ascorbic acid and the 
tocopherols have a nutritional role in many mammalian species and are 
not usually considered as foreign compounds. Synthetic antioxidants 
(BHA., BHT, gallate esters, ethoxyquin, etc.) used as food additives 
are not essential nutrients and if accumulated in the body might 
ultimately reach toxic levels; they are thus properly classed as 
foreign compounds. Since these antioxidants are fat soluble the process 
of elimination necessitates prior bio transformation by mechanism common 
to many such foreign compounds and which facilitate excretion by increasing 
the polarity of the foreign compound.
4v (A) Hepatic endoplasmic reticulum
(i) Reactions
The metabolism of foreign compounds generally involves two phases 
of reactions (Williams, 1967). The first phase includes such reactions 
as oxidations, reductions and hydrolyses, while the second phase involves 
conjugations. In the first phase reactions there occurs introduction 
or unmasking of functional groups rendering a non-polar compound polar, 
or a polar compound to be more polar in order that it is more readily 
excreted than the original compound. These functional groups often 
act as centres, in the second phase reactions, for conjugations with
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endogenous molecules for excretion of the products, usually as water 
soluble acids. Most foreign compounds are metabolized by both phases 
of reactions. The antioxidant BHT falls within this category (Dacre,
1961; Wright et al, 1965, 1967; Ladomery et al, 1967). However, 
there are some compounds, particularly those which already possess one 
or more functional groups, that often undergo only phase II reactions.
Thus, BHA. is partly excreted in the urine, mostly as glucuronides and 
ether sulphates (Dacre et al, 1956; Dacre, 1960; Golder et al, 1962;
Astill et al, 1962; Danniel et al, 1967).
(ii) Site
The principal site of detoxication of foreign compounds described 
above lies in the liver and the enzymes involved are generally located 
in the endoplasmic reticulum which, on disruption of the cell is isolated 
as microsomes. The hepatic smooth endoplasmic reticulum contains the 
highest enzyme activities (Gram and Fouts, 1968; Holtzman et al, 1968;
Gram et al, 1967), but there are other sites which include the kidney, 
lungs and gastrointestinal tract, and the placenta of the pregnant mother 
(Hutson, 1970).
Phase I reactions can activate as well as deactivate a foreign 
compound, and thus influence its toxicity. The new functional group may 
also subsequently undergo phase II reactions (conjugation) resulting in 
deactivation and decrease in toxicity. A typical example of these processes 
is given below:-
Phenobarbitone Phase I p-Hyaroxyphenobarbitone Phase II •
(active) deactivation .. (inactive)
p-Hydroxyphenobarbitone glucuronide 
(inactive excretory product)
10
Prontosil Phase 3^  Sulphanilamide Phase II N!-Acetyl sulphanilamide 
(inactive) (active) (inactive excretory product)
(iii) Cytochrome P-450
Microsomal oxidation has been identified to be carried out by an 
NADPH-dependent pigment which in its reduced state forms a complex with 
carbon monoxide and gives a soret band in the region of 450 nm, and has , 
therefore, been called cytochrome P-450 by Qmura and Sato (1964) .
Emster and Orrenius (1965) reported that the induction of the oxidative 
metabolism of aminopyrine by phenobarbitone treatment was closely followed 
by increases in the activity of NADPH-cytochrome c reductase, and the 
content of cytochrome P-450 in the microsomes. This fact, and the inhibition 
of drug-metabolizing enzyme activity in vitro by carbon monoxide (Orrenius 
et al, 1964) indicated that cytochrome c reductase and cytochrome P-450 
were involved in drug oxidation. Thus the following sequence was postulated: 
NADPH reduces cytochrome c reductase, which in turn leads to the reduction 
of cytochrome P-450 either directly or through a carrier. Reduced 
cytochrome P-450 and oxygen react to form 'active oxygen' complex which 
then oxidises the substrate.
Cytochrome P-450 has been observed to bind with substrates for 
microsomal hydroxylation. Spectroscopic studies have led to the discovery 
of two types of spectral changes: type I spectra, exemplified by hexobarbitone 
binding and giving a difference spectrum with a peak in the range of 385-390 nm 
and a trough in the range of 418-427 nm (Remmer et al, 1966; Schenkman et al, 
1967a),and type II spectra, produced by the addition of aniline, or several 
other bases'and giving a peak in the range of 425-435 nm and a trough at 
390-405 nm (Imai and Sato, 1967). Using cyclohexane, Ullrich (1969) observed 
that the rate of hydroxylation was proportional to the concentration of 
cytochrome P-450-substrate complex. NADPH oxidation and P-450 reduction
proceed. at a measurable rate in rat liver microsomes in the absence 
of exogenous electron acceptors. The rate of NADPH oxidation increased 
by the addition to the system of substrates giving rise to type I binding 
spectra, and decelerated by the addition of type II substrates (Gigon 
et al, 1969) . Kinetic data shows that type I substrate-P-450 complexes 
are more readily reduced than P-450 itself, and a modified scheme has been 
proposed for microsomal hydroxylation: oxidised P-450 reacts with the 
substrate to form a complex which is then reduced, type I complexes being 
reduced, more readily than P-450, and type II complexes more slowly than 
P-450; the reduced P-450-substrate then reacts rapidly with oxygen to 
form an oxygen-P-450-substrate complex which rapidly decomposes to 
oxidised P-450 and oxidised (hydroxylated) substrate. This indicates 
that the rate-limiting step in drug mono-oxygenation is the rate of 
reduction of the oxidised cytochrome P-450-substrate complex. However, 
Hildebrandt and Estabrook (1971) have suggested the possibility of 
another rate-limiting step, electron transfer to the reduced cytochrome 
P-450-substrate oxygen complex. Two electrons are required for the coupled 
reduction of oxygen and oxidation of substrate (Estabrook et al, 1969).
The NADPH-cytochrome c reductase dependent cytochrome P-450 is a one-electron 
carrier (Ullrich et al, 1969; Waterman and Mason, 1970) while due to 
synergistic effect of NADH on NADPH-catalysed drug oxidation (Cohen and 
Estabrook, 1971) the NADPH-cytochrome c reductase and NADH-cytochrome b^ 
reductase dependent cytochrome b^ is the carrier of the second electron.
A scheme for cytochrome P-450 drug oxidation based on earlier findings 
and incorporating cytochrome b^ has been proposed by Hildebrandt and 
Estabrook (1971) and is shown in Figure 1-1.
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'Figure 1-1. Scheme for cytochrome P-450 drug oxidation
(Hildebrandt and Estabrook, 1971)
(iv) Forms of cytochrome P-450
Several reports have since appeared on the existence of more than 
one form of cytochrome P-450 (Conney et al, 1969; Mannering et al, 1969; 
Hildebrandt and Estabrook, 1969; Kuntzman et al, 1969; Remmer et al, 1969). 
Sladek and Mannering (1966) induced a new haemoprotein by treating 
animals with 3-methylcholanthrene and reported that it contributed largely 
to the N-demethylation of 3-methyl-4-monomethylamino-azobenzene but only 
poorly to the N-demethylation of ehtylmorphine. Hildebrandt et al (1968) 
noted the presence of this haemoprotein in the liver of rabbits pretreated 
with 3-methylcholanthrene, found it to be different from the cytochrome 
P-450 of both normal and phenobarbitone-treated rats and called it 
cytochrome P-446. It has recently been suggested that cytochromes P-450 
and P-448 (or P-446) are physical modifications of the same enzyme system 
(Imai and Siekevitz, 1971), but solubilization of cytochrome P-450 
and chromatography on ion-exchange resin have revealed 3 different entities 
which may be specifically induced by phenobarbitone, methylcholanthrene 
and alcohol respectively (Comai and Gaylor, 1973).
Type I compounds may be substrates for the hepatic microsomal mono­
oxygenase (also called mixed function oxidases or drug-metabolizing 
enzymes) . The intensity of type I spectrum may be considered to parallel 
enzyme activity. The type II spectrum is caused by a direct amine- 
ferroprotoporphyrin interaction via the sixth ligand of iron (Temple, 1971) 
Administration of phenobarbitone to animals cause marked increases in both 
type I and type II binding, whilst 3-methylcholanthrene increases only 
the type II binding (Shoeman et al, 1969; Kato and Takanaka, 1969;
Jefcoate and Gaylor, 1969).
Certain type I compounds (e.g. hexobarbitone), when added to both the , 
reference and sample cuvettes, increase the magnitude of spectral changes
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of type II compounds, e.g. aniline (Schenkman, 1970* Orrenius et,al, 1970).
Some compounds (e.g. desmethylimipramine) at low concentration give type I 
spectra but at higher concentration give type II spectra (von Bahr'and Orrenius, 
1971). Again some organic solvents, such as alcohols, having short carbon 
chain, give a peak in the difference spectrum at 420 nm and trough at 390 nm 
and have been accommodated under a different class of compound occasionally 
called the "modified type II" or "reverse type I". Schenkman et al (1972) 
have attributed these changes as due to the interaction of lipid soluble 
compounds with the substrate-bound form of cytochrome P-450 at a site other 
than the type I site, and distinct from the type II (haem iron) site.
(v) Binding site
Binding sites responsible for spectral changes and for metabolism 
are not necessarily identical, and any given compound may bind to several 
sites (Kupfer and Orrenius, 1970). Pure phospholipase c, which specifically 
hydrolyses phosphatidyl choline and phosphatidyl ethanolamine, destroys 
the type I binding site, but microsomes lose only 401 of their ability to 
oxidise type I substrates, ethylmorphine and hexobarbitone (Chaplin and 
Mannering, 1970). This suggests that type I binding and catalytic sites may 
not be identical. The metabolism of ethylmorphine is stimulated by two sites, 
one of which has a binding constant low enough (about 0.02 mol/1) to be 
relevant to drug-metabolism (Holtzman and Rumack, 1971a, b).
Q3) Regulation of-the., enzymes of the endoplasmic reticulum
Foreign compounds are usually metabolized by several different pathways 
of biotransformation and conjugation, as described above, giving rise to 
many different metabolites. The rate at which each reaction proceeds depends 
upon the mode of regulation of the enzyme involved-and there are several 
factors which affect this regulation. These factors may be genetic,
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physiological or environmental in origin. A brief resum£ of each of 
these factors is given below,
a) Genetic factors
These include species differences and strain differences in the 
same species (Parke, 1968).
Species differences: The metabolism of the antioxidant BHT in the
rabbit, rat and man is a classical example of regulation of enzymes 
involved in these species. In the rabbit the BHT is metabolised to 
glucuronides and hippurates formed by conjugation of two carboxyl 
groups produced by Phase I oxidation of ring C-methyl group and one 
methyl group of one of the tert-butyl groups (Dacre, 1960, 1961; Aoki,
1962; Akagi and Aoki, 1962). In the rat, the BHT straight away produces 
a Phase II conjugate with N-acetyl cysteine to form a mercapturic acid.
In man, a new ester glucuronide is, however, formed after BHT undergoes 
oxidation to produce two carboxyl groups, one in the ring C-methyl group 
and the other in one of the tert.-butyl methyl groups, and the derived 
aglycone undergoes further oxidation (probably to aldehyde) in the 
methyl group of the other tert-butyl group (Daniel et al, 1968).
Strain differences: Differences in response to foreign compounds in the
same species but due to strain differences are often caused by genetically 
determined enzyme defects. Lack of bilirubin glucuronide formation by 
Gunn strain of Wistar rats and slow acetylation of drugs, such as the 
anti-tubercular drug isonicotinic hydrazide by some subjects (Parke, 1968) 
and haemolytic anaemia due to erythrocyte glucose-6-phosphate dehydrogenase 
deficiency in broad bean eaters and certain other human subjects (Mager 
et al, 1965) are typical examples of enzyme defects and genetic disorders 
which are of importance from regulation point of view.
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b) Physiological factors
These include age differences, sex differences, hormones, pregnancy, 
nutrition and diet, disease, etc. (Parke, 1968).
Age differences: The foetus and neonate are deficient in hepatic 
microsomal enzymes and the activities of these enzymes are increased 
to adult levels within 4-6 weeks after birth (Jondorf et al, 1958;
Fouts and Adamson, 1959; Dutton, 1963; Kato et al, 1964;
Basu et al, 1971). In aged animals again the levels of these enzymes 
decline (Kato and Takanaka, 1968a, b; OfMalley et al, 1971) and this 
information is of great therapeutic importance.
Sex differences: Adult male rats cause aliphatic hydroxylation of
hexobarbitone, pentobarbitone, and the N-demethylation of aminopyrine and 
morphine at a higher rate than female rats. Aromatic hydroxylation of 
aniline and zoxazolamine in rats, however, show no such dependence on 
sex hormones (Kato and Gillette, 1965). Mice, guinea pigs, rabbits and 
dogs do not show sex difference in the metabolism of hexobarbitone nor 
does the administration of testosterone or oestradiol measurably change 
the metabolism of barbiturates in mice and rabbits (Quinn et al, 1958).
Female mice, however, metabolize phenobarbitone and hexobarbitone at a 
rate faster than that by male rats (Westfall et al, 1964; Novick et al, 1966). 
These conflicting reports on sex dependence have been attributed to be 
due to substrate affinity for binding (Schenkman et al, 1967 a).
Hormones: The hormones of adrenal glands, thyroid and pancreas are also, 
reported to have some effects on the metabolism of foreign compounds.
Thus, administration of ACTH, adrenaline or thyroxine to male rats 
impairs the metabolism of hexobarbitone and aminopyrine. Alloxan-induced 
diabetes in male rats also reduces the metabolism of hexobarbitone and 
aminopyrine in vitro, and these effects are reversed by insulin (Dixon 
et al, 1963).
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Pregnancy: During late pregnancy the glucuronide conjugation of foreign
conpounds in rats and rabbits (Creaven and Parke, 1965) and sulphate 
conjugation in guinea pigs and rats (Pulkkinen, 1963) are markedly 
reduced due probably to the presence in the tissues of progesterone and 
pregnanediol which are known inhibitors of glucuronyl transferase 
activity in vitro (Hsia et al, 1963). Many hepatic microsomal enzymes 
are similarly affected by certain oral contraceptive steroids (Juchau 
et al, 1966).
Nutrition and diet: Dietary protein deficiency decreases the activity of
microsomal drug-metabolizing enzymes (Dingell et al, 1966) and in 
consequence the toxicity of carbon tetrachloride (Seawright and McLean,
1967), but increases the toxicity of acetyl salicylic acid, particularly 
in pregnant rats when it can result in foetal death and resorption (West, 
1964). In mice, starvation results in a decrease in the rate of metabolism 
of hexobarbitone and certain other drugs, but does not impair the microsomal 
reduction of p-nitrobenzoate. Starvation of male rats decreased the 
metabolism of hexobarbitone and aminopyrine, while starvation of female 
rats increases all the hepatic drug-metabolizing enzymes (Kato and 
Gillette, 1965).
Disease: Patients with obstructive jaundice, hepatitis, cirrhosis and
other liver diseases exhibit impaired formation of glucuronide and 
sulphate conjugates (Muting, 1963). Rats with liver damage given 
2-acetamidofluorene excrete a greater portion of the dose as the 
carcinogenic N-2-hydroxy metabolite than do normal rats (Margreth et al,
1964). Rats with abdominal carcinosarcomas also showed impaired microsomal 
metabolism of foreign compounds (Kato et al, 1963).
c) Environmental factors
These include stress, ionizing radiation, and other foreign compounds 
(Inhibition and Induction).
Stress: Adverse environmental conditions result in an increase of the
NADPH-dependent microsomal oxidations (Parke, 1968) probably due to 
effects on the pituitary adrenal axis and hormone secretion.
Ionizing radiation: Ionizing radiation produces a typical stress response 
which depresses the formation of NADH and NADPH, and in consequence impairs 
hepatic microsomal oxidation (Berliner et al, 1963; Stevens and Berliner, 
1963; Hartiala et al, 1961).
I. Inhibition
A number of foreign compounds is known to be the inhibitors of 
microsomal metabolic reactions (Mannering, 1968). These include SKF 525A, 
metyropone etc..
SKF 525A - This compound inhibits in vitro microsomal oxidation of 
many drugs such as barbiturates, codeine and aminopyrine, at 
concentrations of 10 ^M (Axelrod, 1956; Gaudette and Brodie, 1959;
Kato et al, 1962) and this inhibition has been found to be competitive 
in the case of N-demethylation of ethylmorphine (Anders and Mannering, 
1966) and non-competitive in the case of aniline and O-aminophenol 
(Ikeda et al, 1968). SKF 525A does not inhibit glucose-6-phosphate 
dehydrogenase or NADPH cytochrome c reductase (Cooper et al, 1954).
The compound has surfactant properties (Lee et al, 1968) and the 
ability to interact with L-alpha-lecithin and cholesterol monolayers 
at a concentration of 10  ^mol/1 (Florence, 1970). SKF 525A is a 
type I compound and it would, therefore, appear that most inhibition 
by it is probably due to its acting as an alternate substrate 
(Schenkman et al, 1967a). But the apparent failure of the'K and K^  
values to agree with predictions (Anders, 1971) and the surfactant
properties indicate that the mechanism involved is quite complex.
Metyropone - This compound binds to the oxidised cytochrome P-450 
(Kahl et al, 1969) and in contrast to other type II nitrogeneous 
bases can also bind to reduced cytochrome P-450 (Hildebrandt et al, 
1969; Peterson et al, 1971). It has been postulated (Hildebrandt, 
1971; Netter et al, 1969) that metyropone inhibits by competing with 
the oxygen binding site of cytochrome P-450.
II. Induction
The phenomenon of the stimulation of drug-metabolism by exposure 
.of animals to polycyclic hydrocarbons was first reported by Brown, Miller 
and Miller (1954). Conney and Bums (1959), studying the metabolism of 
carcinogens, and Remmer (1959) studying drug tolerance, discovered that 
phenobarbitone and a number of other common drugs also acted as inducers. 
A large number and variety of foreign organic compounds have been listed 
to be stimulators of hepatic drug-metabolizing enzymes (Mannering, 1968). 
The ability of these compounds to act as inducers has occasionally been 
attributed to their bio-activity and lipid solubility at physiological 
pH, but these classifications have not led to the evolution of a common 
phenomenon in that aspirin (Kato, 1964), thalidomide (Kato, 1959) and 
pyrethrum insecticides (Fouts, 1964) are not inducers of drug-metabolism 
but are still biologically active, and water soluble barbiturates are 
notable inducers.
Site of action of stimulators - The following tests have been made to 
.locate the site of action of stimulators (Parke, 1968).
(i) Stimulation of microsomal enzymes is produced only when foreign 
compounds are administered to living animals, and addition* to 
microsomal preparations in vitro produces no effect.
(ii) Combination of hepatic microsomal enzymes from phenobarbitone 
pretreated rats with the soluble fraction from non-treated rats 
shows that the enhanced activity is in the microsomes and is 
not due to any alteration in the NADPH-generating system.
(iii) Activation occurs even after hypophysectomy, adrenalectomy 
(Minegishi et al, 1968) or thyroidectomy (Kato and Takahashi,
1968) so that stimulation of the hypophyseal-adrenocortical 
system or thyroid is not involved.
(iv) The hepatic microsomal enzyme, benzpyrene hydroxylase, is 
activated by perfusion of isolated rat liver with 3,4-benzpyrene 
(Juchau et al, 1965), showing that induction is independent of 
extrahepatic factors.
Mechanism of stimulation - Foreign compounds produce their stimulatory 
effect by increasing the amounts of the microsomal enzymes. Evidence 
for this induction of the synthesis of microsomal enzymes is as follows :-
(i) The liver increases in weight and in protein content (Golberg, 
1966).
(ii) Pretreatment with phenobarbitone results in proliferation of the 
endoplasmic reticulum, mostly of smooth type (Emster and 
Orrenius, 1965;..Remmer and Merker, 1965; Fouts and Rogers, 1965) 
and to an increase in the content of RNA and phospholipid 
(Remmer and Merker, 1963). Phenobarbitone also increases the 
concentrations of microsomal cytochrome P-450 and NADPH-cytochrome 
c reductase and the activity of aminopyrine demethylase (Orrenius,
1965). The concentration of cytochrome b^ is not appreciably 
altered. NADH-cytochrome c reductase and microsomal protein 
show small increases (Orrenius et al, 1965). Microsomal 
UDPG-dehydrogenase (Conney et al, 1961) and UDPGA-glucuronyl
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transferase (Roberts and Plaa, 1966) are also induced after 
a lag period of about 3 days (Orrenius, 1968).
(iii) Pretreatment with polycyclic hydrocarbon, 3-methylcholanthrene 
(3MC), does not increase the specific concentration of microsomal 
protein (Conney and Gilman, 1963) and does not cause an 
appreciable proliferation of the smooth endoplasmic reticulum 
(Fouts and Rogers, 1965), but does increase the microsomal 
content of messenger RNA and the rate of microsomal incorporation 
of amino acids from aminoacyl s-RNA (Gelboin, 1964; Gelboin and 
Sokoloff, 1964).
(iv) Activation by foreign compounds is inhibited by ethionine - an 
inhibitor of protein biosynthesis, by antibiotic puromycin - 
which blocks the transfer of amino acids from aminoacyl s-RNA 
to microsomal protein (Conney and Gilman, 1963; Orrenius and 
Emster, 1964; Gelboin and Blackburn, 1964) and by actinomycin 
D - an inhibitor of messenger-RNA synthesis (Gelboin, 1964; 
Orrenius and Emster, 1964; Orrenius et al, 1965).
In stimulation with ^C-phenobarbitone the drug first becomes bound 
to the microsomes. This is followed by an increase of phospholipid and 
formation of new endoplasmic reticular membrane. Enzyme synthesis then 
occurs. These changes are reversible when exposure to inducing agent 
ceases. However, this recovery is prevented if antinomycin D is 
administered at the termination of pretreatment with foreign compounds 
'-(Emster and Orrenius, 1965).
The inhibitor SKF 525A is also an inducer (Anders and Mannering, 1966) 
and increasing numbers of inducers are being found to initially act as 
inhibitors of enzyme activity (Conney, 1967). This biphasic effect and the
22
other factors have led to the speculation about the possible sites of action 
of inducers, summarised by Conney (1967):-
(A) interaction with DNA to stimulate DNA-directed synthesis of 
specific messenger ENA;
(B) interaction with repressors or other regulators of gene function;
(C) interaction with the endoplasmic reticulum to enhance the 
translation of messenger ENA on the ribosomes;
(B) interference with mono-oxygenase action, which may lead to an
increase in concentration of an unknown endogenous inducing agent.
Parke.(1968) has suggested that the activity of the drug-metabolizing 
’enzymes may be due to induction of one or more genetic systems by 
de-repression of an operator gene(s). The activating compound (pheno­
barbitone, etc.) would combine with the repressor substance which would 
result in stimulation of the synthesis of messenger RNA and induction of 
the enzyme system (see Figure 1-2 below).
Regulator Operator Structural genes
8°ne gene SGj ' SG2 SG- SG4
opr XDCCpOpopca Chromosome DNA
Actinomycin D inhibits 
Messenger RNA
(*These proteins could be mixed-function
X  oxidases or components of the electron-transport chain involved in microsomal Activating compound hydroxylation)
Fig.‘1-2 Possible mechanism for the induction of the hepatic microsomal 
drug-metabolizing enzymes.
Potential uses of induction - Simultaneous administration may lead 
to drug interaction. This is possibly the cause of the side effects 
noted when phenacetin is given therapeutically with barbiturates 
(Uehleke, 1969). Phenobarbitone reduces the level of diphenylhydantoin 
when the drugs are administered together in the treatment of epilepsy 
(Kutt. et al, 1969). The first therapeutic application of enzyme 
induction was reported by Yaffe and co-workers (1966) and by Crigler 
and Gold (1967) when phenobarbitone was used to prevent hyperbilirubinaemia 
in an infant, by inducing glucuronyl transferase, thus enhancing 
glucuronide formation and thence the excretion of bilirubin.
Stimulation and carcinogenesis - Thermally oxidised com oil has been 
reported to increase the metabolism of 2-acetamidofluorene into its 
carcinogenic N-hydroxy metabolite in rats (Margreth et al, 1964).
Pretreatment of rats and mice with carcinogenic polycyclic hydrocarbons 
stimulates the metabolism of biphenyl to 2-hydroxy derivative, whereas 
non-carcinogenic polycyclic hydrocarbons and various drugs stimulate 
the formation of 4-hydroxybiphenyl (Creaven and Parke, 1966). The 
carcinogenic action of certain polycyclic hydrocarbons could thus be 
associated with their stimulation of enzymes which transform foreign 
compounds into carcinogenic metabolites.
5. Lipid peroxidation as an alternative to drug-hydroxylation, and 
consequent damage of membrane
The membranes of the endoplasmic reticulum are rich in C204 anc^
^22’6 lmsaturated fatty acids and it contains several endogenous radical 
sources. Free radicals, ubiquitous in these membranes, and arising from 
enzymic and non-enzymic sources, may initiate more or less random 
irreversible endogenous reactions with polyunsaturated fatty acids
giving rise to peroxidation products and leading to a multiplicity 
of deleterious changes. Thus, in the simplified reaction of oxygen 
with organic compounds shown below (Swem, 1961; Mesrobian and 
Tobolsky, 1961) for a given rate of initiation,
(Initiation)
R* + 0.2 >R02 ; RO^ + R H  >R* + ROOH (Propagation)
R* + R*  --->R: R (Termination)
where in this case copper is the catalyst, the quantity of RH - any 
organic compound - converted to other confounds depends on the number 
of times the reactions of the propagation steps are repeated, that is, 
on the chain length of the reaction. Since the endoplasmic reticular 
membranes are bathed in an oxygen-rich cell sap (partial pressure of 
oxygen approximately 16 Torr) it may be expected that the propagation 
step would readily be repeated. In fact it is well known that incubation 
of liver, brain or kidney microsomes in buffer at approximately neutral 
pH produces lipid peroxides with an associated formation of malonaldehyde 
and uptake of oxygen (Slater, 1972). An NADPH-depe'clent process which 
enzymically catalyses the peroxidation of endogenous microsomal 
phospholipids has also been reported by Hochstein and Emster (1963).
Working on the oxidation of NADPH by liver microsomes in the presence 
of ADP and a small quantity of iron, Hochstein et al (1964) have 
observed that this process also produces malonaldehyde-like substances.
Wills (1969a, b) has also reported the existence of the NADPH-dependent 
lipid peroxidation process and its stimulation by iron and adenine 
nucleotides.
Similar results have been reported by May and McCay (1968b)* It would the 
fore seem that the mechanisms responsible for the increased lipid
peroxidation in the presence of ADP and a small quantity of iron 
(ferrous ions) would be associated with the NADPH-cytochrome P-450 
chain, however, since Orrenius et al (1964) reported that the lipid 
peroxidation was inhibited by codeine and aminopyrine that undergo 
oxidative demethylation and thus compete with the lipid peroxidation 
pathway for electron flow from NADPH. The work of Wills (1969c) 
also lends support to this view in that aminopyrine and codeine 
inhibit NADPH-induced lipid peroxide formation in rat liver microsomes, 
and that the induction of lipid peroxide formation in the microsomes 
by preincubation with ascorbate or NADPH or by treatment with ionizing 
radiation leads to a sharp decline in the ability of microsomes to 
oxidise aminopyrine or hydroxy late aniline. By boiling microsomes 
Wills (1969a) has, however, shown that the ascorbate-dependent lipid 
peroxidation is a non-enzymic process. The support for association of 
the NADPH-dependent lipid peroxidation with cytochrome P-450 chain 
also comes from the work of May and McCay (1968b) who showed that the 
microsomal NADPH-dependent lipid peroxidation is enzymic and, in 
addition to NADPH, required molecular oxygen. Hie need for iron (II) 
or iron (III) for microsomal NADPH-dependent lipid peroxidation has also 
further been confirmed by Payer and McCay (1971).
Pederson and Aust (1972) have shown that NADPH-dependent lipid 
peroxidation may be catalysed by NADPH-cytochrome c reductase. Further 
studies by Pederson and Aust (1973) have indicated that a N-ethylmaleimide 
sensitive factor as well as NADPH-cytochrome c reductase may be involved 
in microsomal NADPH-dependent lipid peroxidation. Studies by Hrycay and 
O’Brien (1971a, b) have shown that cytochrome P-450 and cytochrome P-420 
may act as a peroxidase, utilizing a fatty acid hydroperoxide as substrate.
The studies of Hrycay and O’Brien implicate cytochrome P-450 and cytochrome 
P-420 in the overal process of NADPH-dependent lipid peroxidation.
Peroxidation of microsomal phospholipids may also be stimulated 
by carbon tetrachloride (Slater and Sawyer, 1971a). This process is 
inhibited by free radical scavengers (Slater and Sawyer, 1971c). By 
the use of various inhibitors of NADPH-cytochrome P-450 electron 
transport chain, Slater and Sawyer (1971b) demonstrated that carbon 
tetrachloride interacted with NADPH-cytochrome c reductase. This 
suggests an involvement of NADPH-cytochrome c reductase in the electron 
transport for NADPH-dependent lipid peroxidation.
May and McCay (1968a) reported that the NADPH-dependent lipid 
peroxidation resulted in the disappearance of polyunsaturated fatty 
acids from membrane phospholipids. A transient formation of phospholipid 
peroxide during NADPH-dependent lipid peroxidation has been observed by 
Tam and McCay (1970). McCay et al (1972) reported that this transient 
factor posesses the properties of a free radical having potential to 
cause peroxidative chain scission of the polyunsaturated fatty acid 
moieties of phospholipids in the microsomal and mitochondrial membranes.
This suggests that, although microsomal NADPH-dependent lipid peroxidation is 
enzymic, requires molecular oxygen as well as NADPH, and may be associated 
with cytochrome P-450 chain somewhere in the vicinity of NADPH-cytochrome 
c reductase, it causes free radical damage to membranes and plays a quite 
different role from that of the cytochrome P-450. A suggestive pathway 
,of lipid peroxide formation (Slater, 1972) is given below in Figure 1-3.
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p-CMB ageing SKF C.
I
NADPH > FP --- > (-SH)  > X1 •>(B.S.) (P-450)
products
(ADP/Fe2+)
CC13 CC14
t
peroxidation
Figure 1-3. Components of the NADPH electron-transport chain in rat
liver endoplasmic reticulum concerned with the metabolism 
of drugj. The lipid peroxidation route stimulated by ADP 
and Fe is indicated. Abbreviations: FP, flavoprotein; 
-SH, thiol depaendent region; X-, rate-limiting component; 
(B.S.) binding site of drug.
6. Role of antioxidants in normal functioning of liver, Seleno-proteins
Vitamin E and some other biological antioxidants stabilize poly­
unsaturated lipids and minimise lipid peroxidation damage. As a 
biochemical model of these deteriorative reactions, Roubal and Tappel 
(1966) studied lipid peroxidation damage to proteins and enzymes, 
characterized some of the oxidised lipid-protein reaction products as 
protein-protein cross-linked polymers and called the polymerization 
mechanism as free radical chain polymerization. The fluorescence 
produced from the cross-linking has been attributed by Chio and Tappel 
(1969) to the conjugated imine structure formed in protein between
2-epsilon-amino groups and malonaldehyde (the peroxidation product of 
polyunsaturated fatty acids). The structure of the fluorescent chromophore 
was determined; 1 mole of malonaldehyde reacts with 2 moles of amino 
compound to yield N,N’-disubstituted 1-amino-3-imino-propenes
of liver
(R-N=CH-CR=CH-NH-R).
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Vitamin E, the major biological antioxidant, shows complex 
relationships with other antioxidants and reducing compounds (Tappel, 
1962). Tappel has attributed the major biological function of 
vitamin E to radical chain breaking in its inhibition of lipid 
peroxidation. Small amounts of ubiquinol can, as an ancillary 
function, react as a chain-breaking lipid antioxidant in a synergistic 
relationship with vitamin E. Vitamin C can also act as a synergist 
for vitamin E. Small amounts of sulphydryl compounds - mainly 
glutathione, sulphydryl proteins, and cysteine - apparently react as 
free radical scavengers and peroxide decomposers as do small amounts 
of methionine as well as seleno-amino acids, which are powerful catalysts 
of sulphydryl-disulphide exchange (Tappel et al,1967; Tappel, 1970).
The history of involvement of selenium dates back to 1957 when 
Schwarz and Foltz showed the metal to be as effective as vitamin E 
in preventing dietary liver necrosis. The close association of these 
two factors was demonstrated soon thereafter in other vitamin E 
deficiencies, among them exudative diathesis in chicks and other fowl 
(Scott et al, 1957; Patterson et al, 1957), white muscle disease in 
sheep and cattle (Muth et al, 1958; Proctor et al, 1958) and "hepatosis 
dietetica" in swine (Grant and Thafvelin, 1958). The latter combines 
the syndrome of liver necrosis and muscular dystrophy with those of 
exudative diathesis. Selenium does not, however, protect chicken 
against encephalomalacia (Dam et al, 1957; Ames and Swanson, 1958), 
..dietary linoleic or arachidonic acid is necessary for the development 
of encephalomalacia (Dam et al, 1958; Century et al, 1959; Century 
and Horwitt, 1959; Machlin and Gordon, 1960), and that the synthetic 
antioxidant, ethoxyquin will prevent encephalomalacia, muscular 
degeneration and exudative diathesis even when added to purified diets
which are essentially free of vitamin E (Machlin et al, 1959; Machlin 
and Gordon, 1962). These latter studies have implicated selenium with 
some processes which may be linked up with antioxidant mechanism. 
Recently, Dip lock and Lucy (1973) reported that the primary function 
of vitamin E in vivo might be to inhibit the oxidation of selenide 
containing proteins, and that the selenide may form a part of the 
active centre of a non-haem iron protein. Other reports (Caygill 
et al, 1971; Caygill and Diplock, 1973; Caygill et al, 1973) have 
indicated that the rat liver microsomal non-haem iron protein ('X') 
is oxidant labile and that this protein may function in hepatic 
microsomal NADPH-dependent electron transport chain, and is protected 
by vitamin E. A similar vitamin E protected mechanism has earlier been 
reported to stabilize phospholipids in the lipid membrane (Hochstein 
et al, 1964; McCay et al, 1972).
7. Role of antioxidants in longevity - antioxidation or induction
Ethoxyquin and a number of antioxidants including butylated 
hydroxy toluene (BHT) and vitamin E increase mice life-span when 
administered at a dietary level of 2.5 to 15.0 g/kg (Harman, 1957,
1968a,b; Comfort et al, 1971). Prolongevity is also caused in rats 
by nordihydroguaiaretic acid (NDGA) when this antioxidant is fed at 
a substantially lower level of 20 mg/kg diet (Buu-Hoi and Ratsimamanga, 
1959). Propyl gallate, a permitted food antioxidant, when given at a 
dietary level of 0.251 to 0.501, has not, however, shown any prolongation 
of mouse life-span (Harman, 1968b).
Several mechanisms for life-span increasing effects have been 
advanced, and these include free radical scavenging (Harman, 1968b) 
which results in stabilization of cell membranes and subcellular
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organelles such as lysosomes (Hochschild, 1971) and mitochondria j
(Tappel and Zalkin,. 1959) , and in the prevention of the formation of 
lipofuscin age pigments and cross “linking in the ageing collagen 
(Chio et al, 1969). Mechanisms may also include enzyme induction 
(Comfort et al, 1971).
Free radical scavenging: In 1968 Harman (Harman, 1968a) showed that
dietary ethoxyquin increased survival of mouse at age 20 months by 
751, BHT by 611, BHT plus vitamin E by 331, and vitamin E by 13%.
This would suggest that antioxidation by free radical scavenging would 
explain pro longevity only in terms of intrinsic antioxidant function of 
each compound.
Comfort et al (1971) suggested that the increase in mouse life-span 
by the antioxidant, ethoxyquin, might result from prevention of the 
formation of toxic materials in the "normal" laboratory diet. Although 
the phraseology is not completely clear, it appears that the term has 
been used to refer to lipid peroxidation products. The inability of 
dietary propyl gallate to increase mouse life-span does not support this 
proposition.
Enzyme induction: BHT induces drug-metabolizing enzymes (Gilbert and
Golberg, 1965) and it is on the basis of this finding that Comfort et al 
(1971) suggested that enzyme induction might be involved in the prolongation 
of mouse life-span. Several reports on enzyme induction by ethoxyquin 
(Cawthome et al, 1970, 1973), vitamin E (Cawthome et al, 1970) and some 
other antioxidants e.g. BHA (Creaven et al, 1966),have since appeared.
No comparative result on the extent of induction of the drug-metabolizing 
enzymes by these antioxidants has, however, been published, and in the 
absence of such data it is difficult to correlate inducibility of enzymes 
with the survival rate of animals.
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8. Need to establish safety of antioxidants - hence present work
There is a world-wide need to step up production and distribution 
of foods in a situation of ever increasing world population. This will 
necessitate extensive use of food additives to stabilize it and keep 
it wholesome. This will call for thorough evaluation of safety of food 
additives from the nutritional and commercial point of view. Such 
evaluation can only be carried out by using experimental animals. 
Unfortunately, the metabolism of these compounds in experimental animals 
is not always the same as in man due to differences in many enzyme systems. 
This suggests that metabolic studies in man using labelled compounds 
should be undertaken, and indeed this type of study has been conducted 
with BHA and BHT (Daniel et al, 1967). These experiments have demonstrated 
that both the antioxidants are completely excreted by man within 14 days 
with no accumulation.
The production of cortical and medullary cysts in the kidney by 
NDGA has been shown in rats only (Grice et al, 1968; Goodman et al, 1970). 
The antioxidant has been in general use for almost 30 years and it is 
still being allowed in several European countries, such as Austria (0.01%), 
Denmark (0.005% to 0.01%), and Norway (0.01%). There is no reason to 
believe that the people of these countries are immune to the toxicity 
demonstrated in rats, while their neighbours across a frontier are not.
If NDGA is really toxic, its use should be banned in all countries.
The anomaly needs to be rectified and as early as possible, and this will 
suggest investigation into some other species.
In a state of free radical attack BHT reacting with peroxides 
produces dimers (Kharasch and Joshi, 1957; Cosgrove and Waters, 1951;
Cook, 1953). It is curious that many investigators, with few exceptions
(Akagi and Aoki, 1962a, b),have not been able to identify any dimers 
among the metabolites of BHT. This may suggest that BHT plays some 
other role more important than peroxide decomposer in animal body.
This will agree with its involvement in induction of hepatic drug- 
metabolizing enzymes (Gilbert and Golberg, 1965; Gaunt et al, 1965; 
Creaven et al, 1966; Gray et al, 1972) and explain its ability to give 
little protection against carbon tetrachloride hepatotoxicity when 
given intraperitoneally or administered intragastrically 6 to 24 hours 
before carbon tetrachloride (Cawthome et al, 1970).,
The levels at which the use of antioxidants in food is permitted 
in a number of countries and the probable levels of their daily 
consumption by man have recently been reviewed by Johnson (1971). He 
arrived at the conclusion that the daily intake would be well below
0.1 mg/kg/day. Such a level can be dangerous under one or more of the 
conditions listed below:-
1. retention in the body;
2. retardation of growth and reproduction;
3. production of structural damage to organs concerned in its 
metabolism, such as the liver and kidneys;
4. adverse effect on age dependent changes, in particular 
in the mechanism involved in drug-metabolism;
5. production of irreversible effects;
6. inhibition of normal electron transport mechanism and
interaction with other drugs, potentiation of carbon 
tetrachloride toxicity by phenobarbitone is a good 
example;
7. embryofcoxic effect;
8. production of any teratogenic effect, the teratogenic 
effect of thalidomide being a good example;
9. production of any mutagenic effect;
10. production of any carcinogenic or tumorogenic effect.
NDGA. (Burk and Wood, 1963), ethoxyquin (Wattenberg, 1972) and 
BHT (Ulland et al, 1973; Grantham et al, 1973) have all some beneficial 
effects.
The report on prolongation of life-span by antioxidant coupled with 
its protective effect against lipid peroxidation and free radical damage 
may lead to its large-scale application in food and feed, and even in 
medicine. Some formulations have already been made in the U.S.A. and 
initial investigative new drug (IND) notice filed with the F.D.A. in 1970. 
A promise in the form of 5 to 10 years human life-span by antioxidant 
therapy alone has also been made (Passwater and Welker, 1971). This may 
turn out to be hazardous. Keeping this in mind and the need for early 
evaluation of safety of antioxidants, the present work has been taken up.
The factors to be examined experimentally are summarized as follows:
1. Enzyme induction by antioxidants in life-span studies,
2. Age dependent changes in hepatic microsomal enzymes and 
their induction,
3. Inhibition as a preliminary step for induction of hepatic 
microsomal drug-metabolizing enzymes,
4. Reversibility of antioxidant-induced hepatic changes as 
a manifestation of adaptive response,
5. Preliminary studies on embryotoxicity due to antioxidant, and
6. Antioxidant-protection against carbon tetrachloride hepato- 
toxicity.
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Chapter 2
EFFECTS OF ANTIOXIDANTS ON ENZYME INDUCTION IN LIFE-SPAN STUDIES
EFFECTS OF ANTIOXIDANTS ON ENZYME INDUCTION IN LIFE-SPAN STUDIES
INTRODUCTION
Ethoxyquin and a number of other antioxidants including butylated 
hydroxytoluene (BHT) and vitamin E have been shown to increase the 
life-span of mice when administered in the diet at a level of 2.5-15 g/kg 
(Harman, 1957, 1968a, b; Comfort et al, 1971). Prolongevity has also 
been observed in rats when nordihydroguaiaretic acid (NDGA) was fed at 
a level of 20 mg/kg diet (Buu-Hoi & Ratsimamanga, 1959). Several 
mechanisms for this effect have been advanced including stabilization 
of cell membranes and subcellular organelles such as the lysosomes 
(Hochschild, 1971) and mitochondria (Tappel & Zalkin, 1959). Additionally, 
by acting as free-radical scavengers, antioxidants may prevent free- 
radical reactions leading to the formation of lipofuscin and cross-linking 
in the ageing of collagen (Chio et al, 1969).
It appears that the common factor in these compounds is their 
antioxidant properties, but not all antioxidants produce similar life- 
prolonging effects (Harman, 1968a,b). Ethoxyquin was found to be most 
effective in increasing survival rates in mice while n-Propyl gallate 
was observed not to do so. By comparison of the biological effects of 
these compounds it might be possible to gain an insight into the mechanisms 
whereby antioxidants influence ageing processes to varying degrees.
Comfort et al (1971), in reporting prolongevity in C3H mice given 
antioxidant in the;diet, were unable to reach a conclusion on the 
mechanisms between several alternatives including that (a) large amounts
of the chemical hindered assimilation or spoiled the appetite and in the
\
absence of strict pair-feeding measurements, the effect might be due to
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calorie restriction, (b) excess antioxidant merely reduced the toxicity 
of a ’’normal” laboratory diet, and (c) many antioxidants (especially BHT) 
were powerful enzyme inducers. With regard to (a), McCay (1934) has 
shown that calorie restriction per se might prolong life-span, while in 
connection with (c), Ross (1969) demonstrated good correlation between the 
activity of a number of hepatic enzymes and life-expectancy in rats. The 
study reported here is aimed at investigating the effects of a number of 
antioxidants on the hepatic enzymes involved in detoxication of dietary 
anutrients and correlating these effects with survival rate.
MATERIALS AND METHODS 
Chemicals
Ethoxyquin, 961 GLC pure grade, and nordihydroguaiaretic acid (NDGA) 
were obtained from Koch Light Ltd. n-Propyl gallate andbutylated hydroxyanisole 
were Laboratory Reagent Grade (BDH). Vitamin E (D-alpha-tocopherol 
acetate, Sigma, type III) contained approximately 1360 I.U. per g (not 
air oxidizable). Antioxidant-free arachis oil (Saladin quality,
Craigmillar) was used as a vehicle for incoiporating ethoxyquin or NDGA 
into the test diets. The absence of antioxidant in this oil was 
ascertained by testing the material according to the methods of the 
Association of Public Analysts (1963), Ishikawa & Katsui (1966) and 
Choy et al (1963), and as mentioned in pages 41-43.
Mention has been made of other chemicals in the text where relevant. 
Animals
Inbred Wistar albino rats were used in these studies amd accommodated 
in the University Animal Unit equipped with facilities to regulate 
temperature (20° to 22°C), relative humidity (501), and electric light 
for 12 h. The feeding protocol was varied as per design of the experiments 
ana detailed where appropriate.
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Intragastric administration of antioxidants
Forty eight 24-day old rats were divided into 4 groups, each 
consisting of 6 males and 6 females, for controls, tocopherol-fed,
BHA-fed and ethoxyquin-fed. The males and females in each group were 
separately caged in polypropylene cages (26 in. x 151 in. x 8 in.) 
and given laboratory pellet diet (Spillers Ltd.) and water ad-libitum.
A 20! solution of each antioxidant was prepared in arachis oil 
for the study of single dose response, and given intragastrically to 
the relevant group of rats at the rate of 2 g/kg body weight. The 
vehicle was given to the controls. After administration of this dose 
five male and all six female rats fed ethoxyquin died in the course 
of 24 h. As a result, the concentration of the test substances was 
reduced by 50! (i.e. 1 g/kg) and after an interval of 5 days other 
antioxidants were administered intragastrically to the relevant 
experimental groups. Thereafter the animals were given the dose every 
day and the dosing protocol continued for a period of 2 months. The 
controls were given the vehicle during this period also.
At the end of the experimental period all animals were weighed and 
killed by decapitation in the morning between 9 a.m. and 10 a.m. to 
avoid differences due to diurnal variation (Radziaiowski & Bousquet, 1968). 
The livers were quickly removed, weighed and processed for the determination 
of microsomal protein and cytochrome P-450 concentrations and biphenyl 
4-hydroxylase activity according to the methods described in Pages 43-46.
Administration of antioxidants in the diet
The animals used in these experiments were male rats. They were 
caged in polypropylene cages (15J in. x 10 in. x 8 in.) placed on mobile 
cage-racks and maintained on a standard powdered diet (Spillers small
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animal diet, meal form) to which was added 2.5% w/w arachis oil. In 
the case of the test diets, ethoxyquin was diluted with the arachis oil 
before mixing with the meal to give the appropriate concentration. NDGA. 
(having low solubility in oil) and n-Propyl gallate (being insoluble in 
oil) were mixed with the dry meal before addition of the oil. Fresh 
diet was made up at frequent intervals (£* 7 days) to eliminate differences *■ 
between test and control diets as a result of accumulation of toxic 
peroxidation products in the latter. The diets were given in special 
food pots each consisting of a perforated lid (2| in. dia.) and one inner 
(2§ in.dia.) and one outer(31 in. dia.) compartments. This arrangement 
reduced the loss due to spillage to a minimum.
In the light of the dose response test after intragastric 
administration of ethoxyquin (2 g/kg) it was proposed to maintain the 
animals on a diet containing 0.5% w/w of this antioxidant for a period 
up to 60 days. An initial 10-day tolerance test was, however, carried 
out at a higher level of 1% w/w ethoxyquin. In rats the LD^ of NDGA 
(5.5 g/kg, orally; Bergel, 1955) and propyl gallate (2.5 g/kg orally; 
Daniyalov, 1966) is considerably higher than that of ethoxyquin (0.8-1.0 g/kg, 
orally; Chaffard & Thiolliere, 1970). Similar tolerance tests with these 
antioxidants were, therefore, considered unnecessary.
Eight 40-day old rats, matched for body weight, were caged singly.
Four control animals received the standard powdered diet and the other 4 
received the diet containing 1% w/w ethoxyquin; food and water were 
available ad-libitum to both the groups. Food intake was recorded, as 
were the initial and final body weights. At the end of the 10-day period 
the animals were killed by cervical fracture. The livers were quickly 
removed, weighed and processed, and then the hepatic microsomal protein
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and enzyme concentrations determined according to the methods described 
in pages 43-47.
In the 60-day comparative study of ethoxyquin, NDGA and propyl 
gallate the following procedure was adopted. One hundred and sixty
eight 18-day old rats were kept with their dams for a 3-day weaning
period during which control powdered diet was available ad-libitum.
Eight animals were then weighed and killed, and liver weights, hepatic 
microsomal protein and enzyme concentrations determined as above.
The remaining weanlings were then caged singly in seven groups 
as follows:
a) 40 animals maintained on the control diet ad libitum,
b) 20 animals given a diet containing 0.5% w/w ethoxyquin ad-libitum,
c) 20 animals, paired with animals in group b, and receiving an
iso-caloric amount of control diet with their experimental 
partners (pair-fed controls),
d) 20 animals given a diet containing 0.5% w/w NDGA ad-libitum,
e) 20 pair-fed control animals for group d,
f) 20 animals given a diet containing 0.5% -w/w n-Propyl gallate
ad-libitum, and
g) 20 pair-fed control animals for group f.
Water was available ad-libitum to all animals.
After 3, 7, 14, 30 and 60 days 8 animals from group a and 4 from each 
of the other groups were killed and examined as before.
Electron microscopy after administration of ethoxyquin in the diet
One group of eight 18-day old rats were kept with their dams for a
3-day weaning period during which control powdered diet and water were 
available ad-libitum. The weanlings were then caged singly. Four of
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these animals were given the diet containing 0.5% w/w ethoxyquin 
ad-libitum and the other 4 were pair-fed with them with an amount of 
control diet equal to that consumed by their respective experimental 
partners during the past 24 h. The animals were then given water 
ad-libitum. At the end of 14 days they were killed by cervical 
dislocation and their livers utilized for electron microscopic studies 
as described in pages 47-5(3.
Gut microfloral transformation of antioxidants
One group of 5 rats (50-day old), kept on standard laboratory 
pellet diet (Spillers Ltd.) from weaning, were killed by cervical 
fracture and their caeca removed. The entire caecal contents of all 
the rats were pooled and processed to study gut microfloral breakdown 
of antioxidants according to the method of Scheline (1966) and as 
described in page 51.
Detection of antioxidants in arachis oil
The presence in arachis oil of permitted synthetic antioxidants 
wa-s ascertained by the methods of the Association of Public Analysts 
(Special Report No. 1, 1963) for gallates, BHA and BHT, and Choy et al, 
(1963) for ethoxyquin. Detection of NDGA was performed by the method 
of Ishikawa & Katsui (1966). These methods are described below:
i) Extraction of gallates, BHA, BHT and NDGA:- Warm arachis oil (10 g) 
was shaken with 25 ml of 95% methanol for 1 min. in a stoppered tube.
The tube was then placed in a water bath at 45°C for 15 min. cooled to 
room temperature, and the upper layer decanted. The extraction was 
repeated with 20 ml of 95% methanol and the upper layer again decanted.
The combined methanol extracts were made up to 50 ml with methanol,* 
calcium carbonate (1.0 g) added, and after thorough shaking the methanolic 
solution was filtered and used for the following identifications:
a) Gallates - to 5 ml of extract was added 1 ml of ammonia 
solution (sp. gr. 0.88); gallates gave a rose pink colour.
b) BHA. - to 2 ml of extract was added 2 ml of methanol, 8 ml of 51 
borax solution and 2 ml of Gibb's reagent (0.011 2,6-dichloro-p- 
benzoquinone-4-chlorimine in 95! methanol).. BHA gave a blue 
colour.
c) BHT - 5 ml of extract was mixed with 5 ml of water and 2 ml of 
freshly prepared o-dianisidine solution in a separating funnel 
covered with foil to exclude light. Sodium nitrite solution 
(0.8 ml of 0.3! w/v) was added, and after mixing and allowing
to stand for 10 min. the coloured BHT complex was extracted with 
4 ml of chloroform. The appearance of a purplish red colour on 
addition of 0.8 ml methanol to the prepared chlorofom layer was 
indicative of the presence of BHT.
The dianisidine solution consisted of o-dianisidine (0.25 g) in 
methanol (50 ml), shaken with 0.1 g of activated charcoal, filtered and 
mixed with 1.5 volumes of 1M HC1. This solution was protected from light 
by wrapping the container in foil.
d) NDGA - 5 ml of extract was evaporated to 1 ml and 5 yl of this 
concentrated extract was spotted on a polyamide powder coated plate 
(250y thick, dried in air for 2-3 h.). The plate was developed
to a front distance of 10 cm in 1-dimension with pure chloroform 
and in the other dimension with methanol. The plate was then 
dried, sprayed with 20! ale. molybdic acid, and exposed to NH^~ 
vapour. NDGA gave a blue spot (R^  = 0.45, detection limit 0.1 yg).
ii) Extraction and detection of ethoxyquin
Arachis oil (10.0 g), not containing BHA and BHT, was vigorously 
stirred with 40 ml of n-Heptane and the resulting solution then shaken with
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about 15 ml of 0.5N HC1 in a 100 ml separating funnel. The presence 
of ethoxyquin in the sample was detected in a Pye Unicam SP 500 
Spectrophotometer by taking the O.D. of the lower acid phase at 296 nm 
against 0.5N HC1 blank (detection limit 0.005 to 0.1 mg/ml).
s.
BIOCHEMICAL STUDIES
(i) Preparation of liver fractions
The livers, as they were removed from the animals, were rapidly 
freed from connective tissue, washed in ice-cold 1.15% KC1 (w/v), 
blotted with tissue paper, weighed, chopped and homogenized in the 
.medium of the cold KC1 solution in a glass homogenizer by two up and 
down strokes by using a loose-fitting Teflon pestle (Potter & Elvehjem, 
1936) driven by a Black & Decker electric drill at a speed of 2950 r.p.m. 
The homogenates (250 mg liver/ml) were centrifuged in 50 ml stoppered 
polypropylene centrifuge tubes in 8 x 50 ml angle head in an MSE High 
Speed 18 refrigerated centrifuge at 0-4°C at 10,000 x g (9,500 r.p.m.) 
for 20 min. to remove debris. The supernatants were carefully decanted 
and an aliquot each of the supernatants was further centrifuged for 1 h. 
in an MSE Super Speed 50 centrifuge in a 10 x 10 ml angle head at a 
temperature of 0-4°C at 105,000 x g (40,000 r.p.m.). The supernatant 
was decanted off and the pellet carefully rinsed free of supernatant with 
a few ml of the cold-KC1 solution. The microsomal pellet was then 
resuspended by gentle homogenization and made up to the original volume 
with the cold KC1 solution. This constituted the ’microsomal suspension'. 
The pellets were occasionally stored overnight in a deep freeze at -40°C.
(ii) Determination of microsomal protein
The microsomal suspension (1 in 4) was diluted 50 times with water 
and 1 ml of this diluted suspension was mixed with 10 ml of freshly 
prepared Lowry's reagent mixture (Lowry et al, 1951). After 15 min.
43
0.5 ml of Folin-Ciocalteu’s reagent was added and mixed immediately.
After 40 min., when development of maximum colour was complete, the 
O.D. was read at 750 nm in a Pye Unicam SP500 Spectrophotometer or 
Cecil CE 272 Linear Readout Ultraviolet Spectrophotometer.
All sajiples were run in duplicate. A reagent blank with water 
instead of dilute microsomal suspension, and standards of bovine 
albumin (Sigma grade, fraction V, powder) were also run through the 
same procedure. The amount of microsomal protein (mg/g liver) present 
in the sample was calculated from a standard curve drawn by plotting 
O.D’s at 750 nm against the concentrations of bovine albumin (20 to 
200 yg) in the standards.
The Lowry’s reagent mixture was prepared by mixing 1 ml of aqueous 
2% potassium sodium tartrate and 1 ml of aqueous IVcupric sulphate 
with 100 ml of 2% sodium carbonate in 0.1 M sodium hydroxide solution.
(iii) Determination of cytochrome P-450
In order to determine the cytochrome P-450 (Sladek & Mannering, 1966) 
the microsomal suspension (1 in 4) was diluted 3 times with 0.2 M 
potassium phosphate buffer (pH 7.4) and the haemoproteins present in 
it were reduced by carefully dissolving a few crystals of sodium 
dithionite. An aliquot (3 ml) of this suspension was transferred to 
each of the two spectrophotometer cuvettes and carbon monoxide was 
bubbled for 30 sec. through the suspension in one (sanple) cuvette to 
make carbon monoxide complex of the reduced haemoproteins present. The 
difference spectrum between the reduced and CO-complexed reduced 
microsomes was then traced at 390-500 nm in a Unicam SP 1800 double beam 
recording ultraviolet spectrophotometer using 1 cm light path. The 
difference in absorbance between 450 nm and 490 nm was measured and 
the cytochrome P-450 concentration ( n mole/g liver) calculated by
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-1 -1using molar extinction coefficient (Ae 490-450 nm) of 91 cm mM 
(Oraura & Sato, 1964).
(iv) Determination of cytochrome
For determining cytochrome (Schenkman et al, 1967) 3 ml of the 
buffered dilute microsomal suspension (1 in 12) was transferred to each 
cuvette and the haemoproteins of the cytochrome b type present in one 
(sample) cuvette were reduced by adding 10 yl of 2% NADH^. The 
difference spectrum between the reduced and oxidised microsomes was 
then traced at 390-500 nm in a Unicam SP 1800 double beam recording 
ultraviolet spectrophotometer using 1 cm light path. The difference 
in absorbance between 410 nm and 424 nm was measured and the cytochrome 
b^ concentration (n mole/g liver) calculated by using molar extinction 
coefficient (Ae 424-410 nm) of 185 cm -
(v) Determination of biphenyl 4-hydroxylation
Biphenyl 4-hydroxy compound, being highly fluorescent, is 
quantitatively estimated fluorimetrically (Creaven et al, 1965; Neale, 
19 7o)* The following incubation mixture was used for this
purpose:-
Tris-HCl buffer, 0.05M, pH 8.1 0.50 ml
NADP (1.5 ymoles) in 1.151 KC1 solution 0.55 ml
MgC^ (10 ymoles) in water 0.20 ml
Biphenyl (3 ymoles) in 1.151 KC1 
solution containing 4 g Tween 80/100ml 0.25 ml
Liver, 10,000 x g supernatant (1 in 4) 0.50 ml
Total 2.00 ml
The incubation was carried out in air for 20 min. at 37°C in a 
Mickle shaking water bath (80 strokes/min.). The reaction was stopped
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partially by cooling in ice-water and completely by adding 2M MCI 
(0.50 ml). The unmetabolized biphenyl and its metabolites were extracted 
by shaking mechanically for 10 min. with n-Heptane (10 ml). After 
centrifugation in a Mistral 6L for 10 min. at 0-4°C at 2,000 r.p.m., 
an aliquot (2 ml) of heptane layer was shaken as before with 0.1M NaOH 
(10 ml), recentrifuged and the fluorimetrie intensity of the NaOH layer 
determined in a Baird-Atomic Fluorescence Spectrophotometer or Perkin 
Elmer Fluorimeter at 400 nm with excitation at 311 nm.
All samples were run in duplicate. A reagent blank (with substrate 
added after termination of incubation) and standards (with 4-hydroxy- 
biphenyl, 30 yg/ml, and substrate added after termination of incubation) 
were run through the same procedure. The extent of hydroxylation of 
biphenyl at the 4-position was then calculated as biphenyl 4-hydroxylase activity, 
ymole/h/g liver.
4-Hydroxybiphenyl standard (recrystallized from light petroleum, 
boiling range 100-200°C) was prepared by dissolving 7.5 mg of the 4-hydroxy- 
biphenyl in 12.5 ml ethanol and then diluting to 250 ml with water.
(vi) Determination of N-demethylation of ethylmorphine
Ethylmorphine on demethylation liberates formaldehyde which produces 
a yellow coloured complex on being heated with Nash’s reagent (Nash, 1953).
The extent of N-demethylation can be determined by reading the O.D. of 
this colour at 412 nm in a spectrophotometer (Holtzman et al, 1968). The 
following incubation mixture was used in the N-demethylation experiments:-
Tris buffer (0.15M, pH 8.1 containing 
2 ymoles of NADP, 10 ymoles of Mg , and 
20 ymoles of glucose-6-phosphate). 0.7 ml
Semicarbazide (20 mg/ml), pH 8.1. 0.3 ml
Ethylmorphine (15 ymoles) in 1.15% KC1 solution 
Liver, 10,000 x g supernatant (1 in 4)
Total
The incubation was carried out in air for 10 min. at 37°C in a 
Mickle shaking water bath (80 strokes/min.). The reaction was stopped 
partially by cooling in ice-water and completely by mixing with 15%
ZnSO^ solution (1 ml) and saturated BapH^ solution (1 ml). After 
centrifugation in a Mistral 6L for 10 min. at 0-4°C at 2,000 r.p.m. 2 ml 
of the supernatant was mixed with 2 ml of the freshly prepared Nash 
reagent (0.4 ml acetyl ace tone/100 ml 4M NH^-acetate in O.lmM glacial 
acetic acid) and then heated in a shaking water bath at 37°C for 40 min. 
to develop maximum colour. The O.D. of the resulting colour was read 
at 412 nm in 1 cm light path in a Pye Unicam SP 500 Spectrophotometer 
or Cecil 272 Linear Readout Ultraviolet Spectrophotometer.
All samples were examined in duplicate. A reagent blank (with 
substrate added after termination of incubation) and standards (with 
formaldehyde, 2 ymoles/ml, and substrate added after termination of 
incubation) were run through the same procedure. The extent of 
demethylation of ethylmorphine was then calculated as ethylmorphine 
N-demethylase activity, ymole/h/g liver.
ELECTRON MICROSCOPIC STUDIES
The method reported here is based on the techniques described by 
Pease (1960) and Hyat (1970).
i) Fixation of specimen
The liver specimen (1 mm dia.) from the lateral lobe was quickly
0.3 ml 
0.5 ml
1.8 ml
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transferred to 2-3 ml cold 4% glutaraldehyde in 0.1M cacodylate buffer 
(pH 7.2) and pre-fixed for 24 h. at 0-4°C so that both intra and inter- 
molecular cross-links were formed with most proteins without effecting 
their coagulation. Thereafter the free glutaraldehyde was removed by 
rinsing the specimen 2-3 times with cold 0.1M cacodylate buffer during 
a total period of 15 min. The washed specimen was then transferred to 
2-3 ml of cold 2% OsO^ in freshly prepared veronal acetate buffer (pH 7.2) 
and allowed to post-fix the lipids in darkness at 0-4°C for 2 h. The 
excess fixative from the post-fixed specimen was thereafter removed by 
rinsing it 2-3 times for about 15 min. with cold veronal acetate buffer.
The veronal acetate buffer was prepared by mixing 20 volumes of 
veronal acetate solution (19 g Na-acetate crystal and 28.9 g veronal 
per litre water), 22 volumes of N/10 HC1 and 58 volumes of water.
ii) Dehydration of the fixed specimen
The fixed specimen was dehydrated by rinsing with cold (0-4°C)
3050, 70 and 90 per cent alcohol and industrial methylated spirit (IMS) 
for 10-15 min. each. After a second rinsing with the IMS the specimen 
was brought to room temperature.
iii) Embedding of the specimen
The alcohol from the dehydrated specimen was removed by rinsing it 
twice during 20 min. with 2-3 ml of propylene oxide. The infiltration 
of the specimen was then carried out as under: -
2 volumes of propylene oxide and 1 volume, 
of resiri mixture 1 h.
1 volume of propylene oxide and 2 volumes 
of resin mixture - 1 h.
Resin mixture alone - 2 h.
On completion of the infiltration the specimen was transferred to a 
pre-dried gelatin capsule and after proper orientation in the embedding 
resin mixture it was polymerized in an oven for 12 h. at 45°C followed 
by a final treatment at 60°C for 36 h. to complete the polymerization.
The resin mixture was prepared as follows
EPON 812 (Taab) 20.0 ml
Araldite (Taab) 12.0 ml
DDSA (dodecenyl succinic anhydride; 
hardener; Taab) 44.0 ml
Dibutyl phthalate (plasticizer; Taab) 3.5 ml
DMP-30 (2,4,6-tri(dimethylaminomethyl) 
phenol) (amine accelerator; Taab) 0.8 ml
Total 80.3 ml
EPON and araldite were mixed with the hardener and plasticizer for 
about 20 min; the accelerator was then added and quickly mixed. This 
embedding resin mixture was thereafter dehydrated by treating with 
anhydrous CaSO^ which was completely removed before use by centrifugation 
at 21,000 x £ for 3 h.
iv) Cutting of sections
After keeping at room temperature for 1 or 2 days or longer, the 
block was mounted in the block holder (chuck), trimmed under a binocular 
microscope and the block-face enlarged ideally into a trapezoid face 
(0.5 to 2 mm) for cutting sections and producing ribbons easily. The 
chuck with the block was thereafter mounted on an LKB Ultramicrotome and 
silver-grey sections (about 600$) cut by a glass knife and collected on 
flotation fluid (distilled water) in the trough made with a piece of 
electrical adhesive tape. The operation was viewed throughout with a 
low power binocular microscope (x 10 to x 80). The wrinkling was removed
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by exposing the sections to vapours of chloroform for about 6 sec. 
by carefully bringing a wisp of cotton dipped in the solvent a few 
centimetres above the section floating in the trough.
v) Staining of sections
Sections, collected in the centre of an uncoated 400-mesh grid 
by carefully lowering it flat on to the upper surface of a ribbon, 
were stained by floating the grid gently for 5 min. (with section side 
down) • on a drop of freshly prepared aqueous 2% uranyl acetate (pH 3.8) 
in a petri dish. Thereafter the grid was carefully washed thoroughly 
with distilled water and the secti cns stained next by floating the grid 
for 10 min. on a drop of lead stain (Sato, 1967) in a second petri dish. 
The grid was finally washed with distilled water and dried by placing 
on a piece of filter paper with the section side up.
The lead stain was prepared as under: -
Lead nitrate (BDH, A.R.) 1.5 g
Lead acetate (BDH, A.R.) 1.5 g
Lead citrate (BDH) 1.5 g
Distilled water 90.0 ml
The above mixture was heated to 40°C and stirred for 1 min.
(small amounts of precipitate were occasionally present). To this 
mixture was added 3.0 g of Na-citrate and then stirred again for 1 min. 
(solution was milky). Thereafter 24 ml of 1M NaOH followed by 40 ml 
of distilled water was added when the solution became clear.
vi) Photomicrography
Each grid ivas finally examined under a Jeol 100B Electron 
Microscope and photomicrographs of fields of interest taken on quoted 
glass plates at a magnification of x 10,500.
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DETECTION OF GUT MICROFLORAL BREAKDOWN OF ANTIOXIDANTS
The pooled caecal contents were mixed thoroughly with 5 volumes of 
medium and the resulting suspension centrifuged for 15 min. at the lowest 
speed on a bench centrifuge to remove the gross debris.
The medium was prepared by dissolving 0.5% yeast extract (Difco),
0.5% peptone (Difco) and 0.5% glucose in 0.1M phosphate buffer (pH 7.4).
One ml of ethanolic solution of antioxidant and 1 ml of caecal 
supernatant were added to the cooled sterilized medium (10 ml) in the 
medium tube, flushed with nitrogen, stoppered, mixed by inverting a few 
times, and incubated at 37°C in a Mickle shaking water bath (80 strokes/min.) 
for 22 h. The incubation mixture was then acidified with conc. HC1 (1 ml), 
extracted twice with 25 ml portions of diethyl ether, dried over anhydrous 
sodium sulphate, filtered and evaporated to dryness under vacuo. The 
residue was dissolved in 1 ml of 96% ethanol and spotted (100 yl) on 250 y 
thick TLC plate (20 x 20 cm) made by coating with kieselgel G (adsorbent- 
water, 1:2, w/v) and activating for 1 h at 105°C. The chromatogram was 
developed up to 17 cm in benzene-glacial acetic acid-water (6:7:3 by 
volume, upper layer) and then dried in hot air. The various compounds 
were detected by spraying with aqueous 0.5% Fast Blue B salt and then 
drying and spraying 0.1M NaOH solution.
Samples of BHA., NDGA. and n-Propyl gallate were each studied in 
triplicate. A reagent blank (with 1 ml of ethanol instead of antioxidant 
solution) and standards (with antioxidant solution after termination of 
incubation) were run through the same procedure.
Chromatograms of sample, standard, blank, and possible metabolites 
were developed side by side for easy identification of various compounds.
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RESULTS
a) BIOCHEMICAL STUDIES
Effect of intragastric administration of antioxidants on drug metabolizing 
enzymes and certain other parameters of developing rats.
The results of this experiment are given in Table 2-1. It is 
observed from this Table that the male rats grew heavier than the females 
and maintained this sex-dependent difference in the parameters studied 
in the control as well as the antioxidant-dosed groups. There was no 
significant difference in the body weight of controls and tests in both 
male and female rats. The liver weight in the tocopherol-dosed rats 
was normal, but in the BHA-dosed animals the liver weight and consequently 
the relative liver weight (g/100 g body weight) was higher than, and 
significantly different from, the controls. In both the experimental 
groups the microsomal protein content (mg/g liver) was significantly 
increased but this was accompanied by an elevated level of cytochrome 
P-450 (n mole/g liver) only in tocopherol-dosed rats. The increased level 
of cytochrome P-450 was not matched by any increase in the biphenyl 
4-hydroxylation.
Effect of chronic administration of ethoxyquin on hepatic drug metabolizing 
enzymes and certain other parameters of rats during a 10-day tolerance 
test period
The results of the 10-day tolerance test with ethoxyquin at a dietary 
level of 1.0% w/w are shown in Table 2-II. These animals had been reared 
on a pellet diet free from added antioxidants for 20 days prior to the 
experimental period. It can be seen from the Table that there was a marked 
difference in the acceptability of the control and ethoxyquin-containing 
powdered diets resulting in a significantly reduced food-intake (40% of 
control levels) and body weight gain, which emphasized the need of pair
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feeding in the longer term experiment. While the absolute liver weight 
in the test group was not significantly different from the controls the 
relative liver weight (g/100 g body weight) was significantly higher, 
indicating a nett enlargement of liver compared with other tissues. The 
concentrations of microsomal protein and cytochromes P-450 and b^ and 
the activity of biphenyl 4-hydroxylase were all greatly increased, the 
increases varying from 41% in the case of microsomal protein concentration 
to almost three-fold for biphenyl 4-hydroxylase activity. Ethylmorphine 
N-demethylase activity, expressed in ymole/h/g liver, was significantly 
elevated but to a very much lesser extent than microsomal protein or 
cytochrome P-450, i.e. the specific activity of this enzyme in the micro- 
somes was, in fact, reduced.
Effect of chronic administration of ethoxyquin, NDGA. and n-Propyl gallate 
on mean daily food-intake, body weight, liver weight and hepatic microsomal 
enzymes of developing rats
The results of the 60-day study with these antioxidants are given 
in Table 2—III and shown in Figures 2-1 to 2-16. The results shown in 
the Figures are also given in Tables 2-V to 2-XII in the Appendix for 
ready reference.
i) Food-intake
From Table 2-III it is observed that rats receiving a diet containing 
0.5% ethoxyquin or NDGA consistently ate less than controls fed ad-libitum 
on an antioxidant-free diet, the reduction in food-intake over the whole 
experimental period was 9% and 12% respectively. n-Propyl gallate at a 
similar level in the diet did not impair food-intake which, overall, was 
4% higher than in controls fed ad-libitum and during the final 10 days of 
the experiment was significantly higher (P< 0.01) in test animals than in 
controls.
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Fig. 2-2 Effect of chronic administration of ethoxyquin, NDGA,
and propyl gallate on body weight of developing rats t
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w/w in the diet from weaning at 21 days of age
58
Li
ve
r 
we
ig
ht
 
( g 
) 
Li
ve
r 
we
ig
ht
 
( 
g 
)
Fig. 2-3 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on liver weight of developing rats t
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Fig. 2-4 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on liver weight of developing rats t
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•Fig.2-5 Effect of chronic administration of ethoxyquin, NDGA,
and propyl gallate on relative liver weight of developing
rats t
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Fig. 2-6 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate of relative liver weight of developing rats t
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Fig. 2-7 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on hepatic microsomal protein content of
developing rats t
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Fig. 2-8 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on hepatic microsomal protein content of
developing rats t
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Fig. 2-9 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on hepatic cytochrome P-450 content of
developing rats f
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Fig. 2-10 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on hepatic cytochrome P-450 content of
developing rats f
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Fig. 2-11 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on hepatic cytochrome b5 content of
developing rats t
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Fig. 2-12 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on hepatic cytochrome b5 content of
developing rats t
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Fig. 2-13 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on biphenyl 4-hydroxylase activity of developing
rats t
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Fig. 2-14 Effect of chronic administration of ethoxyquin, NDGA,
and propyl gallate on biphenyl 4-hydroxylase activity
of developing ratst
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Fig. 2-15 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on ethylmorphine N-demethylase activity of
developing rats f
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Fig. 2-16 Effect of chronic administration of ethoxyquin, NDGA, and
propyl gallate on ethylmorphine N-demethylase activity of
developing rats t
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ii) Body weight
Figure 2-1 shows the body weight of antioxidant-fed rats and their 
pair-fed controls while Figure 2-2 compares these results with those of 
controls fed ad-libitum. From these Figs. it is observed that all the 
pair-fed controls were initially subject to dietary restriction as they 
were given control diet equal to the amount consumed during the past 24 h 
by their antioxidant-fed partners. As a result of impaired food-intake, 
the weight-gain of rats given ethoxyquin was less than controls fed 
ad-libitum but food utilization was unaffected as pair-fed controls 
gained weight in a similar manner to the antioxidant-fed animals. On 
the other hand, despite reduction in food-intake and body weight during 
early days, there was later on no significant difference in weight gain 
between the controls fed ad-libitum and those given NDGA. By the end of 
the 60-day study these rats were rather heavier and even their pair-fed 
controls gained body weight almost equal to the controls fed ad-libitum. 
Rats fed propyl gallate and their pair-fed controls gained body weight 
similarly to the controls fed ad-libitum.
iii) Liver weight
Figure 2-3 shows the absolute liver weight gains in antioxidant- 
fed rats and their pair-fed controls, whereas Figure 2-4 compares these 
results with those of controls fed ad-libitum. It is observed from Figure 
2-3 that the liver weight in ethoxyquin and NDGA-fed rats was always 
significantly higher and reached the peak level on the 30th day of the 
study when the gain was over 70% in excess than their respective pair-fed 
controls. The propyl gallate-fed rats, however, showed no significant 
increase in liver weight gain compared with their pair-fed controls, 
although from Figure 2-4 it appears that the absolute liver weight in all 
the three antioxidant-fed groups was higher than in controls fed 
ad-libitum.
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iv) Relative liver weight
Figure 2-5 shows the relative liver weight (g/100 g body weight) 
in antioxidant-fed rats and their pair-fed controls, while Figure 2-6 
compares these results with those of controls fed ad-libitum. It is 
observed from these Figures that ethoxyquin and NDGA caused an increase 
in relative liver weight and this increase reached the peak level on 
the 14th day when the value was about 70% higher than in pair-fed 
controls (Fig. 2-5) and about 40% higher than in controls fed ad-libitum 
(Fig. 2-6). Due to decrease in liver weight gain the relative liver 
weight of the pair-fed controls of these two groups was throughout less 
than that in controls fed ad-libitum.
Except for an initial fluctuation, the propyl gallate-fed rats did 
not show any significant difference in relative liver weight from their 
pair-fed controls and also from controls fed ad-libitum.
v) Microsomal protein
Figure 2-7 shows the microsomal protein content (mg/g liver) in 
antioxidant-fed rats and their pair-fed controls, and Figure 2-8 compares 
these results with those of controls fed ad-libitum. It is observed 
from these Figures that the microsomal protein content increased 
dramatically in ethoxyquin-fed rats and the peak level was reached on 
the 14th day when it was higher by over 40% than in pair-fed controls, 
and by about 80% than in controls fed ad-libitum. Thereafter the 
microsomal protein concentration declined and on the 60th day the 
ethoxyquin-fed animals still maintained a higher value of 34% than in 
the pair-fed controls, and 54% than in controls fed ad-'libitum.
The increase in microsomal protein concentration was less dramatic 
in NDGA-fed rats and least in those fed propyl gallate, the peak level 
in both was reached on the 14th day and on the 60th day the concentrations
came down to the leyels in their respective pair-fed controls (Fig. 2-7) 
but was about 30% higher than in controls fed ad-libitum (Fig. 2-8).
The pair-fed controls of all the three antioxidant-fed groups 
also showed increased microsomal protein synthesis, with the peak level 
on the 14th day and coming down to almost weaning levels on the 60th day.
In controls fed ad-libitum the microsomal protein concentration, however, 
showed a drastic fall on the 60th day when it was lower than the weaning 
level by about 30%.
vi) Cytochrome P-450
Figure 2-9 shows the concentration of cytochrome P-450 (n mole/g liver) 
in antioxidant-fed rats and their pair-fed controls, whereas Figure 2-10 
compares these results with those of controls fed ad-libitum. It is 
observed from these Figures that the enzyme concentration sharply increased 
in the ethoxyquin-fed rats, showed a linearity during the first 7 days 
and reached the peak level on the 30th day when it was higher by 50% than 
in pair-fed controls, and by 84% than in controls fed ad-libitum. Thereafter 
the cytochrome P-450 concentration was reduced in the ethoxyquin-fed animals 
but the relative increase with respect to both pair-fed controls and controls 
fed ad-libitum was maintained.
In NDGA-fed rats a similar but less marked increase was observed, with 
peak level similarly being reached on the 30th day. No such change was 
shown in propyl gallate-fed rats.
The concentration of cytochrome P-450 in controls fed ad-libitum was 
at a low level on the 30th day when the ethoxyquin and NDGA.-fed rats as 
well as their pair-fed controls showed peak levels. On the 60th day the 
enzyme concentration in this group of rats fell to a level lower than that 
in the weaned rats and in this respect it followed the pattern shown by 
the microsomal protein.
The propyl gallate-fed rats and their pair-fed controls, although 
resembling controls fed ad-libitum as regards other parameters, showed 
an elevated level of cytochrome P-450 on the 60th day and this might 
explain the reason for the increase in the concentration of microsomal 
protein by 30% at this time.
vii) Cytochrome b^
Figure 2-11 shows the concentration of cytochrome b^ (n mole/g liver) 
in antioxidant-fed rats and their pair-fed controls, and Figure 2-12 
compares these results with those of controls fed ad-libitum. It is 
observed from these Figures that the concentration of this enzyme showed 
a dramatic increase in ethoxyquin-fed rats, reaching peak level on the 
7th day when it was higher by 122% than in pair-fed controls, and by 93% 
than in controls fed ad-libitum. The peak level in propyl gallate-fed 
animals was also reached on the 7th day but it was only 13% higher than 
in pair-fed controls and 25% higher than in controls fed ad-libitum. In 
NDGA-fed rats the induction was slower and the peak level was reached on 
the 30th day when it was 25% higher than in pair-fed controls and about 
20% higher than in controls fed ad-libitum. No significant difference in 
the concentration of cytochrome b^ was observed in pair-fed controls from 
the levels in controls fed ad-libitum.
viii) Biphenyl 4-hydroxylase
Figure 2-13 shows the biphenyl 4-hydroxylase activity (ymole/h/g liver) 
in antioxidant-fed rats and their pair-fed controls, and Figure 2-14 
compares these results with those of controls fed ad-libitum. It is 
observed from these Figures that of the.three antioxidants only ethoxyquin 
significantly increased biphenyl 4-hydroxylase activity. Initially the 
induction was rapid and linear, reaching peak level on the 7th day when 
it was higher by 86% than in pair-fed controls and by 180% than in controls
fed ad-libitum. Thereafter the enzyme concentration fell but continued 
to remain elevated relative to controls, and on the 60th day showed a 
level higher by almost 100% than in pair-fed controls and by over 1401 
than in controls fed ad-libitum.
An important finding of this experiment was that the biphenyl 
4-hydroxylase activity in controls fed ad-libitum was initially at 
its maximum, it then steadily declined and on the 60th day of the study 
reached a level lower by 2901 than the value in the weaned animals.
The NDGA and propyl gallate-fed rats as well as their pair-fed controls 
followed more or less a similar pattern of decline.
ix) Ethylmorphine N-demethylase
Figure 2-15 shows the ethylmorphine N-demethylase activity 
(ymole/h/g liver) in antioxidant-fed rats and their pair-fed controls, 
while Figure 2-16 compares these results with those of controls fed 
ad-libitum. It is observed from these Figures that ethoxyquin Caused 
only initial induction of this enzyme (54% higher than in pair-fed 
controls on 3rd day). Thereafter it was even lower than the pair-fed 
control value (P < 0.05 on the 14th day) but this fluctuation disappeared 
by the 60th day when the activity was almost equal to pair-fed control
value, but lower by 24% than in controls fed ad-libitum.
Ethoxyquin test samples gave a blank value lower than the controls.
An interesting finding of this experiment was an initial rapid
increase in the enzyme activity in NDGA-fed rats, reaching peak 
level on the 3rd day when it was higher by 44% than in pair-fed 
controls and by 170% than in controls fed ad-libitum. Thereafter the 
enzyme activity was reduced and, compared with controls fed ad-libitum, 
it was significantly lower (P < 0.01) in NDGA-fed rats as well as in 
their pair-fed controls on the 60th day of the study.
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The ethylmorphine N-demethylase activity in propyl gallate-fed 
rats showed no significant difference from values in pair-fed controls 
as well as controls fed ad-libitum.
b) ELECTRON MICROSCOPIC STUDIES
The ultras true tural changes in the hepatocytes of ethoxyquin-fed 
rats (Plate 2-2) are compared with those of the pair-fed controls 
(Plate 2-1). It is observed from Plate 2-1 that the rough endoplasmic 
reticulum (RER) in the hepatocytes of the pair-fed controls consisted 
of narrow, stratified cistemae studded on their cytoplasmic aspects 
with small dense ribosomal granules. These cistemae aggregated into 
parallel arrangements characteristic of rat liver cells and were 
identified in the light microscope as ’basophilic.bodies’. Clusters 
of glycogen particles, interspersed with scanty tubules and vesicles 
of smooth endoplasmic reticulum (SER), mitochondria, and a few micro­
bodies were also present. Hie mitochondria were both oblong and 
spherical. These were all manifestations of a normal rat hepatocyte.
Plate 2-2 was prepared specifically to show the magnitude of 
alterations caused in the endoplasmic reticulum by dietary ethoxyquin. 
Here the hepatocyte contained only a little glycogen. The cistemae 
of RER were almost devoid of ribosomes, and the tubules and vesicles 
of SER were in abundance. These indicated a transformation of rough 
to smooth endoplasmic reticulum or a proliferation of the latter, and 
this parameter has often been used to study the origin and magnitude 
of induction of drug metabolizing enzymes.
GUT MICROFLORAL METABOLISM
The results of rat gut microfloral action on n-Propyl gallate,
BHA and NDGA are shown in Table 2-IV. It is observed from this Table
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Plate 2-1 - Electron micrograph of liver cell of pair-fed controls of rats fed 
ethoxyquin ad-libitum. The specimen was prefixed in buffered 4% glutaraldehyde 
and postfixed in buffered 2 % osmium tetroxide. The section was stained in 
aqueous 2 % uranyl acetate and Sato's (1 in 7) lead stain (x 10,500).
The unaltered RER consists of narrow, stratified cistemae studded on their 
cytoplasmic aspects with small dense granules, the ribosomes. The cistemae 
aggregate into the parallel arrangements characteristic of rat liver cell.
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Plate 2-2 - Electron micrograph, of liver cell of rats fed dietary ethoxyquin
ad-libitum. The specimen was prefixed in buffered 41 glutaraldehyde and 
postfixed in buffered 2 % osmium tetroxide. The section was stained in 
aqueous 2% uranyl acetate and Sato's (1 in 7) lead stain (x 10,500).
The hepatocyte contains little glycogen, cistemae of RER devoid of 
ribosomes, and abundance of SER. Parts of four red blood cells are visible 
at the bottom right-side.
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that propyl gallate had undergone some transformation by the microflora, 
although the bulk of the compound appeared on the chromatography plate 
unchanged. The ethereal extract of the incubate contained gallic acid 
(in all three), and trace amounts of pyrogallol (in two) and resorcinol 
(in two). BHA essentially was unchanged and the incubate contained 
only a trace of an unidentified compound (pink-grey, R£ = 0.08).
NDGA did not undergo any transformation.
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DISCUSSION
McCay in 1934 reported prolongation of life-span by under-feeding 
rats. Harman (1957; 1961; 1968a,b) observed similar life-span increasing 
effect in mice by feeding large amounts (0.5-2.0%) of antioxidants, such 
as ethoxyquin, ammonium diethyldithiocarbamate, BHT, BHT plus vitamin E, 
vitamin E, 2-mercaptoethanolamine, and hydroxylamine hydrochloride.
Comfort et al (1971) attributed the dietary restricting effect of 
antioxidants to spoilage of appetite, hindered assimilation of diet or 
reduction in the toxicity of laboratory diet. In the course of the 
experiments reported here it was observed that massive dosage of 
ethoxyquin (2 g/kg, i.g.) to weaning rats caused high mortality.
Calorie restriction due to gross reduction in acceptability was noted 
when 1.01 w/w of ethoxyquin was given for 10 days to 40-day old male 
rats. Similar but less pronounced depression in food-intake was also 
observed with 0.51 w/w ethoxyquin or NDGA. in the diet. The utilization 
of the food eaten by the test rats, however, remained unaffected, as 
pair-fed controls gained weight in a similar manner. These results on 
calorie restriction, although not in disagreement with McCay’s hypothesis 
or the idea of spoilage of appetite (Comfort et al, 1971), do not support 
the other suggestions that the antioxidants hindered assimilation of diet 
or reduced toxicity of laboratory diet.
Ross (1969) observed a correlation between life expectancy of rats 
and the dietary regimen imposed. He also found correlation between life 
expectancy and levels of hepatic enzyme activity, the enzymes studied were 
ATP-ase, alkaline phosphatase, histidase and catalase. Ross noted that 
the regimen which evoked the greatest rate of change with age was most 
detrimental and such rats had the shortest life expectancy. He suggested 
that the rapid growth, structural or biochemical, was not commensurate
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with prolonged life-span. As regards biochemical changes, Comfort 
et al (1971), however, laid importance on drug metabolizing enzymes 
and suggested that the prolongevity might be due to the induction of 
these enzymes.
From the results reported here it is observed that ethoxyquin 
and NDGA-fed rats,as well as their pair-fed controls, grew rapidly and 
maintained reasonable weight gains during the 60-day period of study.
The growth rate was, however, initially depressed, but by the end of 
the study this reduction in body weight was not significant. This 
agrees with the observation made by Comfort et al (1971).
Gilbert and Golberg (1965) observed that daily administration of 
BHT (500 mg/kg, i.g.) to female rats for a prolonged period increased 
liver weight and the activity of hepatic microsomal aminopyrine, codeine 
and nitroanisole demethylases, aniline hydroxylase and hexobarbitone 
oxidase. BHA given similarly showed less pronounced enlargement of 
liver and no increase in the activity of these microsomal enzymes.
Gaunt et al (1965) administered BHA to rats at a level of 0.11 w/w 
in the diet and observed similar changes initially, particularly in the 
females, but noted that the effects were not manifest after 4 weeks.
Creaven et al (1966) conducted experiments along similar lines with 
male rats by incorporating the BHA into the diet at various concentrations. 
After 12 days’ feeding of 0.11 and 0.251 of BHA they observed no significant 
increase in the liver weight nor in specific activities of biphenyl 
4-hydroxylase and 4-methoxybiphenyl demethylase. After 9 days’ feeding 
of 0.51 of the antioxidant they found significant elevation in the specific 
activities of the two enzymes but no increase in the liver weight. In 
the studies reported in this Chapter, daily administration of BHA 
(1 g/kg i.g.) for 60 days resulted in an increase in the liver weight
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and microsomal protein but no increase in cytochrome P-450 concentration 
or the specific activity of biphenyl 4-hydroxylase. These results are 
similar to those of Gilbert and Golberg (1965). It may be pointed out, 
however, that although the concentration of cytochrome P-450 and 
specific activity of biphenyl 4-hydroxylase were not effected their 
total contents were increased due to liver enlargement.
Murty et al (1970) observed that vitamin E deficiency in the rat 
led to decreased activities of bone marrow delta-aminolaevulinic acid 
synthetase and hepatic delta-aminolaevulinic acid dehydratase, and 
consequently of lowered levels of several haemoproteins including 
cytochrome P-450 and cytochrome b^ . These findings were supported by 
the work of Nair et al (1970) who found approximately a 6-fold induction 
of delta-aminolaevulinic acid synthetase by allylisopropylacetamide in 
vitamin E deficient rats than in the controls. Carpenter (1972) and 
Caygill et al, (1973) in contrast, found no difference in deficient
and control rats of cytochromesP-450 and b^ . Current work showed that 
supplementation significantly increased cytochrome P-450 which is in line 
with the observation of Murty et al (1970) and Nair et al (1970) that 
vitamin E may affect synthesis and concentration of cytochromes.
Although Carpenter found no significant difference in cytochrome 
P-450 levels she did observe (1967) lowered activities of codeine and 
aminopyrine demethylases which were restored (Carpenter, 1972) to 
normal levels by vitamin E supplementation. This reversal was dependent 
on protein synthesis, being blocked by actinomycin D. Gram and Fouts 
(1966) found no effect, in vitro, of tocopherol on the activity of these 
microsomal enzymes. This lends indirect support to the results of 
Carpenter (1967) on the role of vitamin E on in vivo protein synthesis.
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Cawthome et al (1970) found that vitamin E supplementation 
increased the activity of aminopyrine demethylase in female rats 24 to 
72 h after oral administration implying enzyme synthesis, but in 
the current studies, despite the elevated level of cytochrome P-450, 
the activity of biphenyl 4-hydroxylase was not increased.
Cawthome et al (1970) observed induction of microsomal drug 
metabolizing enzymes by ethoxyquin and reported that 24 to 72 h after 
single and multiple doses of the antioxidant (300-600 mg/kg orally 
and i.p.) to rats there was an increase in relative liver weight and 
in specific activity of aminopyrine demethylase, hexobarbitone oxidase 
and BHT oxidase. They found that BHT and ethoxyquin gave significant 
protection to rats against CCl^ toxicity, and suggested that treatments 
which protected rats against CCl^ toxicity were, in general, associated 
with an increase in enzyme activity. In a subsequent communication 
Cawthome (1973a) also reported induction of rat hepatic microsomal 
aminopyrine demethylase, hexobarbitone oxidase, aniline hydroxylase and 
cytochrome P-450, and implicated the elevated levels as protective 
effects against CCl^ toxicity, suggesting the induction of a detoxicating 
pathway. Slater (1966) postulated that CCl^ is converted in microsomes 
to the CCl^ radicals which initiate lipid peroxidation and supports the 
view that protection by antioxidants is afforded by their ability to 
scavenge free radicals. Since then, many reports have appeared on free 
radical production from CCl^ and the role of these radicals in cellular 
degeneration. This will be dealt with more fully in Chapter 7.
From the results of the present study it is observed that both 
ethoxyquin and NDGA. caused dramatic increases in relative liver weight, 
and concentrations of hepatic microsomal protein and cytochromes P-450 
and b^ , although these increases were more pronounced with ethoxyquin 
than with NDGA. In addition, ethoxyquin induced the specific activity
of biphenyl 4-hydroxylase but not of ethylmorphine N-demethylase, while 
NDGA increased the specific activity of ethylmorphine N-demethylase but 
not of biphenyl 4-hydroxylase. Among the other antioxidants studied, 
BHA caused hepatomegaly and raised the concentration of hepatic 
microsomal protein without effecting the specific activity of biphenyl 
4-hydroxylase, while vitamin E increased the concentrations of both 
hepatic microsomal protein and cytochrome P-450 but again without 
effecting the biphenyl 4-hydroxylase. Cawthome et al (1970) observed 
that vitamin E increased the activity of aminopyrine demethylase. The 
lack of correlation between the relative activities of demethylase and 
biphenyl 4-hydroxylase, and between these enzyme activities and 
cytochrome P-450 levels suggests that different antioxidants induce 
the synthesis of different forms of cytochrome P-450 or alter the 
conformation in the microsomal membrane in different ways. Alternatively, 
the concentration of cytochrome P-450 may not be rate limiting in both 
cases and the effects may be mediated via other enzymes in the electron 
transport chain.
The antioxidant propyl gallate, administered orally, did not have 
any significant effect on liver weight, microsomal protein or enzyme 
levels. In vitro studies revealed that it undergoes partial breakdown 
by rat gut microflora to gallic acid, pyrogallol and resorcinol which, 
being polar, are not likely to be absorbed. This may explain the 
apparent lack of effect of this antioxidant on prolongation of life-span.
The magnitude of enzyme induction by ethoxyquin and vitamin E 
agrees with Harman’s (1968a) findings on percentage survival of 
mouse at the age of 20 months (control: 9; 0.25% ethoxyquin: 75; 
vitamin E: 13) . Similar reports have not appeared on NDGA and BHA 
which also cause hepatomegaly and influence the inducibility of
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of microsomal drug metabolizing enzymes. As regards propyl gallate, 
Harman (1968b) reported that this antioxidant did not increase the 
life-span of mice. This fitted well with the inability of propyl 
gallate to induce the hepatic microsomal drug metabolizing enzymes.
Lane & Lieber (1967) reported that the antioxidant BHT which 
induces several drug metabolizing enzymes (Gilbert & Golberg, 1965) 
caused proliferation of the smooth endoplasmic reticulum (SER) in 
rat hepatocytes. Similar observation was made by Botham et al (1970) 
with the BHT (0-5%) in the diet. In the present study it has been 
observed that ethoxyquin which, like the BHT, induces the drug 
metabolizing enzymes, also caused a marked proliferation of SER in 
the rat hepatocytes.
Chapter 3
AGE DEPENDENT CHANGES IN SOME RAT HEPATIC MICROSOMAL 
ENZYMES AND THEIR INDUCTION BY ETHOXYQUIN
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AGE DEPENDENT CHANGES IN SOME RAT HEPATIC MICROSOMAL ENZYMES AND
THEIR INDUCTION BY ETHOXYQUIN 
Introduction
Liver microsomal preparations from neonatal rats are deficient in 
drug-metabolising enzymes but the activities of a number of these 
enzymes have been observed to increase progressively with age during 
the first 4-6 .weeks after birth (Kato et al, 1964;Sims and Grover, 1967; 
Gram et al, 1969; Basu et al, 1971). After the peak levrel is reached, 
the activity of these enzymes decreases gradually and in the case of 
biphenyl 2-hydroxylase, Basu et al (1971) observed that the activity fell 
to a negligible value at 52 days of age.
Ethoxyquin has been reported to increase mouse life-span (Harman, 
1968a; Comfort et al, 1971) and cause induction of rat hepatic microsomal 
drug-metabolising enzymes (Cawthome et al, 1970; Parke et al, 1972).
Parke et al (1972) suggested that the pro longevity produced by ethoxyquin 
might depend on its being an enzyme inducer, thus lending support to a 
proposition made earlier by Comfort et al (1971).
Prolonged administration of ethoxyquin has only a limited effect in 
improving. the survival rate and increasing the life-span. This suggests 
that the ability of ethoxyquin to induce and maintain the drug-metabolising 
enzymes at elevated .levels is not sustained even though it may keep it at 
an increased level over a long period of time. Alternatively, death of 
animals given ethoxyquin may result from different causes unrelated to 
hepatic function. To test the hypothesis that ageing may be accompanied 
by a loss in the ability of the animal to adapt to the challenge of 
potentially toxic materials in the diet, age dependent changes in some
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rat hepatic microsomal enzymes and their induction by ethoxyquin was 
studied by administering 0.5% w/w of the antioxidant in the diet from 
(a) weaning at 21st day, (b) 40th day, and (c) 365th day of age of rats.
The development of the enzymes studied was also examined in neonatal rats 
from the same colony to facilitate comparison of results. A preliminary 
report of this work has been published (Walker et al, 1973).
Materials and Methods 
Chemicals
Ethoxyquin, 96% g.l.c. pure grade, was obtained from Koch Light 
Laboratories.
Animals
Inbred male Wistar albino rats were used and accommodated in the 
University Animal Unit (see Chapter 2, page 37) during the experimental 
period.
Studies with neonatal rats
One group of 36 rats (6-day old) were killed, their livers weighed 
and pooled into 4 samples and processed to make 10,000 x £ supernatant 
and microsomal suspensions according to the method described in Chapter 
2 (page 43 ). The 10,000 x supernatant was used to assay the activities 
of biphenyl 4-hydroxylase, ethylmorphine N-demethylase and glucose-6- 
phosphatase. Microsomal protein and cytochromes P-450 and b^ concentrations 
were determined in the microsomal suspensions. The methods followed are 
given in Chapter'2 (pages 43-47) except the one for glucose-6-phosphatase which 
is given in Chapter 4 (page 118-119).
Similar experiments were carried out with 24 and 12 neonates 
respectively at 12 and 18 days of age.
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Long-term studies with weaned rats
One group of 4 rats (21-day old) were given powdered diet containing 
0.5% ethoxyquin ad-libitum and in a pair-feeding experimental protocol 
their controls were fed a control powdered diet equal to the amount 
consumed during the previous 24 h by the ethoxyquin-fed rats. At zero- 
time another 4 rats were killed and their-liver weights, biphenyl 
4-hydroxylase activity, ethylmorphine N-demethylase activity, and 
concentrations of microsomal protein and cytochromes P-450 and b^ determined 
as before. Hie animals on the pair-feeding protocol were maintained on the 
experimental diets for 365 days and thereafter killed on the 386th day of 
age and examined as above.
Long-term studies with 40-day old rats
Twelve rats were reared on control powdered diet from weaning at 
21 days of age and transferred to the pair-feeding experimental protocol 
on the 40th day of age. At zero-time 4 of these rats were killed and 
examined as before. The other 8 rats were maintained on the experimental 
diets for 400 days and killed on the 440th day of age and examined as 
above. In addition, the weights of their hearts, kidneys, brains, spleens 
and testes were also recorded.
Delayed exposure to ethoxyquin
Twenty eight rats reared on control powdered diet from weaning at 
21 days of age were transferred to the pair-feeding experimental protocol 
on the 365th day of age. At zero-time, 4 of these animals were killed and 
their liver weights and enzyme concentrations determined as before. Other 
rats were maintained on the experimental diets and after a period of 30,
60 and 90 days these animals were killed in groups of 8 rats (4 ethoxy­
quin-fed and 4 pair-fed controls) and examined as above.
RESULTS
There are several ways in which the results of the present study 
might have been expressed. Specific activities and concentrations are 
somewhat misleading in this case since ethoxyquin causes an increase in 
both specific activity and liver size. Total hepatic activity appeared 
not to be appropriate since body weight and liver weight were changing 
throughout the study, particularly in the early stages of development.
Hence relating activity to body weight appeared to be a reasonable index 
of the ability of the animal to detoxicate anutrients, particularly since 
in pharmacological and toxicological studies dosages are frequently 
calculated on a body weight basis without considering age related changes 
in hepatic function.
Studies with neonates and long-term studies with weaned and 40-day old rats •
The results of these investigations are given in Tables 3-1 and 3-II, 
and in Figures 3-1 to 3-8. In these figures the various parameters are 
qualified relative to body weight. The detailed data from which these 
Figures have been constructed are contained in the Appendix, Tables 3-IV 
to 3-XI where specific activities and concentrations are also shown. The 
Figures include results of the short-term study reported in Chapter 2 
to maintain continuity.
i) Body weight .
Figure 3-1 shows the body weight gains made by rats during the period 
of study. It is observed from this Figure that neonatal rats made rapid 
body weight gains and the growth was continued in controls fed ad-libitum 
and rats receiving ethoxyquin from weaning at 21 days of age, but the growth 
rate was slightly reduced in ethoxyquin-fed animals. The growth, rate of rats 
receiving ethoxyquin from 40 days of age was, however, more seriously 
impaired. This reduction in body weight gain by ethoxyquin-fed rats was
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Table 3-1 Age dependent changes of glucose-6-phosphatase
activity of male Wistar albino rats
Age
..... . ;..... 1 ‘ ........
Glucose-6-phosphatase activity (ymole/min./g liver) in
(pays) Neo-nates Rats fed ethoxyquin Pair-fed controls
6 8.6 + 0 -
12 9.8 + 0.4 -
18 10.2+0 - , -
35 - 5.5 +0.1 12.2+0.1
386 ■ — 4.6 + 0.1 8.1 +0.3*
The ethoxyquin was administered at a level of 0.5% w/w in the diet of 
treated rats from 21st day of age. Neonatal groups of rats consisted 
of 36, 24 and 12 animals respectively for 6, 12 and 18-day experiments. 
Tests and pair-fed controls of each of 35 and 386-day experiments consisted 
of four rats.
Values given are the means +_ SEM. Significant effects are shorn:
* P < 0.001.
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Table 3-11 Effect of ethoxyquin on age dependent changes in-
organ weights of male Wistar albino rats
Organs
Weight Cg] in
Ethoxyquin-fed rats Pair-fed controls
Heart 1.2 + 0,1 1.0+0*
Kidney 5.0 + 0.3 4.3 +0.3*
Brain 2.2 + 0 2,1+0
Spleen 1.1 _+ 0 1.0 + 0
Testis 3.6 + 0.2 3.2 + 0.1
The ethoxyquin was administered at a level of 0,5% w/w in the diet of 
treated rats from weaning at 40th day of age. The pair-feeding protocol 
was continued till the 440th day of age when the animals were killed and 
examined. Tests and pair-fed controls each consisted of 4 rats.
Values given are the means _+ SEM. Significant effects are shown:
* P < 0.05.
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Fig. 3-1 Effect of ethoxyquin on age dependent changes in body
weight of male Wistar albino rats t
600 -
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■x Neo-natal and controls fed ad-lib,
350 -
Tests from 21st day of age
300 -
Tests from 40th day of age
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Tests from 365th day of age
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150 -
100 -
50 >
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Age ( Days )
t The ethoxyquin was administered at a level of 0. 5 % w/w in the diet
of treated rats from 21st, 40th and 365th day of age
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Fig. 3-2 Effect of ethoxyquin on age dependent changes in liver
weight of male Wistar albino rats t
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15 “
1 0 -
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x  Neo-natal and controls fed ad-lib.
•  Tests from 21st day of age 
o------- o Pair-fed controls from 21st day of age
a------- ▲ Tests from 40th day of age
a------- *  Pair-fed controls from 40th day of age
■— Tests from 365th day of age
d - — —a Pair-fed controls from 365th day of age
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Age ( Days )
t  The ethoxyquin was administered at a level of 0. 5 % w /w in the diet 
of treated rats from 21st, 40th and 365th day of age
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Fig. 3-4 Effect of ethoxyquin on age dependent changes in
relative microsomal protein concentration ( mg/100 g
body weight) of male Wistar albino rats f
x- - - x Neo-natal rats and controls fed
ad-lib.
• --------•  Tests from 21st day of age
o Pair-fed controls from 21st day 
of age
Tests from 40th day of age
-a Pair-fed controls from 40th day 
of age
*-■ Tests from 365th day of age
20 -
D —  n  Pair-fed controls from 365th day 
of age
15 -
10 -
 A
0 50 100 150 200 250 300 350 400 450 500
Age ( Days )
t The ethoxyquin was administered at a level of 0. 5 % w/w in the
diet of treated rats from 21st, 40th and 365th day of age
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Fig. 3-5 Effect of ethoxyquin on age dependent changes in
relative cytochrome P-450 concentration (n mole/
lOOg body weight) of male Wistar albino rats, t
x-- x Neo-natal rats and controls fed ad-lib.
• —— •  Tests from 21st day of age.
o------ o Pair-fed controls from 21st day of age.
*-■ Tests from 40th day of age.
a------ a Pair-fed controls from 40th, clay of age.
b------ ■ Tests from 365th. day of age,
□— —a Pair-fed controls from 365th, day of age.
300
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t The ethoxyquin was administered at a level of 0. 5%w/w in the
diet of treated rats from 21st, 40th , and 365th day of age.
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Fig. 3-6 Effect of ethoxyquin on age dependent changes in
relative cytochrome bg concentration (n mole/lOOg 
body weight) of male Wistar albino rats, t
200 —i
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100 -1
50 n
Neo-natal rats and controls fed ad-lib. 
Tests from 21st. day of age.
Pair-fed controls from 21st. day of age. 
Tests from 40th. day of age.
Pair-fed controls from 40th. day of age. 
Tests from 365th. day of age.
Pair-fed controls from 365th. day of age.
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f  The ethyoxyquin was administered at a level of 0. 5%w/w in the 
diet of treated rats from 21st., 40th. and 365th. day of age.
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Fig. 3-8 Effect of ethoxyquin on age dependent changes in relative
ethylmorphine N-demethylase activity (fi mole/h/lOOg
body weight) of male Wistar albino rats.
X---- x Neo-natal rats and controls fed ad-lib.
• -------•  Tests from 21st. day of age.
o o Pair-fed controls from 21st. day of age.
a------ ▲ Tests from 40th. day of age.
a------ ^  Pair-fed controls from 40th. day of age.
■------ ■ Tests from 365th. day of age.
□------ □ Pair-fed controls from 365th. day of age.
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f  The ethoxyquin was administered at a level of 0. 5%w/w in the 
diet of treated rats from 21st., 40th. and 365th. day of age.
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mainly due to their reduced food-intake.
After about ICO days of age the rate of increase in body weight 
was gradually reduced in all the groups and the ethoxyquin-fed rats 
continued to remain lighter than the controls fed ad-libitum.
ii) Liver weight
Figure 3-2 shows the liver weight gains. It is observed from this 
Figure that liver weight increased rapidly in developing rats up to 
about 81 days of age and thereafter the increase in liver weight was 
more gradual. Rats fed ethoxyquin in the diet had significantly bigger 
livers than their pair-fed controls as well as controls fed ad-libitum.
On 81 days of age the liver weight in rats fed ethoxyquin from 21.days 
of age was 53% and 29% higher than in their pair-fed controls and controls 
fed ad-libitum respectively; on 386 days of age the increase in the 
ethoxyquin-fed rats was about 67% higher than in pair-fed controls. The 
group fed ethoxyquin from 40 days of age had, on 440 days of age, a 39% 
increase in liver weight compared with their pair-fed controls.
iii) Relative liver weight
Figure 3-3 shows the relative liver weight (g/100 g body weight) of 
neonates and rats put on experimental diets from 21 and 40 days of age.
It is observed from this Figure that the animals fed ethoxyquin in the 
diet from 21 days of age initially had a significantly higher rate of 
liver weight gain than thair pair-fed controls and controls fed ad-libitum. 
On 35 days of age when the peak in relative liver weight was reached in all 
groups of rats the level in the ethoxyquin-fed rats was 73% and 42% more 
than in pair-fed controls and controls fed ad-libitum respectively. 
Thereafter, the relative liver weight decreased in all groups of rats till 
maturity on 81 days of age, and from this age onwards there was a slow 
decrease in relative liver weight. On 386 days of age the relative liver.
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weight in rats given ethoxyquin from 21 days of age was 64% higher than 
in their pair-fed ’controls. On 440 days of age the value in the group 
fed ethoxyquin from 40 days of age was 41% higher than in their pair-fed 
controls.
iv) Relative microsomal protein concentration
Figure 3-4 shows the relative microsomal protein concentration 
(mg/100 g body weight). It can be seen from this Figure that the 
relative concentration of microsomal protein increased sharply in neonatal 
rats and controls fed ad-libitum from 21 days of age reaching a peak at 
35 days of age. Ethoxyquin in the diet from 23 days of age caused a 
dramatic increase in microsomal protein concentration reaching a peak 
level at 35 days of age when the relative concentration was more than 
double than in animals receiving control diet ad-l'ibitum. In contrast, 
the peak in pair-fed controls was delayed till the 51st day indicating 
impairment due to initial calorie restriction imposed by the pair-feeding 
experimental protocol. Thereafter, the relative concentration of microsomal 
protein sharply declined in all groups as the animals approached maturity. 
From the 81st day onwards the decline was comparatively less pronounced but 
apparent in ethoxyquin-fed rats as well as their pair-fed controls. On 
the 386th day of age the level, however, remained significantly elevated in 
the ethoxyquin-fed group and was 78% higher than in their pair-fed controls. 
The controls fed ad-libitum did not show continuing fall in relative 
microsomal protein concentration and there was an increase in this parameter 
between the 81st and 365th day of age.
Ethoxyquin administered in the diet from the 40th day of age also 
caused a marked increase (68%) in relative microsomal protein concentration 
compared with pair-fed controls by the 440th day of age. The later 
administration of ethoxyquin and more marked reduction in food-intake
resulted in relative microsomal protein concentrations being higher 
than the corresponding groups placed on the experimental regime from 
21 days of age.
v) Relative concentrations of cytochrome sP-450 and br
The relative concentrations (n mole/100 g body weight) of 
cytochromesP-450 and b^ are shown in Figures 3-5 and 3-6 respectively.
It is observed from these Figures that in general, the relative 
concentrations of these cytochromes paralleled the microsomal protein, 
with ethoxyquin causing a marked increase in the concentration compared 
with both pair-fed controls and controls fed ad-libitum. It is noteworthy 
that after the initial peak cytochrome P-450 concentration in pair-fed 
controls from 21 days of age, fell to weaning level,while the capacity 
for induction by ethoxyquin appeared to diminish with age. In the case 
of cytochrome b^, both the control level and the capacity for induction 
also diminished with age.
Exposure to ethoxyquin from 40 days of age led to a higher level
of induction of both cytochromes at the end of the study on 440 days of
age than did exposure from 21 days, as was also the case with microsomal 
protein.
vi) Relative biphenyl 4-hydroxylase activity
Figure 3-7 shows the relative biphenyl 4-hydroxylase activity 
(ymole/h/100 g body weight) in rats under study. It is observed from 
this Figure that there was a marked increase in the relative activity 
of biphenyl 4-hydroxylase in neonatal rats and on weaning till the peak 
level was reached between 24 and 28 days of age in both treated and
untreated rats. Thereafter the relative activity in all groups rapidly
declined till 81 days of age, and from that date onwards the ra,te of
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decrement was very slow but approached neonatal levels in the pair-fed 
control group by the end of the study.
In contrast to the relative concentrations of microsomal protein and 
cytochromes P-450 and b^, exposure to ethoxyquin from 21 days of age caused 
a more marked increase in this parameter at the end of the study than 
did exposure from 40 days of age. In the former case the relative 
activity of biphenyl 4-hydroxylase was increased to 2571 of pair-fed 
control values whereas in the latter case the activity was 1831 of the 
pair-fed control values.
vii) Relative ethylmorphine N-demethylase activity
Figure 3-8 shows the relative ethylmorphine N-demethylase activity 
(ymole/h/100 g body weight) in rats under study. It is observed from this 
Figure that the relative activity of this enzyme rapidly increased in the
neonates reaching a peak level on 35 days of age in both the pair-fed
controls as well as the controls fed ad-libitum. Subsequently the 
controls fed ad-libitum maintained more or less a constant level butthe 
relative activity in both ethoxyquin-fed and their pair-fed controls 
sharply declined till 81 days of age and thereafter at a comparatively
slower rate till the end of the study. On 386 days of age the level in the
ethoxyquin-fed group from 21 days of age was 371 higher than in pair-fed 
controls while on the 440th day of age the relative activities in both 
ethoxyquin-fed rats and pair-fed controls of the groups started at 40 days 
of age were at somewhat higher levels although the level in the antioxidant- 
fed rats was not significantly different from the pair-fed control value.
viii) ,Glucose-6-phosphatase activity -
The specific activities of glucose-6-phosphatase (ymole/min./g liver) 
in neonates, and 35 and 386-day old rats are given in Table 3-1. It is 
observed from this Table that during the period from the 6th to 18 day of
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of age the specific activity of this enzyme increased by only 18% but 
due to increase in liver weight the total activity increased by about 
3751. On the 35th and 386th day the specific activity in ethoxyquin- 
fed groups from weaning at the 21st day of age declined respectively 
by 551 and 431, but the total hepatic activity in ethoxyquin-fed rats 
was not significantly different from values in pair-fed controls indicating 
dilution of this particular enzyme in the induced endoplasmic reticulum 
by other enzymes and cellular constituents.
ix) Additional organ weights
The weights of some additional organs of the 440-day old rats are 
given in Table 3-11. It is observed from this Table that heart and 
kidney weights in ethoxyquin-fed rats were significantly higher (P< 0.05) 
than the values in pair-fed controls. Visual examination of the kidney 
showed definite signs of haemorrhage. The weights of brain, spleen and 
testes were similar to control values.
Delayed exposure to ethoxyquin
The mean daily food-intake (g) during the first 4 weeks by the rats 
under this study are given in Table 3-III. It is observed from this Table 
that the 1-year old rats given a diet containing 0.5% w/w ethoxyquin 
refused the test diet and the acceptability remained very lowr (P < 0.001) 
during the first 2 weeks resulting in gross calorie restriction. During 
the third week the food-intake was increased and by the end of the fourth 
week it was not significantly different from the mean daily food-intake 
by controls fed ad-libitum.
Other results of this study are given in Figures 3-1 to 3-8 and also 
in Tables 3-IV to 3-XI in the Appendix for ready reference. It is observed 
from these Figures that in pair-fed controls the initial calorie restriction
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Table 3-III Mean daily food-intake by male Wistar albino rats
during 4 weeks from 365th day of age
Period
(days)
Age of rats 
(days)
Mean daily food-intake (g)
Rats fed control 
diet ad-libitum
Rats fed diet containing 
ethoxyquin ad-libitum
0 365 22.0 + 0*5 1.6 + 0.8§
4-7 369-372 21.9 + 1.0 0.9+0.8S
• 8-14 373-379 22,4+0.6 5,0+2.2§
15-21 380-386 23.1+0.6 16.3 + 2.8
22-28 387-393 22.5+0.5 22.0+1.0
i
The ethoxyquin was administered at a level of 0.5% w/w in the diet of 
treated rats from 365th day of age. Tests and controls each consisted 
of four rats.
Values given are the means +_"SEMi Significant effects are shorn:
§ P < 0.001.
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adversely affected the body weight and liver weight gains as well as 
the increases in relative concentrations of microsomal protein and 
cytochrome P-450, and in the relative activity of ethylmorphine N- 
demethylase. Relative liver weight, concentration of cytochrome b^ and 
activity of biphenyl 4-hydroxylase in these rats, however, remained 
unaffected suggesting sparing effect on them. Subsequent increase- 
in food-intake removed the adverse effects of gross dietary restriction.
The relative ethylmorphine N-demethylase activity, however, continued 
to fall and approached the pair-fed control values of the long-term 
studies.
The effect of calorie restriction was also observed on body weight 
of ethoxyquin-fed rats. Ethoxyquin, however, increased liver weight and 
consequently the relative liver weight. As a result, even during the 
period of gross dietary restriction the relative concentrations of 
microsomal protein and cytochromes P-450 and b^, and relative activities 
of biphenyl 4-hydroxylase and ethylmorphine N-demethylase were elevated. 
With the increase in food-intake the body weight and liver weight were 
also increased, resulting in almost a constant relative liver weight.
During the second month of the study the relative concentrations of 
microsomal protein and cytochromes P-450 and b^ were reduced to a level 
lower than that present after the first month. This suggested 
accumulation of other liver constituents during this period. The 
position was thereafter changed and increased levels in the relative 
concentrations of microsomal protein and cytochromes P-450 and b^ were 
observed by the end of the 90-day study. The relative activity of biphenyl 
4-hydroxylase, however, did not increase during the third month, rather 
showed a depression suggesting impairment of the functionality of 
cytochrome P-.450. This was more markedly demonstrated by the pair-fed 
control value which fell below neonatal levels.
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DISCUSSION
The organ weight development in Wistar albino rats from the colony 
under study has been investigated over a period of 100 days by Basu et al 
(1971). They observed that the body weight increased rapidly until 100 
days of age and the liver weight until 70 days, and the total hepatic 
microsomal protein followed a similar pattern with age. In the present 
study the growth of the rat was recorded up to 365 days of age and it was 
observed that after the initial rapid increase in body weight, the growth 
was maintained but at a slower rate. The liver weight and relative 
concentration of microsomal protein rapidly increased in neonatal rats, 
and from the results reported in Chapter 2 and shown in the relevant 
Figures in this Chapter, it may be observed that after the initial peak 
level, the liver weight had continued to increase over the period of 
81 days but at a comparatively slower rate.* After the initial peak, the 
relative concentration of microsomal protein, however, sharply declined till 
the end of the 81-day study period.
The development of activities of a number of hepatic drug-metabolising 
enzymes has also been examined over the period of 100 days by Basu et al 
(1971). They observed that the cytochrome P-450 concentration showed a 
peak level at the age of 31 days and this was followed by a sharp decrease 
at 38 days almost to the value for mature animals. As for the biphenyl 
4-hydroxylase, they found that it showed a maximal activity at 24 days of 
age and then decreased to 401 of this value by 85 days. The results of the 
present study on relative cytochrome P-450 concentration and relative 
biphenyl 4-hydroxylase activity follow the pattern observed by Basu et al 
(1971).
Chronic administration of ethoxyquin to rats from weaning at 21 days 
of age caused slight initial restriction in food-intake and consequently
on body weight gain (Parke et al, 1972). Ethoxyquin also caused 
hepatomegaly and induction of hepatic microsomal protein and several 
drug-metabolising enzymes. After the initial peak, the relative liver 
weight, relative concentrations of microsomal protein and cytochromes 
P-450 and b^, and the relative activities of biphenyl 4-hydroxyalse 
and ethylmorphine N-demethylase sharply declined till the ethoxyquin- 
fed rats approached maturity at 81 days of age. Thereafter the 
relative liver weight, microsomal protein concentration and biphenyl 
4-hydroxylase activity fell slightly whereas the relative concentrations 
of cytochromes P-450 and b^ and the activity of ethylmorphine N-demethylase 
declined markedly, but the induced levels continued to remain at elevated 
levels compared with pair-fed controls. On the 386th day of age the 
relative liver weight, and the relative concentrations of microsomal 
protein and cytochromes P-450 and b^, and the activities of biphenyl
4-hydroxylase and ethylmorphine N-demethylase of the pair-fed controls fell 
to neonatal levels indicating gross loss in the capacity to detoxicate 
foreign compounds by these rats. The capacity to respond to dietary 
ethoxyquin by an adaptive increase in these parameters also diminished with 
age although a marked increase over basal levels in pair-fed controls was 
still observed. The fall with age of the capacity of the liver to 
detoxicate anutrients and its respond to increases in metabolic demand 
have obvious implications in geriatrics when drug dosages may be calculated 
on a body weight basis without taking into account impaired liver function. 
Thus, O’Malley et al (1971) have shown that the plasma half-life of anti- 
pyrine and phenylbutazone are respectively 451 and 30% greater in male 
geriatric patients than in young adults.
Exposure of 40-day old rats to ethoxyquin caused some restriction on 
food-intake during the first week of the study but was far better than the
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effect of introduction of the antioxidant after one year of age when 
the food-intake was grossly impaired over a period of 3-4 weeks. This 
caused a sharp fall in body weight due to the rapid utilization of liver 
glycogen and on the overall basis; the fats and proteins. As a result, 
there was a relative increase in the concentrations of hepatic 
microsomal proteins and enzymes, and these levels quickly went up due 
to the synthesis followed by restoration in the calorie-intake.
Ethoxyquin decreased the specific activity of hepatic glucose-6- 
phosphatase but maintained the total liver level of this enzyme 
indicating that. this parameter remained unaffected by ethoxyquin and 
was simply diluted in the endoplasmic reticulum by the induced levels 
of other enzymes.
Chronic administration of ethoxyquin (0*5% of diet) up to 440 days 
of age increased heart weight and kidney weight,and caused damage to the 
kidney. Recent work in this Department (Rudra et al, unpublished) lias 
shown high mortality due to kidney damage after exposure of rats to dietary 
ethoxyquin CO-51) for a still longer period. These results are in 
agreement with the earlier report of Wilson and DeEds C1959) that ethoxyquin 
CO.0251). increased kidney weight and caused kidney damage.
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REVERSIBILITY OF HEPATIC CHANGES CAUSED BY ETHOXYQUIN
INTRODUCTION
In view of the fact that ethoxyquin is widely used in the 
preservation of food and feed-stuffs, it is important to know if 
the hepatomegaly and other changes previously reported (Cawthome 
et al, 1970; Parke et al, 1972) are adaptive and reversible or 
manifestations of a toxic response. A preliminary report of this 
work has been published (Parke et al, 1973b).
MATERIALS AND METHODS 
Chemicals
Ethoxyquin was obtained from Koch-Light Laboratories. Glucose- 
6-phosphate disodium salt, hydrated and deoxyribonucleic acid (DNA, 
Type I, sodium salt) were obtained from Sigma. Haematoxylin and 
eosin were BDH microscopical staining grade.
Mention has been made of other chemicals in the text where 
relevant.
Animals
Weanling male Wistar albino rats were fed ad-libitum a powdered 
diet containing 0.59o ethoxyquin for 14 days. Controls were pair-fed 
with control powdered diet containing no added ethoxyquin. The 
experimental protocol was similar to that previously reported with 
ethoxyquin and nordihydroguaiaretic acid (Parke et al, 1972 and 1973a) 
and detailed in Chapter 2 (pages 38-39) .All the animals were given 
water ad-libitum.
Biochemical studies
Four animals 'from the ethoxyquin-fed group and four from their 
pair-fed controls were killed by cervical fracture at the end of 
the 14-day period of treatment with ethoxyquin (zero day) and there­
after at intervals of 3, 7, 14 and 30 days. Immediately after 
killing, the livers were rapidly excised, freed from adhering 
connective tissue, washed in ice-cold 1.15% KC1 solution, blotted 
and weighed. Liver homogenates, 10,000 x £ supernatants and 
microsomal preparations were then prepared by the method described 
in Chapter 2 (page 43 ).
Portions of the homogenates were used to separate the DNA 
(Zamenhof et al, 1964) and to determine this qunatitatively by the 
diphenylamine reaction (Burton, 1956). The 10,000 x g supernatant was 
used to assay biphenyl 4-hydroxylase activity by the method of Creaven 
et al (1965), as modified by Neale (1970). This supernatant
was also used to assay ethylmorphine N-demethylase activity by the 
method of Holtzman et al (1968) and glucose-6-phosphatase activity 
by the method of de Duve et al (1955). The microsomal suspension was 
used to determine the concentrations of cytochrome P-450, cytochrome 
bt-, and microsomal protein by the methods of Sladek and Mannering (1966), 
Schenkman et al (1967), (and Lowry et al (1951) respectively. These 
methods have been detailed in Chapter 2 (pages 43-47), 
except those for DNA. and glucose-6-phosphatase which are described in 
pages 117-119.
Light microscopic studies
Liver specimens (5 mm dia.) from lateral lobes of 4 ethoxyquin- 
fed rats as well as their pair-fed controls were, after the 14-day 
period of pretreatment, preserved in 101 formalin buffered with 
phosphate (4.6 g sodium dihydrogen orthophosphate, dihydrated, and
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6.5 g disodium hydrogen orthophosphate per litre) for light microscopic 
studies according to the method of Carleton 0-973) and as described in 
pages 119-122.
i) Determination of DNA
One ml of liver homogenate [250 mg liver) in a 50 ml plastic 
screw-capped Sovirel tube was mixed well with 10 ml of ice-cold 6% 
perchloric acid (PCA) by stirring with a glass rod. After standing 
in the cold for 20 min. the tube was capped and centrifuged at 2,000 
r.p.m. for 10 min. at 0-4°C in an MSE Magnum centrifuge using a 
12 x 50 ml angle head. The supernatant was carefully removed and 
the sediment suspended in 10 ml of ice-cold 951 ethanol. After 10 min. 
extraction of fat the tube was centrifuged as before and the supernatant 
discarded. The operation was repeated to remove the residual fat. 
Thereafter the sediment was suspended in 10 ml of 6% PCA and incubated 
in a water bath at 90°C for 15 min. with occasional stirring. The 
tube was then centrifuged, the supernatant decanted into a 25 ml 
volumetric flask, the pellet resuspended in a further 5 ml of 61 PCA 
and treated as before. The combined supernatant was then made to volume 
with 6% PCA and mixed thoroughly.
The DNA extract 0  ml) was mixed with 1 ml of 6% PCA and 4 ml 
of diphenylamine reagent 0-5 g recrystallised diphenylamine dissolved 
in a mixture of 100 ml of glacial acetic acid, 1.5 ml of conc. ^SO^ 
and 0.5 ml of aqueous acetaldehyde containing 8 mg of redistilled 
acetaldehyde). The mixture was heated in a stoppered tube in an oven 
for 45 h at 30°C for maximum colour development. After cooling, the 
absorbance of the mixture was read at 600 nm in a Cecil CE 272 Linear
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Readout Ultraviolet Spectrophotometer. A reagent blank containing the
%
diphenylamine reagent, and standards with known amounts of DNA (20 to 
100 yg per ml) were run through the same procedure. A standard curve 
for various concentrations of DNA was plotted and the DNA content in 
the sample determined and expressed as mg DNA/g liver.
The stock DNA standard was prepared by dissolving 40 mg of DNA 
in 100 ml of 5 mM sodium hydroxide solution. The working DNA standard 
(200 yg per ml) was made by mixing 1 volume of stock DNA standard with 
1 volume of 10% PCA and then incubating in a water bath for 15 min. at 
70°C.
ii) Determination of inorganic phosphate formation from glucose-6-phosphate 
Glucose-6-phosphate on incubation in the presence of glucose-6- 
phosphatase liberates inorganic phosphate which produces a coloured complex 
on mixing with ammonium molybdate and ascorbic acid. The glucose-6-
phosphatase activity can be determined from the O.D. of this colour 
measured at 720 nm in a spectrophotometer. The following incubation 
mixture was used in the experiment:-
3,3-Dimethylglutarate buffer, 0.2M (pH 6.4) 0.3 ml
EDTA solution, 0.01 M 0.1 ml
Liver homogenate, 10 mg/ml 0.5 ml
Total 0.9 ml
The mixture was warmed in a 10 ml tube at 37°C in a Mickle shaking 
water bath at a shaking speed of 80 strokes per min. After about 2 min.
0.1 ml of glucose-6-phosphate substrate (0.05M) was added and the tube 
incubated in a shaking water bath for exactly 10 min.
The phosphatase activity was stopped by cooling the tube in ice-cold 
water and adding 10% TCA solution (2 ml). Thereafter 1 ml of water was
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added to the tube, the contents mixed and centrifuged at 2,COD r.p.m. 
in a Mistral 6L centrifuge at 0-4°C for 10 min. The supernatant (2 ml) 
was mixed with 3 ml of molybdate solution (6 g ammonium molybdate in 
500 ml 10% PCA and diluted to 1 litre with water) and 1 ml of 0.2% 
ascorbate solution. The tube was allowed to stand at room temperature 
for exactly 60 min. and then the absorbance of the colour developed 
read at 720 nm in 1 cm light path in a Cecil CE 272 Linear Readout 
Ultraviolet Spectrophotometer.
All samples were run in duplicate. A reagent blank (witlx substrate 
added after termination of incubation) and standards (with potassium 
dihydrogen orthophosphate standard, 1 ymole/ml, and substrate added after 
termination of incubation) were run through the same procedure. The 
rate of inorganic phosphate formed from glucose-6-phosphate was then 
calculated as glucose-6-phosphatase activity, ymole/min./g liver.
Light microscopic studies
a) Pre-embedding dehydration
The tissues preserved in buffered formalin and stored at room 
temperature for 7 to 10 days to produce optimal fixation were freed from 
the fixative by washing in water and then dehydrated by processing through 
graded alcohol, as shown below, using an automatic tissue processing 
machine
70 per cent alcohol
90 per cent alcohol
Industrial methylated spirit (IMS)
(2 changes)
Industrial methylated spirit (IMS)
(2 changes)
b) Clearing and impregnation
The dehydrated tissue samples were freed from alcohol by treating with
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3 to 8 h.
2 h.
1 h. each
2 h. each.
toluene which in turn was eliminated in the process of wax impregnation.
The operation was as under_: -
Toluene 1\ h
Toluene 2\ h
Wax bath (in vacuum oven, 60°C),
2 changes 3 h each.
From the second wax bath the samples were transferred to a third 
change of wax in the vacuum oven before embedding so that the evaporation 
of the last traces of the clearing agent was completed and full impregnation 
of the samples took place after expelling the trapped air bubbles. The 
vacuum range used was 300 to 500 mm Hg and the reduction and increase in 
pressure was carried out slowly to avoid danger of rupture of tissue 
materials.
c) Embedding
The samples with faces to be cut down were inserted into molten 
paraffin wax in moulds on rubber block holders and after a skin of wax 
had formed completely over the surface the solidification was hastened 
by carefully immersing the holder in cold water. In about 15 min. the 
structure of the wax blocks became finely crystalline and homogenous., 
and after complete solidification the blocks were removed from the moulds 
and stored in room temperature.
d) Section cutting
The block was then trimmed, affixed on a wooden block holder,fitted 
in the object clamp of a rotary microtome, and the surplus wax from the 
cutting face of the tissue was roughed down with the knife by using a 
cutting thickness of 25y. Thereafter the microtome was readjusted to 
give a cutting thickness of 8y, the sections cut and floated in a 
water bath maintained at 40°C, and the wrinkles that remained were removed
by gentle stretching with fine forceps or needles.
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e) Staining of sections
The floating sections were mounted on clean microscope slides 
(75 x 25 mm) and, after most of the water drained away, dried by 
pressing firmly and uniformly with a wet filter paper. Thorough 
drying was then effected by placing the slides for 24 h in an oven
m oTnf n +• A  C nr\/l rwnn-P-f nv* -fT-»A r»rkr* t . rn •v* r»4-o *i -r«rv/^  o r
i u u x i i L a x i i ^ u  a u  *t j w  v j  c u i u  u i u x u a x  t v i  o v ; c t i . u i i o  n g i u  o  t a x i i v ^ u ^  a .* 7
below, by using the automatic tissue processing machine: -
1. De-waxing in toluene to increase permeability to stain,
2 changes - 2 minutes each.
2. Removing toluene with IMS, 2 changes - 1 minute each.
3. Treating with descending grades of alcohol - 90, 85, 70 and 501,
2 minutes each.
4. Wetting in water - 1 minute.
5. Regressive staining with haematoxylin solution (prepared by 
dissolving 2 parts of the dry substance with 70 parts of warm 
water, 15 parts of glycerol and 15 parts of IMS) - 4 to 5 minutes.
6. Removal of excess stain from unwanted parts of the tissue by
washing with acid alcohol (prepared by mixing 1 part of conc.
HC1 with 99 parts of 70% alcohol) - 5 seconds.
7. Stopping the decolonization and regaining the blue colour by 
washing with alkaline running tap water - 5 minutes.
8. Staining in 1.0% aqueous eosin - 4 minutes.
9. Dehydrating the stained section by passing through ascending
grades of alcohol - 85 and 90% and IMS (lower grades were not 
used because they dissolved and removed eosin) - 1 minute each.
10. Clearing the alcohol by treating the dehydrated section with 
toluene, 2 changes - 1 minute each.
f) Mounting of stained section
The surplus toluene was carefully wiped from around the stained 
section which was then carefully lowered to make contact with a coverslip 
containing on it 1 or 2 drops of a mounting medium such as DPX (mixture 
of distrene, tricresyl phosphate and xylene; BDH) which has a refractive 
index as near as possible to that of glass (1.518).
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g) Photography and printing
Six slides were prepared from each sample. These were studied 
under a Leitz Orthoplan Microscope fitted with an Orthomat Camera, 
eye piece magnification of x 12.5, binocular head magnification of 
x 1.25 and objective magnifications of x 10, x 25 and x 40. The 
fields selected were photographed, and the films utilized were developed 
in ID 11 and fixed in "Kodafix", and finally the photomicrographs made 
from the negatives.
RESULTS
The results of the biochemical studies are given in Table 4-1 and 
shown with SEM in Table 4-II in the Appendix. The photomicrographs 
in Plates 4-1 and 4-2 show the results of the light microscopic studies.
It is observed from the Tables that after 14 days1 pretreatment 
with ethoxyquin the liver weight was increased by 941 compared with 
pair-fed controls while the body weights were not significantly different. 
The DNA concentration was decreased by 34% although the total hepatic 
DNA content was increased by 28% and the light microscopic studies 
(Plates 4-1 and 4-2) revealed no obvious increase in nuclear size or in 
the number of polynucleated cells. The Tables also show relative 
increases in both concentration and total content in liver of pretreated 
rats of microsomal protein, cytochrome P-450 and cytochrome b^, and of 
the specific and total activity of biphenyl 4-hydroxylase. The specific 
activity of ethylmorphine N-demethylase was depressed by about 13%, but 
due to increased liver mass, the total activity in the liver was increased 
by over 68% relative to pair-fed controls. The specific activity of the 
hepatic glucose-6-phosphatase in the pretreated rats was reduced to 45% 
of control values while there was no significant difference in the total 
content in the liver of both the groups.
TABLE 4-1 Percentage change in the level of some hepatic
microsomal enzymes and certain other parameters 
of male Wistar albino rats during the period of 
recovery from the effects of dietary ethoxyquin
Parameters Period after withdrawal of ethoxyquin (days)
0
1
1 1 7
1. Body weight (g) 7.1 5.0 3.4 0.5 2.4
2. Liver weight (g) 94.4 33.3 24.0 16.5 3.3
. 3. DNA content 
(a) mg/g liver -34.4 -3.6 -11.4 -6.5 0
(JO mg/liver 27.8 28.6 9.6 9.0 3.2
4. Microsomal protein content
(a) mg/g liver 42.6 11.9 0,4 -1.5 -5.8
(JO mg/liver 178.5 49.4 29.2 14.6 -2,8
5. Cytochrome P-450 content •
(a) nmole/g liver 100.9 33.5 7,8 -3,3 -4,8
(JO nmole/liver 289.9 77.4 33,3 12,5 -1.7
6. Cytochrome content
(a) nmole/g liver 76,4 . 53,5 44,6 15,4 7.9
(JO nmole/liver 272.3 105.9 77.8 35.1 11.6
7. Biphenyl 4lhydroxylase 
activity
(a) ymole/h/g liver 56,9 39.7 12.5 -5.6 3.3
(JO ymole/h/liver 211.1 85.0 39.1 10.7 5.4
8. Ethylmorphine N-demethylase 
activity
(a) ymole/h/g/liver -13.2 18.2 -4.5 -4.0 -2.9
(bj ymole/h/liver 68.6 57.6 18.6 11.9 0.2
9. Clucose-6-phosphatase 
activity
(a) ymole/min/g liver -54,9 -14,9 -15.1 6.2 -1.8
(JO ymole/min/liver -11.4 14.7 5.3 23.6 1.4
—
Ethoxyquin was administered at a dietary concentration of 0.5% during the 14-day 
pre treatment period.
Controls and tests each consisted of 4 animals.
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Plate 4-1. Photomicrograph of liver of rat killed after pair-feeding 
with control diet for 14 days (H.E.: x 390.6).
The photomicrograph shows normal histological pattern of liver.
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Plate 4-II. Photomicrograph of liver of rat killed after feeding ethoxyquin 
in the diet ad-libitum for 14 days (H.E.: x 390.6).
The photomicrograph shows some vacuolation of hepatic cells.
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The course of recovery after withdrawal of ethoxyquin is also 
shown in the Tables. It is observed from the Tables that the DNA 
concentration was normal by the third day while microsomal protein 
concentration and enzyme concentrations other than that of cytochrome 
b^ were not significantly different from control levels by the seventh 
day. The liver weight and the total contents of microsomal protein 
and the enzymes studied did not fall to control levels until the 
thirtieth day although in most cases the difference was not statistically 
significant after fourteen days.
DISCUSSION
Bolender and Weibel (1973) reported that the induction of microsomal 
enzymes by phenobarbitai did not produce an increase in nuclear volume. 
The present light microscopic studies of* liver sections from rats 
pretreated for 14 days with ethoxyquin also showed similar results.
This suggests that in view of the decrease in hepatic DNA concentration 
and increase in total DNA content the enlargement of liver in treated 
rats may have resulted from both cell hypertrophy and cell hyperplasia.
On this basis it was calculated from the results of the DNA analyses 
that the increase in liver mass was due to a 28% increase in cell number 
and a 52% increase in cell mass.
Ethoxyquin causes induction of drug-metabolising enzymes (Cawthome 
et al, 1970; Parke et al, 1972). In reporting their findings, Parke 
et al (1972) noted that ethoxyquin did not consistently increase the 
specific activity of ethylmorphine N-demethylase. The results of the 
present investigation agree with this observation.
The reduction of the specific activity of glucose-6-phosphatase to 
451 of control values appears to result mainly from changes in the nature
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of the. proliferated endoplasmic reticulum rather than from inhibition 
by ethoxyquin, as the total amount of glucose-6-phosphatase in the 
liver was not significantly reduced and in vitro studies (see 
Chapter 5) have shown that ethoxyquin is not an inhibitor of this 
enzyme. A fall in glucose-6-phosphatase activity frequently is observed 
in hepatitis and during the development of some tumours, but long-term 
studies in rats (Walker et al, 1973), and mice (Comfort et al, 1971), 
using high dietary levels of ethoxyquin did not reveal any obvious signs 
of chronic hepatitis or tumorigenesis. From this it appears that 
induction of the drug-metabolising enzymes of the endoplasmic reticulum 
may lead to a ’dilution’ of the microsomal glucose-6-phosphatase.
Feuer and co-workers (1965) have proposed that glucose-6-phosphatase 
be used as a biochemical index of hepatotoxicity and demonstrated that 
several known hepatotoxic compounds caused a lowering in the specific 
activity of this enzyme. However, 2-phenylindole and the antioxidant 
butylated hydroxytoluene, which are not known to be hepatotoxic, also 
caused a lowering of glucose-6-phosphatase activity and ethoxyquin 
appears to fall into this category. The specific activity of microsomal 
glucose-6-phosphatase may be lowered by interference with synthesis or 
function of this enzyme, or by ’dilution’ with other enzyme proteins.
The former may be considered to be a toxic response whereas the latter 
may be adaptive, and a distinction needs to be made in the interpretation 
of glucose-6-phosphatase activity as an indicator of toxicity.
The return to normal level (not significantly different from controls) 
of liver size and DNA content by the end of the 30-day period of study, 
after terminating ethoxyquin administration indicated that both the 
hypertrophy and hyperplasia were reversible as would be expected of an 
adaptive response. Recovery appeared to be biphasic in that the recovery
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from cell hypertrophy was rapid and DNA concentration was increased 
to normal level by the 3rd day after stopping ethoxyquin administration 
while the concentrations of microsomal protein and enzymes studied 
(except cytochrome bj.) returned to control levels by the 7th day.
Hie recovery from the hyperplasia was somewhat slower, as the return 
to control levels of the total contents of microsomal protein and 
various enzymes was delayed till the 30th day.
Cytochrome b^ was unusually slow to recover, the specific 
activity remaining elevated even after 14 days recovery when micro­
somal protein concentration was normal. That cytochrome b5 is slower 
to return to normal than other microsomal enzymes after induction 
may be due to the slower turnover rate of this cytochrome compared 
with cytochrome P-450 and other microsomal enzymes (Greim et al,1970).
The course of recovery from liver enlargement and induction of 
the microsomal enzymes by ethoxyquin appears to parallel that 
reported after induction with phenobarbital by Kurijama et al (1969) 
and Bo lender and Weibel (1973). The former workers reported that 
enzyme activities and membranes of the smooth endoplasmic reticulum 
(SER) disappeared together over about eight days while the latter 
workers, in a detailed morphometric study, also found fairly rapid 
removal of the SER over the course of five days. This compares with 
the time of 7 days for microsomal protein concentration to return to 
normal in this study and contrasts with the results of Orrenius and 
Ericsson (1966) who found that SER membranes persisted for up to 
15 days. However, as in the present study microsomal protein was 
taken as an indicator of the amount of SER whereas Orrenius and
j '
Ericsson used phospholipid concentration, the results are not strictly /. 
comparable.
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The slow recovery of cytochrome after microsomal enzyme proteins 
had returned to normal indicates that some quantitative differences in 
enzyme activity occur between induced and recovering endoplasmic reticulum 
and these may be a necessary preliminary to the formation of and scavenging 
by autophagic vacuoles, as observed by Bolender and Weibel fl973).
The complete reversibility of the hepatic changes produced in rats 
by dietary ethoxyquin suggests that the observed hepatomegaly and enzyme 
induction should be considered a truly adaptive response. However, some 
microsomal enzyme inducers, particularly phenobarbital, have been shorn 
to potentiate the carcinogenicity of 2-acetamidofluorene when administered 
subsequently (Peraino et al, 1971). Conversely, the antioxidant butylated 
hydroxytoluene which also induces hepatic microsomal enzymes, has been 
reported to inhibit the carcinogenicity of acetamidofluorene and its 
N-hydroxy derivative, but not of diethylnitrosamine or propane sultone 
[Ulland et al, 1973; Grantham et al, 1973). No information is available 
concerning the potentiating or inhibitory effect of ethoxyquin on the 
carcinogenicity of these compounds although it has been reported that 
ethoxyquin protects against the carcinogenecity of benz(a)pyrene and 
7,12-dimethylbenz (a)anthracene QVattenberg, 1972).
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INHIBITION OF RAT HEPATIC MICRQSQMAL MIXED FUNCTION OXIDASES BY ETHOXYQUIN
INTRODUCTION
Ethoxyquin causes induction of hepatic microsomal drug-metabolizing 
enzymes when administered to rats at a concentration of 0.51 (w/w) in 
the diet for 60 days post-weaning (Parke, Rahim & Walker, 1972). The 
induction in these rats was maximal after 7 to 30 days of exposure to 
dietary ethoxyquin. Single or multiple doses (oral or intraperitoneal) 
also cause induction of some drug-metabolizing enzymes '24 to 72 h after 
the administration of ethoxyquin (Cawthome et al, 1970). Single doses 
are rapidly metabolized in vivo (Wiss et al, 1962) and in this respect 
ethoxyquin resembles the short-acting barbiturates which undergo rapid 
metabolism and generally cause induction only after massive or repeated 
dosing, when the increased demand for microsomal metabolism is sustained 
(Ioannides & Parke, 1973). This suggested that the enzyme.induction 
observed with ethoxyquin might result from initial (competitive) inhibition 
leading to a demand for increased enzyme synthesis.
To test this hypothesis that ethoxyquin might be an initial inhibitor, 
the effects of this antioxidant were investigated on (a) in vitro inhibition 
of biphenyl 4-hydroxylase, ethylmorphine N-demethylase, and glucose-6- 
phosphatase, (b) drug-metabolizing enzymes and certain other parameters 
at various intervals of time after single intragastric doses, and (c) 
in vivo inhibition of hexobarbitone metabolism after single intragastric 
doses and after chronic administration in the diet for 14 days. In 
addition, the spectral dissociation constant (K ) of ethoxyquin was studied 
to see if, in the event of its being an inhibitor of microsomal enzymes,
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it could bind to cytochrome P-450 and act as a substrate for terminal 
mixed function oxidases.
MATERIALS AND METHODS 
Chemicals
Ethoxyquin, 96% g.l.c. pure grade, was obtained from Koch Light 
Laboratories Ltd. Hexobarbitone (B.P.C. 1959) was procured from May &
Baker Ltd., and phenobarbitone sodium (BDH) was Laboratory Reagent Grade. 
Ethanol (96% v/v) was obtained from James Burrough.
Mention has been made of other chemicals in the text where relevant. 
Animals
Inbred male Wistar albino rats were used and accommodated in the 
University Animal Unit (see Chapter 2, page 37) during the experimental 
period.
In vitro inhibition studies
Four rats (48-day old) reared on control .powdered diet (see Chapter 2, 
pages 38-39) from weanling at 21 days of age were killed by cervical 
fracture, their livers pooled and the double-washed microsomal preparation 
made according to the method described in Chapter 2 (Page 43) . The 
enzyme activities of this microsomal preparation were measured over a 
range of substrate concentrations and in the absence or presence of various 
concentrations of ethoxyquin. Ethoxyquin was added as a 2QmM solution in 
aqueous 651 ethanol (v/v) at a maximum volume of 6 yl per incubation 
mixture and a similar volume of aqueous ethanol was added to controls 
without ethoxyquin.
Biphenyl 4-hydroxylase activity was assayed by the method of Creaven 
et al (1965), as modified by Neale (1970) (see Chapter 2, pages 45-46),
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except that the substrate concentration was varied between 0.6 and 1.2mM 
and ethoxyquin was added at a concentration of 0 to 0.06mM. Ethylmorphine 
N-demethylase activity was assayed by the method of Holtzman et al (1968)
(see Chapter 2,pp.46-47) at substrate concentrations of 2.08 to 4.16mM and 
ethoxyquin concentrations of 0 to 0.066mM. Glucose-6-phosphatase activity 
was assayed by the method of de Duve et al (1955) (see Chapter 4, pages 118-119)' 
at substrate concentrations of 0.31 to 0.62mM and ethoxyquin concentrations 
of 0 to 0.06mM.
Single dose effect
Fifty-six weanling rats (21 days old) were intragastrically dosed with 
ethoxyquin at a level of 500 mg/kg. The ethoxyquin was administered as a 
251 (w/v) solution in arachis oil. A second group of rats was used as 
controls and given the vehicle only. At zero-time 8 rats dosed with ethoxy­
quin and 8 controls were killed by cervical dislocation and their livers 
removed, weighed and processed in groups of 2 animals. The 10,000 x £ 
supernatant was used to assay biphenyl 4-hydroxylase activity and ethylmorphine 
N-demethylase activity. The microsomal suspension was used to determine the 
concentrations of microsomal protein and cytochromes P-450 and b^ by the 
methodsjjdescribed in Chapter 2, pp.43-45) of Lowry et al (1951), Sladek 
& Mannering (1966), and Schenkman et al (1967) respectively.
The remaining rats were given the control powdered diet and water 
ad-libitum. After 2, 4, 8, 12, 24 and 48 h, 8 rats from each group were 
killed and examined as before.
In vivo inhibition studies
The effects of ethoxyquin on hexobarbitone metabolism were studied 
in vivo in two experiments. In the first experiment 8-9 week old rats 
reared on laboratory pellet diet (Spillers Ltd.) from weanling, were given
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the hexobarbitone (100 mg/kg) and its rate of metabolism studied by observing 
the sleeping-time at various intervals after a single intragastric dose of 
ethoxyquin (500 mg/kg). The ethoxyquin was administered as a 25% (w/v) 
solution in arachis oil and the hexobarbitone was dissolved in 2N_NaOH 
(100 mg/2 ml) adjusted to pH 11 and administered by intraperitoneal injection. 
The sleeping-time was taken as the time between loss and recovery of the 
righting reflex.
In the second experiment, ethoxyquin at a level of 0.5% (w/w) in the 
diet was fed for 14 days to rats from weaning at 21 days of age. Their 
controls were pair-fed with the control powdered diet during the 14-day 
period. The hexobarbitone metabolism in these rats was studied after this 
pretreatment period.
Spectral dissociation constant (K ) of ethoxyquin
The Kg of ethoxyquin was determined by observing the difference 
spectrum at 380 to 425 nm when ethoxyquin (0.004 to 0.04mM) was added to 
a suspension of a double-washed liver microsomal preparation (2 mg of protein 
per ml) in 0.1M potassium phosphate buffer (pH 7.6). The ethoxyquin (maximum 
volume lOyl) was added as a solution in aqueous 65% (v/v) ethanol to 2.5 ml 
of microsomal suspension in a split cuvette to allow for the absorption of 
ethoxyquin at these wavelengths. The microsomal suspension was prepared 
from the livers of weanling rats which had been pretreated with three daily 
intraperitoneal doses of phenobarbitone sodium (100 mg/kg)-
RESULTS
In vitro inhibition studies
The results of the enzyme inhibition studies in vitro are shown as 
Dixon plots (Dixon, 1953) in Figures 5-1 to 5-3. The graphs in Figures
5-1 and 5-2 are typical of competitive inhibition of both biphenyl
Fig. 5-1 Dixon plot showing competitive inhibition of biphenyl
4-hydroxylase activity by ethoxyquin.
2.4-
2.0-
1.2-
0.8-
Ki =  4. 3 x 10-6 M
0.4*:
20 -K i 0 20 40 60
10~6 x Ethoxyquin concn. (M )
Biphenyl 4-hydroxylase activity ( p mole /  h /g  liver) was 
assayed by the method of Creaven et al (1965), as modified 
by Neale (1970), at substrate concentrations of 0. 6m M (©) 
and 1. 2m M (o) and ethoxyquin concentrations of 10 to 60 juM*
135
Fig. 5-2 Dixon plot showing competitive inhibition of ethylmorphine
N-demethylase activity by ethoxyquin.
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10~6 x Ethoxyquin concn. (M )
Ethylmorphine N-demethylase activity ( jumole/ h /g  liver ) 
was assayed by the method of Holtzman et al. (1968) at 
substrate concentrations of 2. 08 mM ( © ) and 4.16 ( O ) and 
ethoxyquin concentrations of 11 to 66 /iM .
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Fig. 5-3 Dixon plot showing effect of ethoxy quin on
glucose-6-phosphatase activity.
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Glucose-6-phosphatase activity ( ju mole/min/g liver ) was 
assayed by the method of de Duve et al. ( 1955 ) at 
substrate concentrations of 0. 31 mM ( © ) and 0. 62 mM  
( o ) and ethoxyquin concentrations of 10 to 60 juM.
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Fig. 5-4 Lineweaver-Burk reciprocal plot showing 
apparent Michaelis constant ( Km ) for 
biphenyl 4-hydroxylase with respect to 
biphenyl.
1.0 0 1.0 2.03.0 2.0
1_________
[ Biphenyl ] x 10~3 M
Biphenyl 4-hydroxylase activity ( jii mole/ h /g  liver ) 
was assayed by the method of Creaven et al. (1965), 
as modified by Neale (1970), at substrate concentrations 
of 0. 6 to 2.4 mM.
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Fig. 5-5 Lineweaver-Burk reciprocal plot showing 
apparent Michaelis constant (Km ) for 
ethylmorphine N-demethylase with respect 
to ethylmorphine.
0.020
Km= 2. 2x10!0.010
0.005
0.5 0 0.51.54.5 3.5 2.5
[ Ethylmorphine] x 10“3 M
Ethylmorphine N-demethylase activity ( jimole/ h /g  liver ) 
was assayed by the method of Holtzman et al. (1968) at 
substrate concentrations of 1. 04 to 8. 33m M.
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Fig. 5-6 Lineweaver-Burk reciprocal plot showing apparent 
Michaelis constant ( Km ) for glucose-6-phosphatase 
with respect to glucose-6-phosphate.
0.40
O  rH Km =  6. 45 x 10~4M
2.02
1
—3
[Glucose-6-phosphate ] x 10 M
Glucose-6-phosphatase activity ( jumole/min/g liver ) was assayed 
by the method of de Duve et al. ( 1955 ) at substrate concentrations 
of 0.31 to 2. 5 mM.
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4-hydroxylase and ethylmorphine N-demethylase, the IC values being 
respectively 4.3 x 10 and 6 x 10 M^, ethoxyquin is thus a very 
powerful inhibitor of the activities of these enzymes. The graph in 
Figure 5-3, however, shows no inhibitory effect of ethoxyquin on the 
activity of glucose-6-phosphatase.
From double-reciprocal plots (Lineweaver & Burk, 1934) of the 
results (Figures 5-4 to 5-6) obtained over a range of substrate 
concentrations in the absence of ethoxyquin, the of biphenyl 
4-hydroxylase, ethylmorphine N-demethylase and glucose-6-phosphatase 
was calculated, giving values of 3.2 x 10 M^, 2.2 x 10 and 6.9 x 10 
respectively. The values of biphenyl 4-hydroxylase and ethylmorphine 
N-demethylase correlated well with the theoretical values calculated from 
the relevant Dixon plots by using the formula -JC (s/Km+ 1) = - x where 
x is the intersection on the abscissa (see Figs. 5-1 and 5-2).
Effect of single dose of ethoxyquin
The results of this investigation are given in Table 5-1 and shown 
with SEM in Table 5-IHin the Appendix. It is observed from this Table 
that 2 h after administration ethoxyquin at the dose level (500 mg/kg) 
given to rats caused slight but statistically not significant inhibition 
of cytochrome P-450 (2.41), biphenyl 4-hydroxylase (9.5%) and ethylmorphine 
N-demethylase (3.0%). The liver weight, and consequently the relative liver 
weight (g/100 g body weight), showed some increase 8 to 48 h after the dose 
but was never statistically significant. The specific activity of ethyl­
morphine N-demethylase showed the quickest recovery and the earliest sign 
of induction (P < 0.05 : 12 h after dosing). The concentrations of hepatic 
microsomal protein and cytochrome P-450 were elevated (P < 0.05) 24 h after 
the dose. The specific activity of biphenyl 4-hydroxylase also followed
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TABLE 5-1 Percentage change in the levels of drug-
metabolizing enzymes and certain other parameters 
of weaning male Wistar albino rats after a single 
intraperitoneal dose of ethoxyquin (500 mg/kg)
Period after dose (hour)
Pai aineters 0 2 4
1
8 1
12 24 j 48
1. Body weight (g) 0 -2.0 -2.0 -2.0 -2.0 -14.0 -6.0
2. Liver weight (g) 0 0 0 11.0 16.7 5.0 4.0
3. Relative liver wt. 
(g/lOOg body wt)
0 2.8 2.8 11.1 16.7 22.2 9.5
4. Microsomal protein 0.4 
concentration 
(mg/g liver)
0.8 -0.8 2.0 5.0 4.4 8.0
5. Cytochrome P-450 
concentration 
(nmole/g liver)
-0.5 -2.4 -1.4 -1.4 6.1 7.6 6.1
6. Cytochrome b^ 
concentration 
(nmole/g liver)
0.8 -0.8 -0.8 0.8 0.8 1.5 8.7
7. Biphenyl 
4-hydroxylase 
activity
(ymole/h/g liver)
0 -9.5 -3.3 4.8 7.8 17.5 30.6
8. Ethylmorphine 
N-demethylase 
activity
(ymole/h/g liver)
0.5 -3.0 0.5 16.3 19.0 36.0 15.3 j
The ethoxyquin was administered as a 25% Cw/v) solution in arachis oil. 
Controls and tests each consisted of 8 animals.
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this increase and demonstrated induction to a similar extent as shown 
by ethylmorphine N-demethylase (P < 0.01). Cytochrome was the last 
to be induced; its concentration was elevated (P< 0.001) 48 h after the 
dose.
In vivo inhibition studies
The results of the hexobarbitone sleeping-time, after single 
intragastric dose of ethoxyquin, are shown in Fig. 5-7. It is observed 
from this Figure that ethoxyquin is a potent inhibitor of hexobarbitone 
metabolism in vivo. When hexobarbitone was administered 1 h after the 
ethoxyquin the sleeping-time was more than 8 h compared with 16 min. in 
controls, and after 24 h the sleeping-time was still double that of 
controls. Recovery was not complete until 48 h after the dose of 
ethoxyquin.
Table 5-II contains the results of hexobarbitone sleeping-time after 
administration of ethoxyquin in the diet for 14 days. It is observed from 
this Table that the sleeping-time was reduced in the pretreated rats to 
almost 501 of the control value and this pattern continued even 3 h after 
the withdrawal of the diet containing ethoxyquin. This contrasts with the 
prolonged sleeping-time observed in rats after a single intragastric dose 
of ethoxyquin.
Spectral dissociation constant of ethoxyquin
When added to microsomal suspensions ethoxyquin exhibited a type I 
difference spectrum with a peak at 385 nm and a trough at 420-422 nm. The 
magnitude of the difference (Ae) between the absorbance at 385 nm and at 
420 nm varied with ethoxyquin concentration and was taken to represent the 
extent of binding to cytochrome P-450. The results of this experiment are
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Fig. 5-7 Hexobarbitone ( 100 mg/kg, i.p . ) sleeping-time 
of 8-9 week-old male Wistar albino rats after 
single dose of ethoxyquin ( 500 mg/kg, i.g . )
500
450
350-
300-
250-
150-
100-
-o---— o
50 70403020100
Time after administration of ethoxyquin ( hour )—►
Ethoxyquin was given as a 25 % ( w /v  ) solution in arachis 
oil. Hexobarbitone was administered asa  5% ( w / v )  
solution in dilute aq. NaOH, pH 11.
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TABLE 5-II Hexobarbitone (100 mg/kg sleeping time of 36 days
old Wistar male albino rats after administration of 
ethoxyquin at a dietary level of 0.5%(w/w) for 
14 days from weaning at 21 days of age
SI. No.
Time (min.) after 
withdrawal of diet 
containing 
ethoxyquin
Sleeping-time (min.)
Control Ethoxyquin-fed 
rats
1 30 20.8 + 0.5 9.5 + 0.55
2 180 26.0 + 0.3 14.0 + 0.35
Hexobarbitone was administered as a 51 (w/v) solution in dilute aqueous 
NaOH, pH 11.
Controls and tests each consisted of 4 animals.
Values given are the means +_ SEM.
Significant effects are shown: § P < 0.0 .
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shown in Figure 5-8 as a double reciprocal plot of Ae against ethoxyquin 
concentration. By extrapolating this plot to the abscissa the concentration 
of the ethoxyquin (substrate) required for half-maximal spectral change 
(or spectral dissociation constant, K ) was determined and found to have 
a value of 1.06 x 10 M^, indicating that ethoxyquin binds to cytochrome 
P-450 with a high affinity.
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Fig. 5-8 Lineweaver-Burk reciprocal plot showing spectral 
dissociation constant (K g) of ethoxyquin.
50 -
40 -
30 -
20 -
Kc =  1.06 x 10
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Spectral dissociation constant of ethoxyquin was 
determined by the method of Schenkman et al (1867a) 
from a Lineweaver-Burk plot made from the 
difference spectrum observed at 380 to 425nm after 
adding aq. 65% ethanolic solution of ethoxyquin 
(0. 004 to 0. 04 mM in a max. vol. 10/ii) to a split 
cuvette containing 2, 5ml suspension of a double- 
washed rat liver microsomal preparation ( 2mg. 
protein per m l) in 0 .1M phosphate buffer pK 7. 6
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DISCUSSION
The in vitro studies described in this Chapter indicate that 
ethoxyquin binds strongly to cytochrome P-450 and is a potent 
competitive inhibitor of. the drug-metabolizing activity of this 
enzyme. The induction of the drug-metabolizing enzymes previously 
reported by Parke et al (1972) and detailed in Chapter 2 would then 
appear to result from the increased metabolic demand in the presence 
of ethoxyquin and might thus be considered a physiological adaptive 
response.
This view may be substantiated by the observation that, while 
single doses of ethoxyquin dramatically increased hexobarbitone 
sleeping-time, repeated dosing had the effect of increasing hexobarbitone 
metabolism and decreasing the sleeping-time. The induction of hexo­
barbitone oxidase by single and multiple doses of ethoxyquin has been 
reported previously by Cawthome et al (1970). The apparent disagreement 
in the results after single doses may result from the fact that in the 
present work hexobarbitone sleeping-time was determined in vivo and 
inhibition was- observed over a period of time during which residual 
ethoxyquin.might be expected to be present in the liver (Wiss et al,1962). 
On the other hand, Cawthome et al (1970), examined hexobarbitone oxidase 
up to 72 h and found .induction from 24 h and it is likely that ethoxyquin 
levels in the incubation mixture were lower than those occurring in vivo 
due to losses and dilution in the preparative procedures used. In support 
of this argument, the in vitro studies described in this Chapter after 
single intragastric doses of ethoxyquin revealed induction of microsomal 
protein synthesis and of cytochrome P-450 after 24 h with associated 
increases in biphenyl 4-hydroxylase and ethylmorphine N-demethylase
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activity despite the fact that these latter enzyme activities have been 
shown to be markedly inhibited by low concentrations of ethoxyquin.
It was shown (Chapter 4, page 122) that the total hepatic activity 
of glucose-6-phosphatase was not significantly affected by 14-days ’ 
pretreatment of rats with ethoxyquin and these dn vitro studies revealed 
ethoxyquin to be without effect on the activity of this enzyme. This 
adds further weight to the view that the drop in specific activity of 
glucose-6-phosphatase in the liver microsomes of rats treated with 
ethoxyquin results from dilution with other enzyme proteins, the 
synthesis of which has been significantly induced.
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Chapter 6
EFFECT OF TRANSFER OF ETHOXYQUIN THROUGH PLACENTA AND RAT-MILK ON 
THE HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYMES AND CERTAIN OTHER 
PARAMETERS OF NEONATAL RATS
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EFFECT OF TRANSFER OF ETHOXYQUIN THROUGH PLACENTA AND RAT-MILK ON THE
HEPATIC MICROSOMAL DRUG-METABOLIZING ENZYMES AND CERTAIN OTHER PARAMETERS 
OF NEONATAL RATS
Introduction •
Ethoxyquin is rapidly absorbed and almost all the ingested antioxidant 
is excreted in the urine and faeces. The materials in the urine have been 
identified as metabolites exhibiting strong fluorescence similar to 
ethoxyquin (Wilson et al, 1959).
When administered to pregnant rats ethoxyquin is transferred across 
the placenta and is secreted in rat-milk (Wilson et al, 1959). A 
preliminary investigation with 3 female rats (20 weeks old) fed ethoxyquin 
(0.51 w/w) in the diet during the period of pregnancy resulted in litters 
having body weight lower than that ordinarily observed with infants bom 
of mothers fed on a diet containing no added ethoxyquin. As ethoxyquin 
is transferable to the foetus and neonate, through the placenta and milk 
and is also an inhibitor of the hepatic microsomal mixed function oxidases 
(see Chapter 5), the manifestation of a toxic response might be due to 
inadequate metabolism of ethoxyquin by the foetus and neonatal rats which 
are known to be deficient in drug-metabolizing enzymes (see Chapter 3).
The present investigation has been undertaken to test this hypothesis and 
to examine if the neonates receiving ethoxyquin (or its metabolites) 
through rat-milk from their dams could demonstrate an adaptive liver 
response during the developmental period of the drug-metabolizing enzymes.
Materials and Methods
Ethoxyquin, 96V g.I.e. pure grade, was obtained from Koch Light 
Laboratories.
Inbred Wistar albino rats were used and accommodated in the University 
Animal Unit (see Chapter 2) during the experimental period.
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Sixty female and 20 male (12 week old) rats were fed ethoxyquin at 
a level of 0.5! w/w in the diet for a period of 3 weeks. Thereafter 
they were distributed in 20 cages, each containing 3 females and 1 male 
rat, and maintained on the diet containing ethoxyquin until the 
appearance of signs of copulation and sperms in vaginal smears examined 
under the low power microscope. A second group of rats were maintained 
similarly but on a control diet containing no added ethoxyquin.
Each pregnant rat was caged singly until the litters were delivered.
The male infants were then segregated and distributed in groups of 6 to 
each mother which were maintained thereafter on the relevant diet.
On the 2nd day after birth, 48 neonates, 24 delivered from the 
controls and 24 by ethoxyquin-fed female rats, were weighed and killed, 
and their livers pooled in groups of 6 and processed according to the 
method described in Chapter 2 to prepare the 10,000 x £ supernatant and 
microsomal suspension.
The activities of biphenyl 4-hydroxylase and ethylmorphine N-demethylase 
were determined using the 10,000 x £ supernatant according to the methods 
of Neale (1970) and Holtzman et al (1968) respectively. The concentrations 
of microsomal protein, and cytochromes P-450 and b,. were determined with 
the microsomal suspension by the methods of Lowry et al (1951), Sladek 
and Mannering (1966) and Schenkman et al (1967) respectively. These 
methods have been described in Chapter 2.
Similar experiments were carried out at 6, 12 and 18 days of age 
respectively with 24, 12 and 12 neonates delivered by each of control and 
ethoxyquin-fed female rats.
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Results
The results, of this investigation are given in Table 6-1. It is 
observed from this Table that feeding of ethoxyquin to rats from 3 weeks 
before pregnancy resulted in the delivery of litters which were 
significantly smaller than those bom of female rats fed control diet 
containing no added ethoxyquin. The lower body weight was maintained 
in affected infant rats when their dams were continued on dietary 
ethoxyquin. The liver weight was likewise lower in neonates bom of 
ethoxyquin-fed dams, but the relative liver weight was significantly 
higher in these rats.
Concomitant with reduction in body weight and liver weight, the 
concentrations of microsomal protein and cytochromes P-450 and b^ , and 
the specific and total activity of ethylmorphine N-demethylase in litters 
delivered by treated rats were, on the second day after birth, also 
significantly lower than in ones bom of untreated rats. Thereafter 
recovery was followed by significant induction in the specific 
concentration or activity of these parameters, the inducibility being 
slower in case of cytochrome b^ concentration and ethylmorphine 
N-demethylase activity. The total level of cytochrome bj- was, however, 
elevated by the twelfth day after birth and this pattern was maintained 
till the end of the investigation on the eighteenth day.
Pretreatment of mothers with ethoxyquin showed that, despite the 
lower concentration of cytochrome P-450, there was a significant increase 
in the specific activity of biphenyl 4-hydroxylase of the neonatal rats; 
the total activity was also raised on the sixth day after birth and from 
then onwards both the specific and total activity of this enzyme remained 
significantly elevated in these rats.
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The growth of body hair in litters bom of treated rats was 
impaired in that the neonatal rats did not show the characteristic 
of dry skin even up to the twelfth day after birth. The date of 
mating, the period of pregnancy and the extent of weight gained by 
the pregnant rats were not recorded. The number of pups per litter in 
the two groups did not, however, show any significant difference.
Discussion
Ethoxyquin undergoes placental transfer and is secreted in the 
milk from rats eating diet containing the antioxidant labelled in the 
ring at carbon atoms in 2 and 4 positions (Wilson et al, 1959). The 
neonatal rats are deficient in hepatic microsomal drug-metabolizing 
enzymes (see Chapter 3). Furthermore, ethoxyquin is an inhibitor of 
the microsomal mixed function oxidases in vitro (see Chapter 5), and 
transfer of the antioxidant from dams through the placenta or milk may 
cause inhibition of these enzymes, thus further lowering the activities 
in the newborn rats. Withdrawal of ethoxyquin reverses the hepatic 
changes caused by the antioxidant (see Chapter 4), but continued 
exposure of the dams to dietary ethoxyquin maintains the supply of 
the antioxidant to the neonates through the rat-milk. This ethoxyquin 
in the milk causes subsequent induction of hepatic microsomal drug- 
metabolizing enzymes in neonatal rats. Such metabolic demand for 
enzyme induction to detoxicate foreign compounds is a manifestation 
of an adaptive response and it is worth noting that induction of drug- 
metabolizing enzymes can be effected in rats from the very beginning of the 
stage of enzyme development.
The specific activity of biphenyl 4-hydroxylase in neonatal rats 
delivered by the treated rats is induced by the second day after birth 
and this suggests some difference in its mode of action and dependence
155
upon hepatic cytochrome P-450 compared with the inducibility of 
ethylmorphine N-demethylase which remains inhibited at this stage and 
is induced by the twelfth day after birth after exposure to milk- 
ethoxyquin during these days.
The inducibility of cytochrome b^ concentration in neonatal rats 
bom of the treated mothers is delayed till the twelfth day and this 
pattern agrees with previous findings (see Chapter 5) with a single 
intragastric dose of ethoxyquin, in that this parameter was the last 
to be induced in the treated rats.
Impaired hair growth, and lower body weight, liver weight and 
drug-metabolizing enzymes may reflect prematurity and in the absence 
of data on the gestation period it is not possible to eliminate this; 
the delay in post-partum development also suggests possible prematurity. 
However, the effects on biphenyl 4-hydroxylase cannot be explained purely 
on the grounds of prematurity since lower levels would have been expected 
in less than full-term offspring. Further, the results on day 12 
suggest induction from ethoxyquin received via milk, since at this age 
the pups would not yet have received the maternal powdered diet. By the 
eighteenth day the rats may have been on a mixed diet of maternal milk 
and powdered ration.
In the absence of reliable data on the gestation period no firm 
conclusion on the embryo toxicity of ethoxyquin can be drawn, and further 
reproduction studies would appear to be desirable to confirm these 
observations and elucidate the mechanism involved.
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Chapter 7
PROTECTION AGAINST CARBON TETRACHLORIDE HEPATOTOXICITY 
IN RATS BY ETHOXYQUIN . .
157
INTRODUCTION
Carbon tetrachloride, an industrial solvent, is frequently used 
in many industrial operations including extraction of animal and 
vegetable oils and fats. It has also been employed therapeutically in 
the treatment of hookworm and other helminthic infections in domestic 
animals. In consideration of these uses of carbon tetrachloride and 
in view of man's possible exposure to it, the effects of this solvent 
have been studied extensively in rats and to a lesser extent in dogs 
and chickens. It has now been established that prolonged inhalation 
and even single oral doses of carbon tetrachloride cause fatty changes, 
hydropic degeneration and necrosis of liver cells, while multiple doses 
cause cirrhosis of the liver. An interesting account of histopathological 
changes in rat liver was reported by Cameron and Karunaratne (1936).
Recently Slater (1972) presented a well-documented account of the major 
areas of interest concerning the hepatotoxic action of carbon tetrachloride.
Carbon tetrachloride undergoes metabolism to carbon dioxide by liver
microsomal preparations in the presence of the supernatant fraction
14(Rubinstein and Kanics, 1964). The microsomal conversion of CCl^ to 
■^CC^ in vitro resembles a typical microsomal oxidation reaction in that 
it requires an NADPH-generating system and oxygen (Seawright and McLean, 
1967).
Diets' low in protein protect against carbon tetrachloride hepato- 
toxicity (McLean and McLean, 1966; Seawright and McLean, 1967). Rats 
on a protein-free diet are able to tolerate much larger amounts of this 
toxic compound due to reduced activity of hydroxylating enzymes present 
in the liver microsomes. By giving DDT to these protein-depleted rats, 
these workers were able to induce the microsomal hydroxylating enzymes
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in the liver, and in consequence, carbon tetrachloride then became toxic 
to rats receiving the protein-free diet.
Cawthome et al (1970) observed that ethoxyquin given 72 or 48 hrs 
before carbon tetrachloride was highly effective in preventing hepato- 
toxicity, but single doses 24 or 6 hrs before carbon tetrachloride 
were without effect. They also observed that ethoxyquin increased 
hepatic demethylase activity and protected against carbon tetrachloride 
toxicity in rats that had been previously sensitized by drug-metabolizing 
enzyme inducers such as phenobarbitone or DDT. This led them to postulate 
that the protective effect of ethoxyquin was afforded by inducing the 
synthesis of enzymes that are associated either with the metabolism of 
carbon tetrachloride through a non-toxic pathway or with the removal 
of its toxic metabolites.
It has been suggested that the toxicity of carbon tetrachloride 
is due to a metabolite formed in the microsomes (Wirtchafter and Cronyn, 
1964; McLean and McLean, 1966; .Slater, 1966) and that this
metabolite is a free radical intermediate which causes peroxidation of 
lipids of microsomes and mitochondria (Butler, 1961; Ghoshal.and Recknagel, 
1965; Recknagel and Ghoshal, 1966; Slater, 1966). Ethoxyquin, being an 
antioxidant, might,, therefore, be expected to act as a free-radical 
scavenger, and not, as suggested by Cawthome et al (1970), as an 
inducer of detoxicating enzymes. In the present study these conflicting 
views are examined both biochemically and histologically after giving 
a single oral dose (500 mg/kg) and after chronic feeding in the diet 
(0.5% w/w) of ethoxyquin for 14 days before the administration of carbon 
tetrachloride at zero-time and at 1, 2 and 3 days after treatment with 
ethoxyquin. Of critical importance is the time course of protection
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by ethoxyquin against carbon tetrachloride toxicity, since it is largely 
on the basis of an observed delay in such protection that Cawthome 
et al (1970) have argued in favour of the induction of a detoxicating 
pathway. In the other studies mentioned above, an increase in carbon 
tetrachloride metabolism was associated with an increase in toxicity.
MATERIALS AND METHODS 
Chemicals
Ethoxyquin, 961 g.l.c. pure grade, was obtained from Koch Light 
Laboratories. Liquid paraffin (Laboratory Reagent Grade) and carbon 
tetrachloride (A.R. Grade) were obtained from B.D.H.
Animals
Inbred male Wistar albino rats were* used and accommodated in the 
University Animal Unit (see Chapter 2, page 37) during the experimental
r\AU\^l J . V U *
Biochemical studies .
i) Protection against CCli toxicity by single intragastric doses of 
ethoxyquin
Ethoxyquin (500 mg/kg) was administered intragastrically to 8 rats 
(35-day old) as a 251 w/v solution in arachis oil, and 8 other rats 
(controls) of the same age were given the vehicle. At zero-time carbon 
tetrachloride (2 ml/kg) was administered to 4 control and 4 treated rats 
as a 501 solution in liquid paraffin and the other 8 rats were given 
liquid paraffin. After 24 hrs all the rats were weighed and killed, 
and their livers weighed and processed to prepare 10,000 x £ supernatant 
and microsomal suspensions according to the method described in Chapter 
2 (page 43). The 10,000 x supernatant was used to determine biphenyl 
4-hydroxylase activity by the method of Creaven et al (1965), as modified 
by Neale (1970). Ethylmorphine N-demethylase activity was assayed with
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the 10,000 x g supernatant according to the method of Holtzman et al 
(1968). The concentrations of microsomal protein and cytochromes P-450 
and were determined in the microsomal suspensions by the methods 
of Lowry et al (1951), Sladek and Mannering (1966) and Schenkman et al 
(1967) respectively. All these methods are given in pages 43-47.
Similar experiments with 35-day old rats were carried out 1, 2 and 
3 days after the dose of ethoxyquin.
ii) Protection against CCl^ toxicity by dietary ethoxyquin
Ethoxyquin at a dietary level of 0.51 w/w was fed to rats from 
weaning at 21 days of age and after 14 days of treatment they were 
given carbon tetrachloride (2 ml/kg) at zero-time and 1, 2 and 3 days 
after the withdrawal of dietary ethoxyquin. Then 24 hrs after the 
dose of carbon tetrachloride the animals were killed and examined as 
before.
Light microscopic studies
Parallel to biochemical studies two other groups of rats of the 
same age were treated with carbon tetrachloride (2 ml/kg) at zero-time and 
1, 2 and 3 days after single oral doses of ethoxyquin (500 mg/kg), or after 
administration of the antioxidant in the diet (0.5% w/w) for 14 days.
Then 24 hrs after the dose of carbon tetrachloride the rats were killed, 
liver sections made and examined under the light microscope, and photo­
micrographs of fields of interest taken according to the method described 
in Chapter 4 (pages 119-122).
RESULTS
Biochemical studies
The findings of these studies are given in Tables 7-1 to 7-III and 
the results showing percentage changes are shown in Tables 7-V and 7-VI
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in the Appendix.
Tables 1-11 and 7-III show that carbon tetrachloride reduced the 
concentrations of rat hepatic microsomal protein (mg/g liver) and 
cytochromes P-450 and b^ (nmole/g liver) and the activity of biphenyl 
4-hydroxylase (ymole/h/g liver), in both control and ethoxyquin 
treated rats. This reduction was more marked in the concentrations 
of cytochromes P-450 and b^ and in the activity of biphenyl 4-hydroxylase 
than in the concentration of microsomal protein. Administration of 
ethoxyquin to rats afforded some protection and this protection was 
greater in rats dosed with carbon tetrachloride after feeding dietary 
ethoxyquin for 14 days than in rats given carbon tetrachloride after 
single intragastric doses of ethoxyquin. The extent of protection of 
these parameters was similar whether the administration of carbon 
tetrachloride was made immediately after ethoxyquin or delayed for up 
to 3 days except in the case of cytochrome b^ in rats fed dietary 
ethoxyquin. In this case the concentration increased from the initially 
reduced level of 401 to over 60% when carbon tetrachloride was administered 
3 days after the withdrawal of dietary ethoxyquin. -The activity of 
ethylmorphine N-demethylase appeared to be very sensitive to carbon 
tetrachloride toxicity (see Table 7-1II) but was also protected by 
ethoxyquin although the time course and magnitude of protection did not 
show any definite pattern except in rats fed dietary ethoxyquin in which 
case the activity of this enzyme completely disappeared when carbon 
tetrachloride was administered 3 days after the withdrawal of dietary 
ethoxyquin.
It might be noted, however, that even when the percentage fall in 
concentration/activity was substantial, after treatment with carbon 
tetrachloride the individual enzyme levels were usually substantially
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higher in animals pretreated with ethoxyquin.
Light microscopic studies
The results of these studies are given in Table 7-TV and important 
histological changes are shown in photomicrographs in Plates 7-1 to 
7-18 in Armfindix.* ~ ^ * T I - - - - - - -
It is observed from Table 7-IV that 2 days after single intragastric 
doses the ethoxyquin caused enlargement of the centrilobular cells with 
vacuolation of the cytoplasm and these changes disappeared after the 
3rd day. Exposure to dietary ethoxyquin for 14 days also caused 
vacuolation of the hepatic cell and an almost normal condition was 
restored 3 days after withdrawal of the diet containing ethoxyquin.
This finding correlated well with the decrease -in enzyme activities 
in reversibility studies (see Chapter 4).
When examined 24 hrs after the dosing, it was observed that carbon 
tetrachloride caused fatty changes, hydropic degeneration and necrosis 
of hepatic cells (see Table 7-IV). Single intragastric doses of ethoxyquin 
at zero-time and at 1 day before the administration of carbon tetrachloride 
reduced the appearance of hydropic changes to a minimum, but extensive 
hydropic changes occurred when ethoxyquin was given 2 or 3 days before 
the dosage of carbon tetrachloride.
Dietary ethoxyquin fed for 14 days before the administration of 
carbon tetrachloride afforded complete protection when carbon tetrachloride 
was given at zero-time and at 1 day after the withdrawal of ethoxyquin.
This protection also diminished when ethoxyquin was removed from the 
diet 2 or 3 days before giving the carbon tetrachloride.
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DISCUSSION
Carbon tetrachloride causes fatty accumulation, hydropic degeneration 
and necrosis of hepatic cells (Cameron and Karunaratne, 1936; Recknagel, 
1967; Reynolds and Lee, 1967; Cawthome et al, 1970; Slater, 1972) and 
the histology of the lesion observed in the present, investigation is 
typical.
Biochemical examination shows that carbon tetrachloride produces early 
loss ' (10-15 min. after poisoning) of hepatic microsomal protein (Smuckler 
and Benditt, 1965; Dianzani, 1973) and significantly destroys the components 
of its oxidative system (Recknagel, 1967; Dingell and Heimberg, 1968; Vome 
and Arvela, 1971; Cawthome et al, 1973a) .Within 3 hours after dosing it 
causes destruction of about 50% of cytochrome P-450 (loss of haem) with 
little or no change in the activity of cytochrome c reductase or in the 
amount of cytochrome b^ (Smuckler et al, 1967; Castro et al, 1968; Greene 
et al, 1969; Reynolds and Ree, 1971). In the present investigation studying 
the effects of carbon tetrachloride 24 hrs after dosing the rat, it was 
observed that carbon tetrachloride reduced the concentrations of hepatic 
microsomal protein and cytochromes P-450 and b^ , and the activities of 
biphenyl 4-hydroxylase and ethylmorphine N-demethylase.
The protection afforded by ethoxyquin against this damage to the 
microsomal mixed function oxidases was essentially independent of the 
delay between administration of ethoxyquin and the challenge with carbon 
tetrachloride up to a period of 3 days. This contrasts markedly with 
the protection given by ethoxyquin against hydropic changes where maximal 
protection occurred when carbon tetrachloride was administered within 
24 hrs of ethoxyquin and little protection was observed after 2 or 3 days. 
This suggests that the mechanism of protection differs and that the 
hydropic changes are not necessarily causally related to the changes in
the mixed function oxidases of the endoplasmic reticulum.
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Cawthome et al (1970) observed that ethoxyquin protected rats against 
carbon tetrachloride hepatotoxicity when the antioxidant was administered 
72 or 48 hrs before dosing with carbon tetrachloride, but no protection 
was afforded when the ethoxyquin was given 24 or 6 hrs before carbon 
tetrachloride. In the present study single intragastric doses of ethoxyquin 
and chronic feeding of the antioxidant in the diet for 14 days prior to the 
administration of carbon tetrachloride also gave protection against carbon 
tetrachloride hepatotoxicity. The protection was, however, found to be 
maximal when carbon tetrachloride was administered immediately after the 
treatment with ethoxyquin (zero-time). The protective effect disappeared 
as the time between pretreatment with ethoxyquin and dosing with carbon 
tetrachloride increased, and administration of carbon tetrachloride 3 days 
after the treatment with ethoxyquin afforded little protection against the 
carbon tetrachloride. These findings, therefore, do not agree with the 
time-dependent changes reported by Cawthome et al (1970).
On the basis of their results, Cawthome et al (1970) argued that 
the mechanism of protection by ethoxyquin must involve induction of a 
detoxicating pathway rather than free radical scavenging since, after 3 
days, levels of ethoxyquin in the tissues would be expected to be low 
(Wiss et jal, 1962). The present investigation provides no support for 
this argument. In the first instance, in the single dose study using an 
experimental protocol similar to Cawthome et al (1970), maximal protection 
occurred early and diminished over a 3-day period. Secondly, in the 14-day 
dietary study, where enzyme induction was already maximal (see Chapter 2) 
the level of protection and the fall-off in protection was similar to that 
in the single dose study where no enzyme induction could have taken place, 
as the carbon tetrachloride was given immediately after ethoxyquin.
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It has been demonstrated (McLean, 1967; Cawthome et al, 1973b) that 
carbon tetrachloride binds to cytochrome P-450 and that inducers of 
microsomal mixed function oxidases such as DDT [l,l,l-trichloro-2,2-bis 
(p-chlorophenyl) ethane] increase metabolism of carbon tetrachloride to 
carbon dioxide with a potentiation of the toxic effects (Seawright and 
McLean, 1967). It might appear, therefore,' that ethoxyquin protects by 
inhibiting microsomal oxidation since it was observed (see Chapter 5) that 
ethoxyquin is a potent inhibitor of the mixed function oxidases in vitro.
If this were the relevant mechanism, it would be expected that protection 
would be greatest after a single dose of ethoxyquin by analogy with the 
in vivo inhibition of hexobarbitone metabolism (see Chapter 5). Conversely, 
repeated dosing with ethoxyquin in the diet for 14 days stimulated hexobarbitone 
metabolism with a decrease in the sleeping time and-, using the same analogy, 
this would be expected to increase carbon tetrachloride metabolism and, like 
other inducers of the microsomal oxidases, potentiate the toxicity. No such 
potentiation occurred and the inhibition mechanism would not appear applicable 
after repeated dosing with ethoxyquin.
In reviewing the evidence on carbon tetrachloride metabolism, Slater
(1972) pointed out that production of free radicals could possibly occur 
at the flavoprotein level in the electron transport chain or result from 
non-haem iron catalysed peroxidation. No published evidence is available 
on the effects of ethoxyquin on flavoprotein but the antioxidant propyl gallate 
was found to be an inhibitor of NADPH-flavoprotein (Torrielli and Slater,
1971). Ethoxyquin might operate similarly by suppressing metabolism of 
carbon tetrachloride at this level or by scavenging free radicals produced 
enzymically or by non-specific peroxidation.
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Chapter 8 
GENERAL DISCUSSION
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GENERAL DISCUSSION
Vitamin E and a number of synthetic antioxidants such as ethoxyquin
I
(6-ethoxy-l,2-dihydro-2,2’,4-trimethylquinoline), butylated hydroxytoluene (2,6- 
di-tert-butyl-4-me.thylphenol), and nordihydroguaiaretic acid [~meso-2,3-bis- 
(3,4-dihydroxybenzyl)butane] have been reported to prolong mouse or rat 
life-span (Harman, 1957; 1968a, b; Comfort et al, 1971; Buu-Hoi and 
Ratsimamanga, 1959). Comfort et al (1971) suggested that this prolongevity 
might be due to induction of the drug-metabolizing enzymes. Harman’s (1968a) 
studies show that ethoxyquin increases survival of mouse at the age of 20 months 
by 751,BHT by 61%,BHT plus vitamin E by 331,and vitamin E by 13%. From the 
point of view of enzyme induction this suggests that vitamin E should show 
only a marginal effect on the induction of the drug-metabolizing enzymes, 
in contrast to a potent inducing effect for BHT. The findings of the 
present studies and of the earlier works of others (Cawthome et al,
1970; Carpenter, 1967, 1972) support this proposition.
Working on the status of selenium and vitamin E metabolism in rats 
Diplock and Lucy (1973) recently reported that the primary function of 
vitamin E in vivo might be to inhibit the oxidation of selenide containing 
proteins, and that the selenide may form a part of the active centre of 
a non-haem iron protein. Caygill and Diplock (1973) found that the rat 
liver microsomal non-haem iron protein was oxidant labile. Caygill et al
(1973) subsequently observed that vitamin E, or vitamin E plus selenium,
75 75 2-stimulated the incorporation of Se, or its conversion to Se , in the
liver smooth endoplasmic reticulum of rats treated with phenobarbitone.
Furthermore, the selenium-containing non-haem iron protein (’X1) might
function in the hepatic microsomal NADPH-dependent electron transport
chain. This confirmed previous reports that vitamin E-protected selenium-
containing non-haem iron protein was involved in microsomal NADPH-dependent
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electron transport (Caygill et al, 1971; Diplock and Lucy, 1973).
A similar vitamin E - protected mechanism has also been found to 
prevent the production of malonaldehyde-like substance during the 
oxidation of NADPH by liver microsomes in the presence of ADP and 
a small amount of iron (Hochstein et al, 1964), and to stabilize the 
membrane against free radical factors which promote peroxidative chain 
scission of the polyunsaturated fatty acid moieties of phospholipids 
in the microsomal membrane (McCay et al, 1972). No such report 
concerning microsomal NADPH-dependent selenium-containing non-haem 
iron protein and the status of any synthetic antioxidant has so far 
appeared. Further work in this direction is needed to elucidate the 
nutritional status of synthetic antioxidants, as some antioxidants such 
as ethoxyquin and N,N’-diphenyl-p-phenylenediamine (DPPD)show pseudo­
vitamin E activity in that, in deficient rats, they reduce the incidence 
of congenital abnormalities (King, 1964), and aid in responding to a 
second reproduction cycle when carried through resportion-gestation and 
then treated with these antioxidants (Crider et al, 1961). Ethoxyquin 
in particular prevents encephalomalacia, exudative diathesis, muscular 
degeneration (Machlin and Gordon, 1962) and loss of fertility in chicken 
(Arscott et al, 1965), and steatitis in swine (Oldfield et al, 1963), 
typical signs of vitamin E deficiency.
Vitamin E and several synthetic antioxidants including ethoxyquin,
BHT, NDGA and butylated hydroxyanisole (2 or 3-tert-butyl-4-hydroxyanisole) 
(BHA) are inducers of the hepatic microsomal drug-metabolizing enzymes 
(Gilbert and Golberg, 1965; Gaunt et al, 1965; Creaven et al, 1966; 
Carpenter, 1967, 1972; Cawthome et al, 1970,1973a; Parke et al, 1972, 
1973a;Walker et al, 1973). From a structural point of view, they represent 
a variety of different chemical categories such as phenolic, polyphenolic
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and heterocyclic, which suggests that the inducibility of microsomal 
enzymes by antioxidants may depend on function rather than structure.
Two such functions are lipid solubility and non-polarity (Gillette, 1962) 
and this explains the inability of propyl gallate to induce the hepatic 
microsomal drug-metabolizing enzymes, it being water soluble and subject 
to gut floral hydrolysis to polar compounds, namely, gallic acid, 
pyrogallol and resorcinol which are not likely to be absorbed from 
the gut. However, this might not adequately explain differential 
induction.
Ethoxyquin induces cytochrome P-450 and biphenyl 4-hydroxylase 
but not ehtylmorphine N-demethylase, whereas NDGA induces cytochrome 
P-450 and ethylmorphine N-demethylase but not biphenyl 4-hydroxylase 
(Parke et al, 1972, 1973a). Vitamin E induces amiriopyrine demethylase 
(Cawthome et al, 1970) and cytochrome P-450 but not biphenyl 4-hydroxylase, 
whereas BHA induces biphenyl 4-hydroxylase and 4-methoxybiphenyl demethylase 
(Creaven et al, 1966) but not cytochrome P-450. On the other hand BKT 
induces cytochrome P-450, biphenyl 4-hydroxylase and ethylmorphine 
N-demethylase (Gray et al, 1972). The apparent lack of correlation 
between the activities of demethylases ana biphenyl 4-hydroxylase, and 
between these enzyme activities and cytochrome P-450 levels suggests that 
different antioxidants induce the synthesis of different forms of cytochrome 
P-450 or, alternatively, modify the conformation of the microsomal membrane 
in different ways. However, the concentrations of cytochrome P-450 may 
not be rate-limiting in all cases and the effects may be mediated via 
other enzymes in the electron transport chain, e.g. NADPH-cytochrome c 
reductase (Slater, 1972). Further work is needed to elucidate the exact 
mechanism of induction of hepatic microsomal mixed function oxidases by 
this range of antioxidants.
Ethoxyquin received through placental transfer or via the maternal 
milk initially inhibits the hepatic microsomal drug-metabolizing enzymes 
of neonatal rats, but exposure to ethoxyquin in the milk for a period 
of up to 12 days after birth subsequently induces these enzymes. This 
agrees with the findings that single intragastric doses of ethoxyquin 
cause induction of the hepatic microsomal drug-metabolizing enzymes of 
rats after an initial delay, and in vitro studies have revealed that this 
delay is due to inhibition of hepatic microsomal mixed function oxidases.
Of particular importance in this respect is the prolongation of hexo­
barbitone sleeping-time after single intragastric doses of ethoxyquin 
and significant reduction in this sleeping time after chronic administration 
to rats of the antioxidant in the diet for 14 days prior to dosing with the 
hexobarbitone. This biphasic response of the hepatic microsomal drug- 
metabolizing enzymes to ethoxyquin may be more pronounced in the neonate 
due to the inability of the antioxidant to induce drug metabolism 
in the foetus. Hart et al (1962) and Fouts and Hart (1965) demonstrated 
in the rabbit that hepatic microsomal enzyme induction was only possible 
in the later stage of gestation, i.e. about 4 days prior to parturition.
The observed effect of ethoxyquin on neonatal body weight and retarded 
development post partum may be reflected in a similar delayed maturation 
of the adaptive response of the liver to anutrients. Alternatively, 
ethoxyquin administered to the dam might have induced premature 
parturition before completion of foetal development to the stage at which 
the foetus is normally capable of responding to increased demands on the 
hepatic microsomal enzymes. Further work on foetal development in 
ethoxyquin-fed rats is needed to clarify the position.
The hepatomegaly and increases in concentration of microsomal protein, 
cytochromes P-450 and b^ , and in the activities of biphenyl 4-hydroxylase 
and ethylmorphine N-demethylase, caused by ethoxyquin, are age dependent
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and decline with age after attaining the post-weaning maxima. This 
decrease with increasing age, of the hepatic microsomal drug-metabolizing 
enzyme activity observed in rats (Kato et al, 1964) indicate a lost 
capacity of aged animals to detoxicate foreign compounds. The induced 
enzyme levels caused by ethoxyquin, although also falling-off with age, 
continue to remain at levels which are elevated compared with pair-fed 
controls. This is to the advantage of the aged animals as it assists 
them in responding to increased detoxication demands, as confirmed by 
the shortened hexobarbitone sleeping-time even in older animals repeatedly 
dosed with ethoxyquin. This has obvious implications in geriatrics 
when drug doses are usually calculated on a body weight basis without 
taking impaired liver function into account (O’Malley et al, 1971).
The hepatomegaly, proliferation of the smooth endoplasmic reticulum 
of the hepatic cell and induction of hepatic microsomal drug-metabolizing 
enzymes of rats caused by ethoxyquin have been demonstrated to be 
reversible over a period of 30 days after the withdrawal of ethoxyquin. 
Similar results were reported with BHT (Gilbert and Golberg, 1965;
Botham et al, 1970) and it would, therefore, appear that similar to BHT, 
ethoxyquin is also non-hepatotoxic. Long-term studies over a period of 
400 days after feeding ethoxyquin (0.5% w/w of diet) from 40 days of age did 
not reveal it to be hepatotoxic, although at this high dietary level some 
nephrotoxicity was evident.
Ethoxyquin decreases the specific activity of hepatic microsomal 
glucose-6-phosphatase, an enzyme which plays a very important role in 
carbohydrate metabolism. Lowering of the level of this enzyme has also 
been found to take place during the development of various tumours 
(Ashmore et al, 1953; Albert and Orlowski, 1960; Pitot, 1960), in the
liver of rats fed with butter yellow (Weber and Cantero, 1955), nitroso- 
morpholine (Friedrich-Freksa et al, 1964) or diethyInitrosamine(Heise 
and Gorlich, 1964). Feuer et al (1965) studied the effect of several 
hepatotoxic compounds including carbon tetrachloride on rat hepatic 
microsomal glucose-6-phosphatase and observed a decrement in the level 
of this enzyme. BHT which is not a hepatotoxic compound also reduced 
hepatic glucose-6-phosphatase when the antioxidant was fed at a level 
of 500 mg/kg. This led them to suggest that the falling-off of enzyme 
activity was indicative of hepatic damage and was a toxic response.
However, in the present study it has been observed that the reduced 
level of this enzyme was due to a * dilution effectT as a result of 
proliferation of the endoplasmic reticulum caused by induction of 
microsomal drug-metabolizing enzymes, because the total liver activity was 
not much different from control values; in reversibility studies it has 
been demonstrated that the change in specific activity of glucose-6- 
phosphatase of liver is reversible and not a toxic response. The 
prolongation of hexobarbitone sleeping-time after single intragastric 
doses, and significant reduction in this sleeping-time after chronic 
feeding of the ethoxyquin for 14 days prior to dosing with the hexo­
barbitone, also suggest that the response of the antioxidant to the liver 
is adaptive.
Single intragastric doses of ethoxyquin and chronic feeding of the 
antioxidant in the diet for 14 days to rats prior to the administration 
of carbon tetrachloride give protection against carbon tetrachloride 
hepatotoxicity. The protection is maximal when carbon tetrachloride is 
administered immediately after treatment with ethoxyquin. This protective 
effect, however, disappears as the time between pretreatment with ethoxyquin 
and dosing with carbon tetrachloride increases in that treatment with
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ethoxyquin 3 days before the administration of carbon tetrachloride 
affords no protection to the experimental rats against hydropic 
degeneration. These findings contrast with the time-dependent hepatic changes 
reported by Cawthome et al (1970) that ethoxyquin gives protection when 
administered 72 or 48 hrs before carbon tetrachloride but not when given 
24 or 6 hrs before dosing with the carbon tetrachloride. Their proposition, 
that the protection afforded by ethoxyquin is due to the synthesis of 
enzymes associated with either the metabolism of carbon tetrachloride 
through a non-toxic pathway or the removal of its toxic metabolite, suffers 
from this apparent contradiction. .
The effect of ethoxyquin on inhibition of hepatic microsomal drug- 
metabolizing enzymes and its ability to bind to the type I site of 
cytochrome P-450 (Parke et al, 1974) where carbon tetrachloride is also 
reported to undergo binding (McLean, 1967) may be taken to suggest 
that the protective effect of ethoxyquin is due to competitive inhibition 
of the metabolism of carbon tetrachloride. However, as repeated dosing 
of the antioxidant shortens the hexobarbitone sleeping-time, that is, 
induces metabolism and yet gives greater protection against carbon 
tetrachloride than a single intragastric dose of ethoxyquin, this cannot 
be the explanation. The antioxidant propyl gailate inhibits hepatic 
microsomal NADPH-cytochrome c reductase (Torrielli and Slater, 1971) and 
vitamin E may function in NADPH-dependent electron transport (Caygill 
et al, 1973) by preventing oxidation of the selenium-containing non-haem 
iron proteins of the hepatic endoplasmic reticulum (Diplock and Lucy,
1973). Slater (1972) suggested that production of free radicals at the 
flavoprotein level in the electron transport chain or by the non-haem 
iron catalysed peroxidation might be involved in carbon tetrachloride 
hepatotoxicity. The participation of ethoxyquin in such mechanisms has 
not been studied and in the light of selective induction of hepatic
178
microsomal drug-metabolizing enzymes by different antioxidants it is 
difficult to rule out all possibilities of free radical scavenging by 
ethoxyquin at its site of binding to cytochrome P-450 and at either or 
both of the other two sites in the electron transport chain. Further 
work in this direction is needed to explain the exact role of ethoxyquin 
in its exhibition of a protective effect against carbon tetrachloride 
hepatotoxicity.
Ethoxyquin, when administered intragastrically at a level of 2 g/kg, 
caused the death of 5 males and 6 females out of a total of 6 male and 6 
female rats in the course of 24 hours. When fed at a reduced level of 
II w/w in the diet it resulted in reduced food-intake (401 of control 
levels) and reduced gain in body weight. Prolonged feeding of ethoxyquin 
(up to 440 days of age) at a dietary level of 0.51 w/w resulted in increase 
in heart weight and kidney weight (P < 0.05) and in kidney damage. This 
confirms the earlier findings of Wilson and DeEds (1959) that this anti­
oxidant was nephrotoxic when fed to rats at a level from 0.0251. The 
thyroids were also affected. These and other effects on foetal and neonatal 
retardation of growth and hepatic microsomal drug-metabolizing enzymes call 
for further study to re-evaluate the safe level of ethoxyquin; the present 
permitted level is a maximum of 3 p.p.m. to stop scald in pears and apples 
(Antioxidants in Food Regulations, 1966).
Throughout these studies it has been observed that cytochrome b^ was
induced more slowly than microsomal protein, cytochrome P-450 and other
drug-metabolizing enzymes. In reversibility studies when smooth endoplasmic
reticulum was disappearing from the tissues, and also in carbon tetrachloride
damaged liver when levels of microsomal protein, cytochrome P-450, etc., were
again falling, cytochrome b^. was slowest to disappear. This may suggest
that cytochrome b^, in addition to having a slower turnover rate (Gmura
et al, 1967; Druyan et al, 1969; Greim et al, 1970), may be involved
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in the turnover of other constituents of the lipoprotein membrane of 
hepatic endoplasmic reticulum and may, in particular, play a functional 
role in the removal of this membrane. In this context, Sato et al (1969) 
demonstrated the involvement of cytochrome b^ in the oxidative desaturation 
of fatty acid but further work is also needed to elucidate the mechanism.
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TABLE 4-II Recovery from the effects of dietary ethoxyquin of some hepatic microsomal
enzymes and other parameters
Period after withdrawal of ethoxyquin (days)
PARAMETERS 0 3 7 14 30
Control Test Control Test Control Test Control Test Control Test
1. Body weight (g) 98+3 105+3 122+10 128+7 149+0 154+7 182+3 183+3 293+7 300+14
2. Liver weight (g) 3.6+0.1 7.0+0.1+ 6.0+0.1 8.0+0+ 7.1+0.2 8.8+0.4t 7.9+0.6 9.2+0.5 12.3+0.7 12.7+0.9
3. DMA content
(a) mg/g liver 3.2+0.1 2.1+0.it 2.8+0.1 2.7+0.1 3.5+0.3 3.1+0.1 3.1+0.1 2.9+0.1 2.3+0.1 2.3+0.1
(b) mg/liver 11.5+0.4 14.7+1.3 16,8+1.0 21.6+0,8f 24,9+1.0 27.3+2.0* 24.5+2.8 26.7+2.6 28.3+1.3 29,2+2.4
4. Microsomal protein 
content 
(a) mg/g liver 28.4+0.6 40,5+1.9-j- 29.4+1,0 32,9+0.8* 25,1+0.8 26.1+0,9 26,8+2.4 26.4+2,0 29,4+0,9 27,7+1,6
(b) mg/liver 102+4 284+4+: 176+15 263+9+r , 178+2 230+16 212+35 243+17 362+16 352+43
5. Cytochrome P;450_. 
content(91mM an ) 
(a) nmoles/g liver 21.9+0.8 44,0+3+ 20.6+1.4 27.5+1.9* 24.5+Q.3 26.4+1,8 24,3+0.9 23.5+2.2 29,4+1.5 28.0+2,9
(b) nmoles/liver 79+2 ' 308+8+ 124+16 220+10+r 174+7 232+1 192+12 216+33 362+26 356+52
6. Cytochrome br_.
content(185mM~ an” ) 
(a) nmoles/g liver 14.4+0.8 25.4+0.8+ 11.4+1.2 17.5+0.7 10.1+0.5 14.6+0.4^ 1. 12.3+0.8 14.2+0.8* 12.6+0,6 13,6^ ), 4
(b) Nmoles/liver 52+2 178+2+ 68+12 140+6+ 72+5 128+8 97+14 131+14 155+6 173+19
7. Biphenyl-4-hydroxylase
activity 
(a) ymoles/g/g liver 5.1+0.5 8.0+0.9+ 3.3+0.1 4.6+0.1+ 3.2+0.3 3.6+0.1 3.6+0.2 3.4+Q.l 3.0+0,1 3.1+0.2
(b) pmoles/h/liver 18+1 56+5+.. 20+1 37+1+ ; 23+1 32+2+ 28+2 31+3 37+1 * 39+1
8. Ethylmorphine-N- 
demethylase activity 
(a) ymoles/h/g/liver 38j+l 33+1* . 33+3 39+6 44+7 42+11 50+2 48+7 34+1 33+1
(b) pmoles/h/liver 137+3 231+13f 198+32 312+60 312+43 370+38 395+47 442+86 418+52 419+33
9. Glucose-6-phosphatase 
activity
(a) pmoles/min/ 
g liver 12.2+0.1 5.5+0.1+ 11.4+0.1 9.7+0.2* 10.6+0,7 9.0+0,5 11.3+0.4 12.0+0.5 11.2+0.3 11.0+0,3
(b) ymoles/min/ 
g liver 44+1 39+5 68+4 78+5t 75+3 . 79+6 89+7 110+9 138+10 140+8
Ethoxyquin was administered at a dietary concentration of 0.5& during the 14-day pretreatment period. 
Values given are the means + S.E.M. Each group (control or test) consisted of four animals. 
Significant effects are shown: * P.<. 0.05; t P < 0.01; + P < 0.001,
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Plate 7-1. Photomicrograph, of liver of rat killed 24 hours after single oral 
aose of^etnoxycpiin followed immediately by single oral dose of liquid paraffin.
The photomicrograph shows normal histological pattern of liver.
Plate 7-2 Photomicrograph of liver of rat killed 24 hours after single oral 
dose of ethoxyquin followed immediately by single oral dose of carbon tetrachloride 
(H.H.: x 390.6).
Tne photomicrograph shows some of vacuolation in periportal region and 
some hydropic changes.
Plate 7-3 Photomicrograph of liver of rat killed 48 hours after single oral 
dose of arachis oil and 24 hours after single oral dose of liquid paraffin 
(H.E: x 390.6).
The photomicrograph shows normal histological pattern of liver.
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Plate 7-4 Photomicrograph of liver of rat killed 48 hours after single oral 
dose of ethoxyquin and 24 hours after single oral dose of liquid paraffin. 
(H.E. • x 3,90.6),
The photomicrograph shows normal Histological pattern of liver.
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Plate 7-5 Photomicrograph, of liver of rat killed 48 hours after single oral 
dose of ethoxyquin and 24 hours after single oral dose of carbon tetrachloride 
(H.E.: x 390.6)
The photomicrograph shows vacuolation in periportal region and some 
nydropic cnanges.
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Plate 7-6. Photomicrograph of liyer of rat killed 72 hours after single 
oral dose of arachis oil and 24 hours after single oral dose of carbon 
tetrachloride (H.E.:x 390.6).
The photomicrograph shows fatty change, perilobular hydropic degeneration 
and cell necrosis.
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Plate 7-7. Photomicrograph of liver of rat killed 72 hours after single oral 
dose of ethoxyquin and 24 hours after single oral dose of liquid paraffin 
(H.E.: x 390.6).
The photomicrograph shows enlargement of the centrilobular cells with 
vacuolation of cytoplasm.
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Plate 7-8. Photomicrograph of liver of rat killed 72 hours after single oral 
dose of ethoxyquin and 24 hours after single oral dose of carbon tetrachloride 
(H.E.: x 390.6).
The photomicrograph shows some reduction in number of hydropic cells compared
with treated controls.
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Plate 7-9 Photomicrograpli of liver of rat killed 96 hours after single oral 
dose of ethoxyquin and 24 hours after single oral dose of liquid paraffin 
(H.E.: x 390.6).
The photomicrograph shows normal histological pattern of liver.
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Plate 7-10. Photomicrograph of liver of rat killed 96 hours after single oral 
dose of ethoxyquin and 24 hours after single oral dose of carbon tetrachloride 
(H.E.:x390.6).
The photomicrograph shows slight reduction in number of hydropic cells.
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Plate 7-11 Photomicrograph of liver of rat pair-fed with control diet 
for 14 days, then given a single oral dose of liquid paraffin and hilled 
24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows normal histological pattern of liver.
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Plate 7-12 Photomicrograph, of liver of rat pair-fed with control diet 
for 14 days, then given a single oral dose of carbon tetrachloride and 
killed 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows fatty change, hydropic degeneration of 
hepatic cell and cell necrosis.
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Plate 7-15. Photomicrograph of liver of rat fed ethoxyquin in the diet
ad-libitum for 14 days, then given a single oral dose of carbon tetrachloride 
and killed 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows vacuolation of hepatic cells.
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Plate 7-14. Photomicrograph of liver of rat pair-fed with control diet 
for 14 days, then after 1 day given a dose of carbon tetrachloride and 
killed 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows fatty change, extensive hydropic degeneration 
of hepatic cell and cell necrosis.
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Plate 7-15. Photomicrograph of liver of rat fed ethoxyquin in the diet 
ad-libitum for 14 days, then after 1 day given a dose of liquid paraffin 
andHkilled 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows some reduction in vacuolation of hepatic cells.
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Plate 7-16. Photomicrograph of liver of rat fed ethoxyquin in the diet 
ad-libitum for 14 days, then after 1 day given a dose of carbon tetrachloride 
and killed 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows reduction in vacuolation of hepatic cells.
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Plate 7-17. Photomicrograph of liver of rat fed ethoxyquin in the diet 
ad-libitum for 14 days, then after 2 days given a dose of carbon tetrachloride 
and killed 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows hydropic degeneration of hepatic cells.
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Plate 7-18. Photomicrograph of liver of rat fed ethoxyquin in the diet 
ad-libitum for 14 days, then after 3 days given a dose of carbon tetrachloride 
and killed 24 hours thereafter (H.E.: x 390.6).
The photomicrograph shows fatty change, hydropic degeneration and cell
necrosis.
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Table 1. Inhibition constants and rates of transport o f sugars into human erythrocytes 
Experimental details are given in the text.
Rate of transport (25°C)
Ki (app.) Kt (app.) - — N
(sorbose (glucose V Inhibition
inhibition) inhibition) Concn. (fi mol/min by 50 mM-
Sugar (mM) (mM) (mM) per ml) glucose (%)
D-Galactose 85 — . - —  ■ — —
6-Deoxy-D-galactose 48 — 5 8 64
6-Deoxy-6-iodo-D- 8 — 5 3 50
galactose
6-0-Methyl-D-galactose 45 54 10 0.5 78
6-0-Propyl-D-galactose 33 48 10 0.1 0
6-0-Pentyl-D-galactose 3 10 10 0.6 0
6-0-Benzyl-D-galactose 2.5 6 10 0.4 0
D-Glucose 7 — 5 8* —
3-OPropyl-D-glucose 59 — — — —
3-0-Pentyl-D-glucose 30 oo — — —
Propan-l-ol — oo --- — —
Pentan-l-ol 30 00 — — —
Benzyl alcohol 11 Non­
competitive
— — —
D-Xylose 69 — — . —
5- C-Phenyl-D-xylose 3.5 — — — —  .
* At 15°C.
The values given for the penetration rates are at the concentrations shown, and are not 
maximum velocities. 6-Deoxy-6-iodo-D-galactose and 6-0-methyl-D-galactose therefore 
have a much lower rate of transport than expected from their Kt values, suggesting some 
interference with their translocation.
6-OPropyl-D-galactose and the sugars with a larger group at C-6 penetrated more 
slowly, and penetration was not inhibited by 50mM-D-gluCose. The penetration rate 
seemed to be greater the more lipophilic the side chain, and it must be assumed that these 
sugars penetrate the membrane by a route other than the glucose-sorbose carrier. Similar 
behaviour has previously been observed for 4,6- O-ethylidene-D-glucose, which com­
petitively inhibits the glucose carrier system, but only slowly penetrates the membrane, 
by an alternative route (Baker & Widdas, 1971).
The inhibition of L-sorbose entry increased with the length of the alkyl side chain 
(Table 1), but some doubt was cast on the specific nature of the inhibition in this system 
because pentan-l-ol and benzyl alcohol were also found to be inhibitors, as was 3-0- 
pentyl-D-glucose, which from previous work (Barnett et al., 1973) would have been 
expected to be too bulky for binding to the carrier. The kinetic treatment of the inhibition 
of L-sorbose penetration cannot distinguish competitive inhibition from other forms of 
inhibition and requires a long preincubation time of the inhibitor with the cells. We there­
fore measured the inhibition constants of the sugars and alcohols as inhibitors of d- 
glucose entry.
By plotting Lineweaver-Burk plots (Fig. 1), it was found possible to distinguish com­
petitive and non-competitive inhibition over a very short time-course. A ll the 6-O-aIkyl- 
D-galactoses were found to be competitive inhibitors, propan-l-ol and pentan-l-ol did 
not inhibit and benzyl alcohol was a weak non-competitive inhibitor. As predicted,
3-0-perityl-D-glucose was not an inhibitor in this system.
The affinity of the sugars for the carrier measured by D-glucose inhibition again in­
creased with the length of the C-6 side chain. 6-0-Benzyl-D-galactose had an affinity 
15 times that of the parent sugar.
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Fig. 1. Lineweaver-Burk plots for D-glucose entry into human erythrocytes
Glucose was measured at 15°C alone (o) or in the presence of lOmM-6-O-benzyl-D- 
galactose (a), 10mM-6-O-pentyl-D-galactose (□) or lOmM-benzyl alcohol ( • ) . Experi­
mental details are given in the text.
Together with 4,6-0-ethylidene-D-glucose (Baker & Widdas, 1971), the 6-0-alkyl- 
D-galactoses and 5-C-phenyl-D-xylose represent a new class of non-transported competi­
tive inhibitors of sugar transport in the human erythrocyte, with a high affinity for the 
carrier. The sugars tested in this work bound very much more strongly than do the parent 
sugars. In  this respect they contrast with maltose and cellobiose, which also act as com­
petitive inhibitors but bind more weakly than glucose.
The enhanced binding of the 6-0-alkyl sugars and 5-C-phenyl-D-xylose can be ex­
plained by hydrophobic interaction with a lipid region. Such a region would also explain 
the competitive inhibition of phloretin and related compounds, which have a very high 
affinity for the transport system.
We thank Dr. Inch, Chemical Defence Establishment, Porton Down, Salisbury, Wilts., U.K., 
for the gift of 5-C-phenyl-D-xylose.
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Barnett, J. E. G., Holman, G. D. & Munday, K. A. (1972) Abstr. Commun. FEBS Meet. 8th 
no. 95
Barnett, J. E. G., Holman, G. D. & Munday, K. A. (1973) Biochem. J. 131, 211-221 
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Reversibility of Hepatic Changes Caused by Ethoxyquin «.
DENNIS V. PARKE, ABDUR R A H IM  and RONALD WALKER  
Department ofBiochemistry, University o f Surrey, Guildford GUI 5 XH, Surrey, U.K.
Ethoxyquin (6-ethoxy-l,2-dihydro-2,2,4-trimethylquinoline) is a synthetic antioxidant 
permitted for limited use in food in the U .K . and also used in animal feedstuffs. It  pre­
vents some of the symptoms of vitamin E deficiency, such as encephalomalacia, exudative 
diathesis, muscular degeneration (Machlin &  Gordon, 1962) and loss of fertility 
(Arscott et al., 1965).
Parenterally administered ethoxyquin was non-carcinogenic to Swiss mice (Epstein 
et al., 1970), and orally administered it inhibited the carcinogenicity of benzo[a]pyrene
1973
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and 7,12-dimethylbenz[a]anthracene in mice and rats (Wattenberg, 1972). Ethoxyquin 
has been reported to protect against dietary liver necrosis (Schwarz, 1958) and the 
hepatotoxicity of CC14 (Cawthome et al., 1970, 1971, 1973).
Ethoxyquin has low oral acute toxicity and has even been reported to prolong lifespan 
in mice (Comfort et al., 1971). It  is rapidly metabolized and excreted by rats (Wiss et al., 
1962).
In  view of the many beneficial effects, ethoxyquin is likely to be more widely used in 
foods and feedstuff’s. It  is therefore important to know whether the hepatomegaly and 
other changes reported by Parke et al. (1972) are adaptive and reversible or manifesta­
tions of a toxic response.
Weanling male Wistar rats were given a diet containing 0.5 % ethoxyquin for 14 days, 
with the use of a pair-feeding experimental protocol similar to that reported previously 
(Parke et al., 1972,1973). A ll the animals were then placed on control antioxidant-free 
diet. Immediately on withdrawal of ethoxyquin, and at intervals of 3, 7,14 and 30 days 
thereafter, four experimental animals and their respective pair-fed controls were killed by 
cervical dislocation and their livers excised. Liver homogenates, 10000# supernatants 
and microsomal suspensions were prepared, and microsomal protein, cytochrome P-450, 
cytochrome b5, biphenyl 4-hydroxylase activity and ethylmorphine A-demethylase 
activity were assayed as described previously (Parke et al., 1973). Additionally DNA  
was determined in the homogenate (Zamenhof et al., 1964; Burton, 1956) and glucose 
6-phosphatase in the 10000# supernatant (de Duve et al., 1955).
The results are shown in Table 1. After 14 days pretreatment with ethoxyquin the liver 
weight was increased by 90 % compared with pair-fed controls. The decrease of 35 % in 
D N A  concentration compared with the 25 % increase in total D N A  in the liver at this 
time suggests that liver enlargement may result both from cell hypertrophy and hyper­
plasia. Assuming no increase in nuclear size, this indicates that the increase in liver mass 
is due to a 25% increase in cell number and a 50% increase in cell size.
Concomitant increases in both concentration and total amount in the liver were ob­
served with microsomal protein, cytochrpme P-450 and cytochrome b5 after pretreat­
ment with ethoxyquin, and there was a similar increase in biphenyl 4-hydroxylase activity. 
The specific activity of ethylmorphine iV-demethylase in the microsomal fraction was 
depressed by about 13 %, but, owing to the increase in liver size, the total activity in the 
liver was elevated by 65 %. This observation agrees with a previous report that ethoxyquin 
did not consistently increase the specific activity of this enzyme (Parke et al., 1972).
The decrease of the specific activity of glucose 6-phosphatase to 45 % of control values 
appears to be due to changes in the composition of the induced endoplasmic reticulum 
rather than inhibition by ethoxyquin, as the total amount of glucose 6-phosphatase in 
the liver was only slightly diminished and studies in vitro (A. Rahim & R. Walker, 
unpublished work) have shown that ethoxyquin does not inhibit this enzyme. Glucose 
6-phosphatase activity is frequently lowered in hepatitis, but long-term studies by our­
selves and other workers at high dietary doses of ethoxyquin (Walker et al., 1973; 
Comfort et al., 1971) did’not reveal obvious signs of chronic hepatitis. It  appears, then, 
that induction of the drug-metabolizing enzymes of the endoplasmic reticulum leads 
to a ‘dilution’ of the microsomal glucose 6-phosphatase.
By the end of the 30-day recovery period the liver size and DNA content had returned 
to normal, indicating that both the hypertrophy and hyperplasia were reversible, as 
would be expected of an adaptive response. The course of the recovery in these growing 
rats appeared to be biphasic. The recovery from cell hypertrophy was rapid, as D NA  
concentration was normal by the third day and the microsomal protein concentration and 
other enzyme concentrations except cytochrome bs were similar to control values by the 
seventh day. The recovery from the hyperplasia was somewhat slower, however, and the 
total amount of microsomal protein and enzymes studied did not fall to control values 
until the 30th day, by which time the differences between test and control animals were 
not significant for any of the parameters studied.
From these results it appears that the hepatomegaly and enzyme induction effected by 
ethoxyquin in the rat should be considered a truly adaptive and reversible response.
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However, some microsomal enzyme inducers, particularly phenobarbitone, have been 
shown to potentiate the carcinogenicity of 2-acetamidofluorene when administered sub­
sequently (Peraino et al., 1971). No evidence of the potentiating effect of ethoxyquin on 
this carcinogen is available, but the ability of ethoxyquin to inhibit the carcinogenicity of 
benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene (Wattenberg, 1972) relates to 
tumours at sites other than the liver. It  would therefore seem pertinent to investigate the 
effects of ethoxyquin on the activity of known hepatic carcinogens.
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Wiss, O., Bunnell, R. H. & Gloor, U. (1962) Vitam. Horm. (New York) 20, 441-455
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The Control of Tetrahymanol Biosynthesis by Tetrahymena pyriformis
A. S. BEEDLE, K . A. M UN D A Y and D. C. W ILTON
Department of Physiology and Biochemistry, University o f Southampton,
Southampton S09 3TU, U.K.
The protozoan Tetrahymena pyriformis divides rapidly when incubated in a suitable 
growth medium at 28°C. The culture grows exponentially until the 0 2 supply becomes 
limiting (Levy & Scherbaum, 1965) and then cell division rapidly ceases, although cell 
viability is maintained for some time. The precise biochemical changes that are initiated 
by an inadequate 0 2 supply and that lead to a cessation of growth are not known. There­
fore it was decided to measure those aspects of metabolism that should be directly related 
to growth in order to establish which parameters cause a cessation of growth and which 
are a result of it. Of particular interest was the biosynthesis of the triterpenoid tetrahyma­
nol (I). This compound is an important structural component of the cell (Jonah & Erwin,
HO'
(I) Tetrahymanol
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Fig. 1. Changes in the rates of biosynthesis o f tetrahymanol, protein and RNA and also in 
cellular respiration during growth o f a culture o f Tetrahymena pyriformis
Experimental details are given in the text, (a) Growth rate (©) and cellular respiration (o );
(b) protein synthesis (H) and RNA synthesis (□); (c) tetrahymanol biosynthesis (a).
1971; Thompson et al., 1971) and is metabolically inert (Thompson et al., 1972), so that 
its biosynthesis should provide an excellent index of the growth state of the culture.
Tetrahymanol biosynthesis was determined during the growth of a culture of Tetra­
hymena pyriformis by measuring the conversion of [2-3H]acetate into the triterpenoid.
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treated cells it enters at about twice the rate. I f  the 4h point is taken, a plot of radioacti­
vity found in the rRNA/cell against density reveals that the higher the density the less 
newly made RNA enters the ribosomes, even though incorporation of [3H]uridine/cell is 
a constant. Also, at any density twice as much newly formed RNA enters the ribosomes 
of androgen-treated cells (Fig. 2).
In  many eukaryotic cells an important level of control of ribosome production is 
found at the stage of processing of the newly formed ribosome precursor molecules 
(Cooper, 1970, 1971; Rizzo & Webb, 1969). For instance in resting lymphocytes, 
Cooper (1970,1971) has found that 45 S RNA is formed at a constant high rate and pro­
cessed to 18 S and 28 S RNA. However, rapid turnover of the components means that 
very little newly formed rRNA enters the cytoplasm. When the lymphocytes are stimu­
lated, this wastage ceases, allowing rRNA to accumulate.
A difference in the wastage of newly formed 18 S and 28 S RNA between the treated 
and the untreated cells could account for the differences seen in the specific radioactivity 
of their rRNA. A  difference in wastage related to density could account for the different 
concentrations of RNA found in cells growing at different densities, even though the 
incorporation of [3H]uridine/cell is a constant.
To summarize, the results so far acquired point to a relationship between growth rate 
and the turnover of newly synthesized rRNA. These findings cannot rule out the possi­
bility that the rate of synthesis of 45 S RNA is so small compared with gross RNA  
synthesis that differences in its rate of synthesis would be difficult to notice. Analysis of 
the RNA on polyacrylamide gels should clarify this.
Cooper, H. L. (1970) Nature (London) 227, 1105-1107 
Cooper, H. L. (1971) / .  Biol. Chem. 246, 5059-5066 
Hamilton, T. H. (1968) Science 161, 649-661
Rizzo, A. J. & Webb, T. E. (1969) Biochim. Biophys. Acta 195, 109-122 
Smith, J. A. & King, R. J. B. (1972) Exp. Cell Res. 73, 351-359 
Wick, W. D. & Kenney, F. T. (1964) Science 144, 1345-1351
Effects of Nordihydroguaiaretic Acid on Rat Hepatic Microsomal Enzymes
DENNIS V. PARKE, ABDUR R A H IM  and RONALD W ALKER  
Department of Biochemistry, University o f Surrey, Guildford, Surrey, U.K.
Nordihydroguaiaretic acid [m^o-2,3-bis-(3,4-dihydroxybenzyl)butane] is a naturally 
occurring antioxidant that until recent years was used in foods. The biological pro­
perties are therefore of some importance in relation to man’s exposure to nordihydro­
guaiaretic acid, and have been discussed in a recent review (Oliveto, 1972).
Of particular interest was the observation that continuous administration of 
nordihydroguaiaretic acid in the diet prolonged the life-span of rats (Buu-Hoi &  
Ratsimamanga, 1959). In  this respect nordihydroguaiaretic acid resembles the anti­
oxidants ethoxyquin (6-ethoxy-l,2-dihydro-2,2,4-trimethylquinoline) (Comfort et 
al., 1971) and butylated hydroxytoluene (BHT) (Harman, 1968), which increased life­
span in mice. The mechanism whereby these antioxidants prolong life-span is not 
clear, but it may possibly be related to their ability to act as inducers of those hepatic 
enzymes involved in detoxication of xenobiotics. Earlier work with butylated hydroxy­
toluene (Gilbert & Golberg, 1965; Botham et al., 1970) and with ethoxyquin (Parke et 
al., 1972) has demonstrated that both are potent inducers of hepatic microsomal drug- 
metabolizing enzymes.
In the work now reported, nordihydroguaiaretic acid was fed to rats at a dietary con­
centration of 0.5 % for a period of up to 60 days, a paired-feeding experimental protocol 
similar to that previously reported with ethoxyquin (Parke et al., 1972) being 
used. Two groups of 18-day-old male Wistar rats were kept with their dams for a 3-day 
weaning period during which the dams were fed ad libitum on a control powdered diet
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(Spillers small-animal diet, meal form) containing 2.5% (w/v) of antioxidant-free 
arachis oil. At the end of the weaning period the weanlings were caged singly and 
nordihydroguaiaretic acid was incorporated in the diet of the experimental group at a 
concentration of 0.5 %, the arachis oil being used as a vehicle. This group were fed ad 
libitum and the second group were pair-fed with an equal amount of food to that con­
sumed by the experimental group. Food intakes and body weights were checked daily. 
Fresh diet was made up at weekly intervals to avoid the possible accumulation of toxic 
products of peroxidation.
Four animals from each group were killed by cervical dislocation after 0, 3, 7,14, 30 
and 60 days and the livers were rapidly excised. Liver homogenates and microsomal 
fractions were prepared as described by Basu et al. (1971). Portions of the lOOOOg- super­
natant were used to determine biphenyl 4-hydroxylase activity (Creaven et al., 1965) and 
ethylmorphine iV-demethylase activity (Holtzman et al., 1968). The microsomal sus­
pension was used to determine cytochrome P-450 (Sladek & Mannering, 1966), cyto­
chrome bs (Schenkman et al., 1967) and microsomal protein (Lowry et al., 1951).
The results of these experiments are shown in Table 1. Nordihydroguaiaretic acid had 
no significant effect on growth rate or food intake, but caused a gross increase in liver 
weight, which was almost double the control liver weight on days 30 and 60. Microsomal 
protein, cytochrome P-450 and cytochrome bs concentrations were significantly elevated 
in test animals, in each case maximal values being achieved at 14-30 days on the experi­
mental diet. The microsomal protein concentration fell to control values by the 60th 
day, but the concentration of cytochromes P-450 and bs remained significantly elevated 
throughout.
In  contrast with the observed increase in cytochrome P-450 concentration, the specific 
activity of biphenyl 4-hydroxylase was not markedly increased at any stage of the experi­
ment. Ethylmorphine JV-demethylase activity was significantly increased initially, reach­
ing almost 150% of control values on day 3, but the specific activity had fallen to near 
control values (not significantly different) by the 60th day. Although specific activities of 
both enzymes were near normal by the end of the experiment, total metabolic activity 
in the liver was elevated because of the increase in liver weight.
The pattern of liver microsomal-enzyme induction by nordihydroguaiaretic acid 
contrasts with that observed with ethoxyquin (Parke et al., 1972). In  the latter case bi­
phenyl 4-hydroxylase activity was induced whereas ethylmorphine jV-demethylase 
activity was not very different from control values. The increase in microsomal protein 
and cytochrome b5 concentrations was very much less with nordihydroguaiaretic acid 
than ethoxyquin. On the other hand the cytochrome P-450 concentration was elevated 
to a similar extent. The lack of correlation between cytochrome P-450 concentrations 
and activities of biphenyl 4-hydroxylase and ethylmorphine TV-demethylase may be due 
to at least three possible causes: (a) the induced cytochrome P-450 differs from the 
normal in its enzyme specificity; (b) cytochrome P-450 activity is not rate-limiting;
(c) although nordihydroguaiaretic acid results in increased synthesis of cytochrome 
P-450, its increase may lead to subsequent inhibition. With regard to (c), nordihydro­
guaiaretic acid has been reported as an inhibitor of microsomal enzyme function in vitro.
The three antioxidants butylated hydroxytoluene, ethoxyquin and nordihydroguai­
aretic acid, which have been reported to cause prolongevity, have all been shown, in this 
and previous studies, to be active in increasing liver size and total metabolic activity of 
several ‘drug-metabolizing’ enzymes, whereas propyl gallate, an antioxidant that has 
been reported not to prolong life (Harman, 1968), does not induce hepatic microsomal 
enzymes (Parke et al., 1972). McLean & Marshall (1971) have reported that lipid per­
oxides are necessary for the maximal induction of cytochrome P-450 by phenobarbitone, 
although they do not induce per se. The induction reported in this and previous studies 
with butylated hydroxytoluene, ethoxyquin and nordihydroguaiaretic acid was not 
enhanced due to the presence of dietary peroxides as experimental conditions did not 
favour their formation. Conversely it has been suggested (Dormandy, 1969) that aging 
may involve oxidation of lipids in vivo by free-radical attack, and the ability of these 
antioxidants to delay aging and to induce hepatic microsomal enzymes may reflect their
Vol. 1
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ability to stabilize phospholipid in the membranes of the cell and subcellular organelles, 
including the endoplasmic reticulum.
During these experiments post-mortem examination did not reveal any caecal lesions 
similar to those described by Lehman et al. (1951) in a 2-year study at this dietary con­
centration of nordihydroguaiaretic acid.
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The Kinetics of 5-Hydroxytryptamine Uptake by Rat Brain Synaptosomes
M ICHAEL R. KIBBY and HAM ISH M cKENZIE
Department of Biochemistry, University o f Strathclyde, 204 George Street,
Glasgow G\ 1XW, U.K.
A large part of synaptosomal 5-hydroxytryptamine exists in a bound form within synap­
tic vesicles (Whittaker, 1961). Synaptosomes take up the amine against a concentration 
gradient and the process exhibits saturation kinetics (Bogdanski et al., 1968; Segawa &  
Kuruma, 1968). Qualitative models of the functional relationships of 5-hydroxytrypt­
amine in the nerve ending have been proposed, derived from whole-brain turnover 
measurements and enzyme studies (Moir, 1972).
The rabbit blood platelet has been used previously in this laboratory as a model for 
the uptake and storage of 5-hydroxytryptamine in the nerve ending. A  computer-based 
interpretation of the kinetics of uptake and subcellular distribution of 5-hydroxytrypt­
amine has shown that two amine pools exist within the platelet and that transport of 
material between them and the extracellular medium is governed by simple chemical 
kinetics (Kibby, 1970,1971). We have now extended the technique to the synaptosome in 
order to formulate models of 5-hydroxytryptamine uptake, storage and metabolism 
based directly on experimental results.
Synaptosomes were isolated from rat brain (less the cerebellum) by the method of 
Whittaker (1961). Treated animals were injected with reserpine suspension (lOmg/kg 
body wt. intraperitoneally) 16h before they were killed. Control animals received the 
vehicle only. The synaptosomes were incubated at 37°C in 4ml of Ringer bicarbonate 
solution containing glucose (12/zmol/ml) and sodium pyruvate (5/xmol/ml). At zero 
time 5-hydroxy[3H]tryptamine (0.1 nmol/ml) was added and incubations were continued 
for 1.5, 3, 6 or 12min. After incubation the synaptosome suspensions were rapidly 
washed, sonicated and passed through a column of Sephadex G-50 at 0°C. 5-Hydroxy- 
indol-3-ylacetate was separated from the fractions by extraction with ether.
The gel filtration yielded a vesicle and protein fraction (‘bound’) and a ‘soluble’ frac­
tion free of protein. Each fraction contained both labelled 5-hydroxytryptamine and
1973
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Table 1. Cumulative excretion o f radioactivity in urine and faeces after intraperitoneal 
administration of [1,2-3H]dexamethasone in the rat
Experimental details are given in the text. A ll results are given as means± s.e .m . obtained 
from four animals.
Dose excreted (%)
Time after dosing /------------------*------------------>
(h) Urine Faeces
6 18.0±1.0 0.3 ±0.1
24 26.7 ±1.4 11.7 ±2.8
48 28.9±1.6 36.9 ±7.0
72 29.8 ±1.7 41.6±7.5
96 30.4 ±1.6 43.6 ±8.0
These findings with dexamethasone and a previous report (Tredger et al., 1973) on 
betamethasone (the 16jS-methyl isomer) show that in the rat the urinary excretion rates 
of these two compounds are the same. In  contrast, the faecal excretion of dexamethasone 
is considerably slower than that of betamethasone. In  48 h after drug administration 
36.9% of the dosed radioactivity was excreted in the faeces compared with 54.4% ob­
served with betamethasone (Tredger et al., 1973). The presence of a high proportion of 
free steroids in the metabolites of urine agrees with previous reports on synthetic cortico­
steroids (Butler & Gray, 1970; Haque et al., 1972). In  the human, the urinary free 
steroids after dexamethasone administration consisted of unchanged drug and three 
polar metabolites (Haque et al., 1972). The relative amounts of these metabolites are not 
known. From our investigations it appears that 32% of the urinary radioactivity in the 
rat is associated with one polar metabolite of dexamethasone. Chromatographic studies 
of this metabolite and dexamethasone compared with that of 6-hydroxybetamethasone 
and betamethasone indicate that this dexamethasone metabolite is likely to be 6-hydroxy- 
dexamethasone.
We thank Roussel Laboratories Ltd., for a gift of dexamethasone and the Science Research 
Council for the award of a studentship to J. M. T.
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Inhibition of Rat Hepatic Microsomal Mixed-Function Oxidases by 
Ethoxyquin
DENNIS V. PARKE, ABDUR R A H IM  and RONALD W ALKER  
Department o f Biochemistry, University o f Surrey, Guildford GUI 5XH, U.K.
Ethoxyquin (6-ethoxy-l,2-dihydro-2,2,4-trimethylquinoline), a synthetic antioxidant, 
has been reported to cause induction of hepatic microsomal drug-metabolizing enzymes 
when administered to rats at a concentration of 0.5 % (w/w) in the diet for 60 days post- 
weaning (Parke et al., 1972) and similar results were obtained in a long-term study, up to 
455 days of age (Walker et al., 1973). In  weanling rats the induction was maximal after 
7 to 14 days of exposure to dietary ethoxyquin, whereas no such dramatic induction
Vol. 2
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was observed after single intragastric doses of 500mg/kg (A. Rahim & R. Walker, 
unpublished work) and single doses are rapidly metabolized in vivo (Wiss et al., 1962). 
In  this latter respect ethoxyquin resembles the short-acting barbiturates which are 
rapidly metabolized and only cause induction on repeated dosing, when the increased 
demand for microsomal metabolism is sustained (Parke & Ioannides, 1973). This sug­
gested that the enzyme induction observed with ethoxyquin might result from initial 
(competitive) inhibition leading to a demand for increased enzyme synthesis.
To test this hypothesis that ethoxyquin might be an initial inhibitor, the effects of 
ethoxyquin on hexobarbital metabolism were studied in vivo in 8-9-week-old male Wistar 
albino rats by observing the hexobarbital (lOOmg/kg) sleeping-time at various intervals 
after a single intragastric dose of ethoxyquin (500mg/kg). The ethoxyquin was admin­
istered as a 25 % (w/v) solution in arachis oil and the hexobarbital was dissolved in dilute 
aq. NaOH (100mg/2ml) adjusted to pH 11 and administered by intraperitoneal injection. 
The sleeping-time was taken as the time between loss and recovery of the righting reflex.
Inhibition by ethoxyquin of microsomal biphenyl 4-hydroxylase and ethylmorphine 
7V-demethylase in vitro was also studied. A  rat hepatic microsomal preparation was made 
as described by Basu et al. (1971) and the activity of the enzyme measured on double­
washed microsomal fractions at a range of substrate concentrations and in the absence 
or presence of various concentrations of ethoxyquin. The ethoxyquin was added as a 
solution in aq. 65 % (v/v) ethanol at a maximum volume of 6/xl per incubation mixture 
and a similar volume of aqueous alcohol was added to controls without ethoxyquin.
Biphenyl 4-hydroxylase was assayed by the method of Creaven et al. (1965) except that 
the substrate concentration was varied between 0.6 and 1.2mM and ethoxyquin was 
added at a concentration of 0 to 0.06mM. Ethylmorphine A-demethylase was assayed 
by the method of Holtzman et al. (1968) at substrate concentrations of 2.08 to 4.16mM 
and ethoxyquin concentrations of 0 to 0.066mM.
In  addition, the spectral dissociation constant (Ks) of ethoxyquin was determined by 
observing the difference spectrum at 380 to 425nm when ethoxyquin (0.004 to 0.04mM) 
was added to a suspension of a double-washed microsomal preparation (2 mg of protein/ 
ml) in 0.1 M-phosphate buffer at pH7.6. The ethoxyquin (maximum vol. 10/xl) was added
Table 1. Hexobarbital (100 mgfkg) sleeping-time of 8-9-week-old Wistar male albino rats 
after single oral dose of ethoxyquin (500mg j kg)
Ethoxyquin was administered intragastrically as a 25 % (w/v) solution in arachis oil. 
Hexobarbital was administered intraperitoneally as a 5 % (w/v) solution in dilute aq. 
NaOH, pH 11. N.S., not significant. Values given are means ±  s.e.m ., n — 4.
Sleeping-time (min)
Period of
Sample pretreatment Ethoxyquin-treated
ratsno.
1
2
(h) Control rats
0 16.75 ±0.07
1 16.0 ±0.12 Expt. terminated as 
animals were sleeping 
for more than 8h 
455 ±1.37 
185.26 ±2.49
Significance
3
4
5
6 
7
2
3
6
12
24
48
72
96
17.0 ±0.46
15.25 ±0.07
15.75 ±0.32
14.5 ±0.08
15.75 ±0.11
15.5 ±0.08
13.25 ±0.30
15.0 ±0.24
75.75 ±0.49
64.0 ±0.54 
33.5±0.14
16.0 ±0.12 
14.25 ±0.22
15.0 ±0.62
P <0.001 
P <0.001 
P <0.001 
P <0.001 
P <0.001 
N.S. 
N.S. 
N.S.
8
9
10
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Fig. 1. Dixon plots showing competitive inhibition of hepatic microsomal mixed-function 
oxidases by ethoxyquin
(a) Biphenyl 4-hydroxylase activity (jumol/h per g of liver) was assayed by the method of 
Creaven et al. (1965) at substrate concentrations of 0.6 mM ( • )  and 1,2mM (o) and ethoxy­
quin concentrations of 10 to 60/*m. (b) Ethylmorphine iV-demethylase activity (jumol/h 
per g of liver) was assayed by the method of Holtzman et al. (1968) at substrate concen­
trations of 2.08mM (©) and 4.17mM (o) and ethoxyquin concentrations of 11 to 66 [xm.
112 BIOCHEMICAL SOCIETY TRANSACTIONS
as a solution in aq. 65% ethanol to 2.5ml of microsomal suspension by using a split 
cuvette to allow for the absorption of ethoxyquin at these wavelengths. The microsomal 
suspension was prepared from the livers of weanling male Wistar rats which had been 
pretreated with three daily intraperitoneal doses of phenobarbital (sodium salt; 
lOOmg/kg).
The results of the hexobarbital sleeping-time shown in Table 1 clearly demonstrate 
potent inhibition of hexobarbital metabolism by ethoxyquin. When hexobarbital was 
administered 1 h after the ethoxyquin the sleeping-time was >8 h compared with 16 min in 
controls and after 24h the sleeping-time was still double that of controls. Recovery was 
not complete until 48 h after the dose of ethoxyquin, the time-course being consistent 
with the rapid metabolism and excretion of ethoxyquin reported by Wiss et al. (1962).
The results of the enzyme inhibition studies in vitro are shown as Dixon plots (Dixon, 
1953) in Fig. 1. The graphs are typical of competitive inhibition of both biphenyl 4- 
hydroxylase and ethylmorphine Ar-demethylase, the K t values being respectively 
4.3 x 10~6m and 6 x 10-6m; ethoxyquin is thus a very powerful inhibitor of these enzyme 
activities.
From a double-reciprocal plot of the results obtained over a range of substrate con­
centrations in the absence of inhibitor, the Km for biphenyl and for ethylmorphine was 
calculated, giving values of 3.2x10~4m and 2.2x10~4m respectively. These values 
correlated well with the theoretical values calculated from the Dixon plots by using the 
formula —Kt (s/Km+ l)  =  —x, where x is the intersection on the abscissa.
When added to microsomal suspensions, ethoxyquin exhibited a type I  difference 
spectrum with a peak at 385 nm and a trough at 420-422nm. The magnitude of the dif­
ference (AE) between the absorbance at 385 nm and at 420nm varied with ethoxyquin 
concentration and was taken to represent the extent of binding to cytochrome P-450. By 
using a double-reciprocal plot of AE against ethoxyquin concentration and extrapolating 
to the abscissa the spectral binding constant (Ks) was determined and found to have a 
value of 1.06x10_5m, indicating that ethoxyquin binds to cytochrome P-450 with a 
high affinity.
The induction of hepatic mixed-function oxidase previously reported with ethoxyquin 
therefore appears to arise from the increased metabolic requirement in the presence of 
this potent high-affinity inhibitor. It  is still not clear, however, why dietary ethoxyquin 
caused an increase in the specific activity of biphenyl 4-hydroxylase but not of ethyl­
morphine A-demethylase (Parke et al., 1972) since both enzyme activities are similarly 
inhibited.
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Creaven, P. J., Parke, D. V. & Williams, R. T. (1965) Biochem. J. 9 6 ,  879-885 
Dixon, M. (1953) Biochem. J. 55, 170-171
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The Relationship Between Development of Tolerance to Amphetamine 
and its Effect on Liver Microsomal Protein Synthesis
S. MAGOUR, W. CHRIST, H . COPER and CH. FAHNDRICH
Institute o f Neuropsychopharmacology, Free University, Berlin 19, Ulmenallee 30, 
Germany
Chronic treatment with amphetamine develops tolerance to some of its central effects in 
rats (for review see Kosman & Unna, 1968; Kalant et al., 1971).
We made rats tolerant to D-amphetamine by giving them increasing concentrations of 
the drug in drinking water ad libitum for 90 days. The concentrations of the drug were
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Comparative Biology of Ageing
[Abridged]
Dr R Walker, M r A Rahim and Professor D V Parke
{Biochemistry Department,
University o f Surrey, Guildford, Surrey)
The Effects of Antioxidants on Enzyme 
Induction in Developing and Ageing Rats 
Several antioxidants have been shown to prolong 
the lifespan of experimental animals when 
administered at high dietary dose levels. These 
include butylated hydroxytoluene (BHT) (Har­
man 1968), nordihydroguaiaretic acid (NDGA) 
(Buu-Hoi & Ratsimamanga 1959) and ethoxyquin 
(Comfort et al. 1971). Comfort et al. (1971) 
suggested that the observed prolongevity may be 
related to the ability of these compounds to induce 
the activity of hepatic enzymes responsible for 
detoxication of anutrients.
We have examined the effects of NDGA and 
ethoxyquin on some hepatic microsomal enzymes 
during 60 days of post-weaning development in 
the rat and, in a long-term study with ethoxyquin 
up to 455 days of age, we have investigated how 
these basal enzyme levels and the capacity to 
induce them change with age. As induction 
involved both liver enlargement and increase in 
enzyme concentrations, results were calculated 
relative to body weight.
In control rats the relative liver weight in­
creased on weaning, reaching a peak at 40-50 
days of age and then declining to below neonatal 
levels by 440 days. Hepatic microsomal protein 
and cytochromes P-450 and b5 also reached a 
maximum, relative to body weight, at 40-50 days, 
falling to mature levels intermediate between 
those at weaning and the maximum. There was 
subsequently little change in these parameters 
between 80 and 440 days. In  contrast, the relative 
activities of the enzymes biphenyl-4-hydroxylase 
and ethylmorphine-N-demethylase declined 
steadily with age after, a post-weaning peak, the 
former falling to one-quarter its maximal value 
by the 80th day and one-sixth by the 440th day. 
The decline was due to a fall both in relative liver 
weight and in specific enzyme activity.
In  test animals receiving dietary levels of 0.5 % 
antioxidant from weaning at 21 days for a further 
60 days, both NDG A and ethoxyquin caused an 
increase in relative liver weight, in the amount of 
microsomal protein, cytochromes P-450 and b6, 
and in the activity of biphenyl-4-hydroxylase, 
with ethoxyquin having a more marked and rapid
effect than NDGA. The specific activity of ethyl­
morphine-N-demethylase was not significantly 
increased but, due to the increase in relative liver 
weight, the total activity was elevated. The peak 
of induction occurred at a similar time to the 
peak in basal enzyme levels and as basal activity 
fell with age, so did the capacity for induction. 
During the period from 81 to 440 days, the 
microsomal protein remained at about double the 
control level while in contrast the induced levels 
of cytochromes P-450 and b5 continued to fall, 
the decline being most marked with cytochrome 
P-450. Induced levels of biphenyl-4-hydroxylase 
and ethylmorphine-N-demethylase also fell slowly 
over this period and in the former case the induced 
activity was still lower than that observed in 
untreated weanlings.
The extent of induction at 455 days of age was 
similar in animals exposed to ethoxyquin from 
40 days and 365 days of age, and there seemed no 
advantage in prolonged exposure as far as induc­
tion of these enzymes was concerned.
It appears that induction of microsomal protein 
synthesis remains undiminished with age after 
reaching maturity but the ability to induce cyto­
chromes P-450 and b5 is impaired. The basal level 
of and ability to induce biphenyl-4-hydroxyIase 
activity were very age dependent, the particularly 
rapid fall on maturation possibly being due to the 
production of an endogenous inhibitor.
n-Propyl gallate, an antioxidant which does not 
prolong lifespan, did not induce hepatic drug 
metabolizing enzyme activity.
The fact that both the life-prolonging anti­
oxidants studied are potent hepatic microsomal 
enzyme inducers, while n-propyl gallate is not, 
supports the suggestion (Comfort et al. 1971) that 
prolongevity relates to the increased ability to 
detoxicate environmental chemicals. The dramatic 
fall in the activity and inducibility of the drug- 
metabolizing enzymes with age underlines the fact 
that the toxicity of a drug may increase with age 
with obvious consequences. in geriatric chemo­
therapy. ,
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presence of the living adult worms which induces 
this immunity, but it is the younger stages of a 
challenge infection which are killed in an immune 
host (Smithers & Terry 1967).
The interesting feature about this immunity is 
that, although the monkey and the mouse resist 
reinfection with cercarias, the adult worms from 
the primary infection continue to live unharmed 
by the immunity they have induced. We have 
called this situation concomitant immunity. It  is 
a term borrowed from tumour immunology, 
where the host animal with a particular tumour 
becomes resistant to further grafts of the same 
cell line, but does not succeed in destroying the 
primary tumour. By analogy, experimental ani­
mals can resist further challenge with schisto­
somes but cannot destroy their initial infection 
(Smithers & Terry 1969).
The development of a technique which permits 
the surgical transfer of S. mansoni adults from 
one host directly into the mesenteric veins of a 
monkey, has uncovered a probable mechanism of 
concomitant immunity. Adult worms recovered 
from mice survive well when transferred into 
rhesus monkeys; if the monkeys are first immu­
nized against mouse red blood cells, however, 
then worms from mice are rapidly destroyed. The 
effect of immunizing monkeys against mouse red 
cells is specific to ‘mouse’ worms; worms from 
other hosts survive normally on transfer into 
‘anti-mouse’ monkeys. It  has been shown that the 
killing of ‘mouse’ worms by anti-mouse monkeys 
is dependent on antibodies which are directed 
against sites on the worms’ surface. This has 
suggested that molecules of host origin (or host 
antigens) become incorporated into the surface of 
the worm (Smithers et al. 1969).
Similar results were obtained when young 
schistosomes were cultured in human blood for 
14 days and transferred into monkeys immunized 
against human red blood cells. In  this experiment 
worms grown in blood of type A were mostly 
destroyed on transfer into monkeys immunized 
against B cells and vice versa; but a greater 
percentage of worms were killed on transfer when 
they were cultured with the same type of cell used 
to immunize the recipient monkey (Clegg et al. 
1971). In  a second experiment, worms grown in 
A type blood were almost totally destroyed after 
transfer into monkeys immunized against pure A  
blood group substance, although worms grown in 
B blood survived in anti-A monkeys.
These experiments show that schistosomes can 
acquire host antigens in culture and that these 
antigens are related to the blood group substances 
and are possibly glycolipid or glycoprotein in 
nature.
We have suggested that the incorporation of 
host antigen serves to protect the worms from the
host’s immune response by masking in some 
manner susceptible parasite antigens on the sur­
face membrane. In  this way the immune reaction 
would be blocked by a molecule to which the host 
would be immunologically unresponsive. Young 
developing schistosomes which had no time to 
adopt this disguise would be vulnerable to the 
immune attack; older worms which had time to 
incorporate host antigen would be protected. This 
would explain the evasion of the host’s immunity 
by the adult worm and the mechanism of con­
comitant immunity.
Evidence of the protective function of host 
antigen has come from in vitro studies. Young 
schistosomes grow and develop well in serum 
from normal rhesus monkeys, but serum from 
monkeys immune to S. mansoni contains an anti­
body of the IgG class which, in the presence of 
complement, kills all young worms cultured in its 
presence. The damage of young schistosomes by 
immune rhesus monkey serum fits the concept of 
concomitant immunity, but a more important 
requirement of the idea is that older schistosomes 
should become insusceptible to the immune 
reaction.
This is exactly what happens in vitro. When 
young worms are cultured in normal serum for a 
few days before transfer into immune serum, they 
lose their susceptibility to the lethal antibody. 
Similarly, young schistosomes recovered from the 
lungs of mice 4 days after infection are completely 
insusceptible to the effects of immune serum 
(Clegg & Smithers 1972).
Recently it has been shown that protection in 
vitro can be accelerated in the presence of red 
blood cells. Glycolipids extracted from red cell 
membranes gave a similar protective effect. It  
appears, therefore, that protection against anti­
body in vitro is due to the presence of molecules 
similar to the host antigens which have been 
demonstrated on the worm’s surface.
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Effects of Ethoxyquin on Hepatic Microsomal 
Enzymes
B y D e n n is  V. P a r k e , A b d u r  R ah im  an d  R o n a l d  
W a l k er  (Department o f Biochemistry, University of 
Surrey, Guildford, Surrey, U.K.)
Ethoxyquin (6-ethoxy-l ,2-dihydro-2,2,4-trimethyl- 
quinoline) is an antioxidant permitted for limited use 
in foods in the U .K . Claims have been made that 
ethoxyquin improved survival rates in mice (Harman, 
1968; Comfort et al., 1971), and it was postulated that 
this could have been partly due to calorie restriction or 
induction of the hepatic enzyme systems (e.g. see 
Ross, 1969). Paired-feeding studies have been carried 
out with male Wistar rats and some hepatic enzyme 
activities measured.
Three groups of rats were caged singly and main­
tained on a commercial powdered diet containing 
2.5% (w/w) antioxidant-free groundnut oil. In the 
diet of one group ethoxyquin was incorporated at a 
concentration of 0.5 % (w/w). This test group and one 
control group were fed ad libitum, and the third group 
were paired-fed with an equal amount of food to that 
consumed by the test group. Food intakes and body 
weights were monitored daily
Four animals from each group were killed after 0, 
3, 7, 14, 30 and 60 days and liver homogenates were 
prepared. Microsomal protein (Lowry et al., 1951), 
cytochrome P-450 (Sladek & Mannering, 1966) and 
cytochrome bs (Schenkman et al., 1967) concentra­
tions and biphenyl 4-hydroxylase (Creaven et al., 
1965) and ethylmorphine A-demethylase (Holtzman 
et al., 1968) activities were determined on these 
homogenates.
Food intake was decreased in the test group by 
6% over the 60-day period relative to controls fed 
ad libitum and growth rate was consequently de­
pressed, but the difference in body weight was not 
statistically significant by the end of this period.
By the 14th. day ethoxyquin caused a 50 % increase 
in relative liver weight that was maintained thereafter 
for the whole 60-day period. Concentrations of 
hepatic microsomal protein, cytochrome P-450 and
cytochrome bs were all markedly induced (85-100%  
by the 14th day), and the cytochrome concentrations 
remained at this elevated value throughout. Biphenyl
4-hydroxylase activity was increased nearly threefold 
in test rats by the 7th day and remained at more 
than twice control values for the remaining period, 
but there was no evidence for induction or inhibition 
of ethylmorphine TV-demethylase. By comparison 
with paired-fed controls it was seen that the hepato­
megaly, increased microsomal protein and elevated 
enzyme activities were not a consequence of calorie 
restriction.
Similar experiments carried out with «-propyl 
gallate did not result in any of the effects observed with 
ethoxyquin, possibly because hydrolysis occurred 
before absorption and the hydrolysis products would 
not be expected to be substrates for the microsomal 
enzymes.
The antioxidant butylated hydroxytoluene (2,6-di- 
t-butyl-4-methylphenol) is also a powerful inducer of 
hepatic microsomal enzymes (Gilbert &  Golberg, 
1965) and has increased life-span in mice (Harman, 
1968), but these effects have not been reported for 
/z-propyl gallate. The prolongevity produced by 
butylated hydroxytoluene and ethoxyquin may thus 
depend on their being enzyme inducers, and further 
work is in progress with other antioxidants to clarify 
this.
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